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Titre : Modifications structurales, coordination de métaux et auto-
assemblage de foldamères d’oligoquinolines carboxamides 
Résumé : Les foldamères d’oligoquinoline carboxamide forment des structures hélicoïdales en 
solution et dans le solide. Ces structures sont stabilisées par liaisons hydrogène, empilement 
aromatique et interactions électrostatiques. Dans une première partie de ce manuscrit, les fonctions 
amide connectant les unités quinolines ont été substituées par des fonctions vinylène, isostères de 
celles-ci. Ces composés quinolynènes-vinylènes, seuls, forment principalement des structures 
étendues en solution. Toutefois lorsque ces nouvelles unités sont en faible proportion au sein de 
l’oligomères contenant principalement de connections amides, des architectures hélicoïdales ont pu 
être obtenues. Dans une seconde partie, des ions Cu (II) ont été introduits au centre des hélices 
d’oligoquinoline carboxamide. Ces ions sont liés aux atomes d’azote des quinolines, et à ceux des 
fonctions amides après leur déprotonation. Une organisation linéaire de ces ions a été observée dans 
le solide. L’auto-assemblage d’hélices, en faisceaux, par empilement aromatique d’unités acridines 
portées par les chaines latérales a été entrepris dans une troisième partie de ce manuscrit. De faibles 
associations ont pu être mises en évidence en solution. Dans le solide ces interactions, bien que 
faibles, ont permis le contrôle de l’organisation des hélices dans le cristal. Dans une dernière partie de 
ce manuscrit, la coordination de métaux a été utilisée afin de permettre l’assemblage d’hélices 
d’oligoquinoline carboxamide. Des ligands acridine et pyridine ont été fixés sur la périphérie de l’hélice 
de façon à permettre la coordination par des métaux de transition tel que le palladium (II). Ces 
assemblages d’hélices induits par le palladium, ont été caractérisés par RMN en solution et par 
diffraction des rayons X dans le solide. 
Mots clés : Foldamères, Isostères, Auto-organisation, Chimie supramoléculaire, Coordination 
de métal, Diffraction des rayons X, RMN 
 
Title : Structural modifications, metal coordination and self-
assembly of quinoline oligoamide foldamers 
Abstract : Oligo-quinolinecarboxamide foldamers form stable helical structures in solution and 
in the solid state. These helices are stabilized by hydrogen bonds, π-π stacking and electrostatic 
interactions. In a first part of this manuscript, vinyl functions have been introduced as isosteres of 
amides. The resulting quinolylene-vinylene oligomers form mainly extended structures in solution. 
Helical folded conformations can nevertheless be stabilized by attaching two segments of oligoamides 
at both ends of an oligoquinolylene-vinylene. In a second part, copper (II) ions have been loaded into 
the single helices of quinolinecarboxamide foldamers. The copper (II) ions coordinate the nitrogen 
atoms of the quinoline units and also deprotonated amide nitrogen atoms. A one dimensional 
alignment of the copper (II) ions was observed in the solid state. In a third part, acridine functionalized 
foldamers were prepared in order to test their self-assembly into bundles through interactions between 
aromatic functions at the exterior of helices. Associations of the acridine functionalized oligoamides 
are weak in organic solution. In contrast, in the solid state, interactions between helices are mainly 
governed by acridine units. In a fourth part, metal coordination has been used to promote helix-helix 
assembly of quinoline oligoamides foldamers. Acridine and pyridine rings have been attached on the 
side chains of these oligomers to allow coordination with metals, palladium (II) in this case. The helix-
helix assembly of quinoline oligoamides by palladium coordination has been confirmed by NMR and x-
ray diffraction. 
Keywords : Foldamers, Isosteres, Self-assembly, Supramolecular Chemistry, Metal 
Coordination, X-ray Diffraction, MNR 
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General Introduction 
Proteins rely on their particular structures, not only the primary compositions but also 
sophisticated higher order structures, to perform the functions they carry out. Helices, strands 
and turns are major secondary structural motifs found in proteins. Tertiary and quaternary 
structures are assembled from those secondary structural motifs through either covalent or 
non-covalent linkages. The stability of those structures depends on their primary chemical 
sequences and environments. Synthetic compounds that form structures akin to those found in 
proteins are interesting not only to expand the tool-box to create various types of structures 
but also to enable new possibilities towards useful functions. Foldamer chemistry is such a 
branch of science that investigates the structures of synthetic oligomers. 
Over the past few decades, numerous synthetic oligomers have been found to adopt 
folded conformations in solution and also in solid state. Those oligomers include derivatives 
from natural building blocks and completely artificial blocks. Structures motifs such as 
helices, sheets have been found in those oligomers. Tertiary and quaternary structures have 
also been created. The developments in foldamers have already enabled structural based 
design to achieve certain functions such as iterative evolution towards selective sugar binding.  
In the Huc group, aromatic oligoamide-based foldamers have been constantly pursued. 
Various monomers of different covertures and diameters have been developed which allow 
structural evolution of foldamers. Both side chains and main chain can be tuned for the 
purpose needed. Hydrophobic, hydrophilic, anionic or cationic side chains are all subjected of 
choices. Diameter and shapes of the foldamers are modulated by the selection of monomers. 
Depending on the monomers used, single, double or even quadruple helix can be formed. 
Assemblies of helical foldamers either by covalent bonding or non-covalent interactions have 
been demonstrated. Developments towards functions such as mediation of electron transport 
between electron donor and electron acceptor have been demonstrated. 
In this thesis, modifications of quinoline oligoamide foldamers towards creating new 
modes of foldamers and side chain functionalization towards foldamer assemblies have been 
X 
 
described. This thesis is written as following 5 chapters. 
Chapter 1 is a short review about foldamers with special attention paid to recent 
developments towards application in materials and so on. Applications of foldamers as 
electron transport mediator, self-assembly materials, artificial channels, catalysts, guest 
recognition and circular polarized luminescence have been surveyed. This short review serves 
to provide a general background towards materials-oriented applications of foldamers. 
Chapter 2 discusses vinylene double bond isosteres of quinoline oligoamide foldamers. 
Oligomers of quinolylene-vinylene alone do not show strong propensity to form helical 
folded structures in organic solution. The helical folded conformation, however, can be 
stabilized by attachment of two segments of oligoamides at both ends.  
Chapter 3 shows copper ions can be loaded into single helical quinoline oligoamides. A 
series of oligomers loaded with copper (II) ions have been synthetized. The copper ions 
coordinate with nitrogen atoms inside the helices and small structural variations observed. 
Chapter 4 discusses the self-organization of acridine functionalized quinoline oligoamide 
foldamers. Acridine was introduced as side chains which enable π-π interactions between 
them. The interactions between acridines allowed association of helical foldamers in the solid 
state. The packing of helices in the solid was strongly guided by acridine units. 
Chapter 5 discusses the self-assembly of helical foldamers through metal coordination. 
Acridine and pyridine units are introduced on the side chains. Upon complexation with 
palladium (II) ions, helix-helix assemblies have been demonstrated. Due to handedness of the 
helices and relative orientation of the helices, four possible stereoisomers are observed. By 
introducing C2 axis into the helices or fixation of the handedness, the possibilities of 
stereoisomers are reduced. 
 
NB: Each chapter constitutes a distinct scientific topic which can be considered individually. 
Therefore, this thesis was written as chapters that can be potentially developed into scientific 
publications. The numbering of sections, figures and references is also restarted in each 
chapter.  
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I Recent Developments of Foldamers towards Applications 
1.1 Introduction 
Foldamer was defined by J. S. Moore as any oligomer that folds into a conformationally 
ordered state in solution and the structures of which are stabilized by a collection of 
noncovalent interactions between nonadjacent monomer units.
1
 This definition of foldamer 
emphasizes several aspects about foldamer: 1) foldamer is a chain molecule of several 
repeating monomers; 2) the ability to fold which implies the conformational dynamics; 3) a 
small set of conformations has much lower energy than any other reachable conformations; 4) 
noncovalent interactions are important factors to stabilize the folded conformation and 5) the 
folded conformation is preserved in solution. Although this definition of foldamers limits the 
scope to oligomers, helical polymers which have helical structures are considered as a class of 
foldamers under a broader view point.
2
 Another definition of foldamer was given by S. 
Gellman as any polymer with a strong tendency to adopt a specific compact conformation.
3
 
This definition includes polymers as foldamers and uses the conformations preferences as 
main factors to classify a compound as a foldamer or not. As both definitions pointed out, 
foldamers concern with the structures/conformations and the interactions involved.  
Foldamers are considered to be at the interface of covalent and noncovalent chemistry 
where synthetic efforts to bring the chain molecules and careful control of a collection of 
intra/intermolecular interactions to bring the folded conformations joint together. Noncovalent 
interactions such as hydrogen bonds, van der Waals interactions (such as dipole-dipole 
interactions), electrostatic forces, and π-π stacking work synergistically to drive the folding. 
Solvophobic effect, hydrophobic effect in particular, is also an important factor involved in 
the folding. Metal coordination is also used as stabilizing force of foldamers.  
Foldamer is inspired by the naturally occurring higher order structures such as helices, 
sheets and turns found in proteins and nucleic acids. As mimics of peptide structures, 
peptidomimetics constitute a large family of foldamers. This type of foldamers includes 
α-peptide, β-peptide, γ-peptide and δ-peptide. Peptoids, azapeptides, azatides, vinylogous 
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peptides also fall into this category. These foldamers are largely based on the modification of 
bio-macromolecules or derived from biological systems which also called “top-down” 
approach of foldamer design. Another family of foldamers is called abiotic foldamers which 
is based on the “bottom-up” design strategy in which arylamide, oligohydrazide, phenylene 
ethynylene are included. A simple classification of foldamers into aliphatic and aromatic can 
be drawn based on aromatic units used or not in the backbone.
4
 Foldamers based on 
“top-down” approach fall often into the aliphatic class where a large number of “bottom-up” 
designed foldamers belong to aromatic category.  
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Figure 1-1: Examples of repeating units of aliphatic and aromatic foldamers. 
 
Design, identification and characterization of chain molecules that fold into specific 
compact structures in solution are central parts of foldamer chemistry. During the past 
decades, many synthetic oligomers have been found to adopt folded structures akin to the 
secondary structures of proteins. Tertiary and quaternary folds of oligomers were also 
developed.
5,6
 The vast knowledge accumulated along the path certainly advances the field 
further. Foldamers with more and more complexed structures have been successfully prepared 
and applications of foldamers attract more and more attentions. Here, recent progress of the 
foldamers will be described and the applications of foldamers especially applications towards 
materials will be stressed. 
 
1.2 Electron transfer across foldamer bridge 
Photosynthesis which converts solar energy into chemical energy is the essential source 
of the energy flowed through biological systems. During photosynthesis, the solar energy 
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absorbed by chromophores (antenna chlorophylls in photosystem II for instance) in 
photosynthesis systems is transferred to the reaction center which catalyzes the splitting of 
water to convert the solar energy to chemical energy and finally stored as carbohydrates.
7,8
 
The success of this process relies on the long range electron transfer in proteins after photo 
excitation and charge separation. The detailed mechanism of how electron transport in 
proteins attracts great attentions due to its importance. Chemical mimics of that process have 
also been extensively made to study the electron transfer in order to accomplish artificial 
photosynthesis for the production of renewable energy from solar energy. 
 
Figure 1-2: a) Crystal structure of photosynthesis system II
9
 and b) Spatial arrangements of 
photosynthesis systems within the thylakoid membrane
10
. 
 
Usually, the molecular system that mimics the charge separation and electron transport in 
photosynthesis comprises electron donor, acceptor and bridge known as 
donor-bridge-acceptor (D-B-A) dyad. The bridge serves dual role as structural motif to 
organize the chromophores at well-defined distances and orientations, and as a medium to 
modulate the electron transfer. The electron transfer rate (𝑘𝑒𝑡) is empirically considered to 
decay exponentially with distance (𝑟).11 
𝑘𝑒𝑡 = exp⁡(−2𝛽𝑟) 
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Where 𝛽 is the attenuation coefficient. The value of attenuation coefficient can be varied 
depending on the chemical nature of the spacer, such as for proteins (1.0-1.4 Å
-1
), saturated 
hydrocarbons (0.8-1.0 Å
-1
), DNA (0.2-1.4 Å
-1
) and unsaturated phenylene, polyyne, polyene 
(0.2-0.6 Å
-1
).
12
 The dependence of electron transfer rate on the free energy (∆𝐺𝐸𝑇
0 ), the 
reorganization energy (𝜆), and the electronic coupling (𝐻𝐷𝐴) can be expressed as:
11,13
 
𝜅𝑒𝑡 = √
𝜋
ℏ2𝜆𝜅𝐵𝑇
𝐻𝐷𝐴
2 exp⁡(−
(𝜆 + ∆𝐺𝐸𝑇
0 )2
4𝜆𝜅𝐵𝑇
) 
The magnitude of electronic coupling between donor and acceptor decreases exponentially 
with the distance which results the exponentially dependence of the electron transfer rate on 
the distance.  
 
Figure 1-3: a) Cartoon representation of electron transfer between Donor-Bridge-Acceptor system; b) 
Bell-shaped electron transfer rate dependence on reaction free energy (∆𝐺0). 
 
The electron transfer can occur through electron-exchange known as superexchange 
which is directly relates to the orbital overlap and the energy gap or through 
oxidation/reduction states involving the bridge known as hopping. The electron transfer 
through superexchange becomes less important at long distances due to the exponentially 
dependence on the distance. However, the overall electron transfer rate is not necessary 
monotonously depending on the free energy as predicted by Marcus theory that inverted 
region exists (Fig. 1-3b).
13,14
 The electron transfer through hopping mechanism is less 
distance dependent and more effective at long distance. 
In the past, many artificial molecular systems
11,15,16
 and natural biomolecules such as 
proteins
17,18
 and DNA
19-22
 have been studied in order to understand the mechanisms and 
dependences of the electron transfer rates. For example, the electron transfer through DNA 
was found to occur through superexchange or hopping mechanisms depending on the 
energetics of the D-B-A dyad. The superexchange mechanism was only found to occur at 
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short donor-acceptor distances and at longer distances, hopping mechanism was found to be 
the major electron transfer process in the Adenine-Thymine (A-T) base pair hairpin motif.
22
 
Guanine (G) has the lowest ionization potential among four DNA bases (Adenine, Thymine, 
Guanine and Cytosine) which makes it the major target during oxidation damage of DNA 
under oxidative stress and UV irradiation. It was found that electron transfer can occur 
effectively between the oxidized guanine (guanine radical cation G
+·
in this case) and guanine 
rich sequence (GGG for example) at long distance through hopping mechanism where 
guanines located in between serve as mediation spot.
20
 
 
Figure 1-4: a) Stilbene inked A-T hairpin structure motif
22
; b) Electron transfer between oxidized G 
(G
+·
) and G rich sequence in DNA
20
. 
 
The electron transport across quinoline-carboxamide oligomers bridged donor-acceptor 
dyads was found to be through superexchange mechanism for the short oligomers (oligomers 
length less than 5 units) but are dominated by hopping mechanism for the oligomers longer 
than nine by using perylene bis-imide (PB) as acceptor and oligophenylene-vinylene (OPV) 
as donor.
23,24
 It has been found that even if the conjugation through different monomers are 
relatively weak, the quinoline-carboxamide bridge can mediate very well the electron 
transport. In a serie of short oligomers, relatively low attenuation coefficient (𝛽 = 0.05 Å-1) 
has been found
23
 and for the long oligomers, subnano and nanosecond charge separation as 
well as long distance over 306 Å charge separation has been found.
24
 The electron transfer 
through quinoline-carboxamide oligomer bridge can be described as a hole injection into the 
bridge shortly after photoexcitation of PB, the hole hopes along the bridge and is finally 
trapped by OPV. The charge separated state was found to be very long lived (𝜏 > 80⁡𝜇𝑠) as 
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well as the very long life time of charge recombination of triplet state of PB (𝜏 > 80⁡𝜇𝑠) has 
been found.
24
 In the short oligomers, there are two factors varying between the donor and 
acceptor: distance and orientation. In the longer oligomers, since the oligomers were chosen 
to have multiple five units’ differences, the orientation of the donor and acceptor was fixed 
and the only variable was the distance between them. 
 
Figure 1-5: a) Photo-electron transfer using short oligo-quinolinecarboxamides bridges and b) chemical 
design of photo-electron transfer with long oligo-quinolinecarboxamide bridges.  
 
Direct measurement of electron transfer across oligo-quinolinecarboxamide foldamers 
was realized using conductive atomic force microscopy (C-AFM).
25
 Conductive AFM is a 
technique that is able to measure very small current across a small collection of molecules in 
contact with the AFM tips. In order to employ this technique, mono-layers of foldamers 
functionalized with thiol (Fig. 1-6a) were prepared on gold surface. The conductance 
measured showed increasing resistance with the length of foldamers. The factor of length 
dependent resistance was found to be small (𝛽 = 0.06 ± 0.015⁡Å−1) (Fig. 1-6c) which was in 
accordance with hopping mechanism of the electron transfer across 
oligo-quinolinecarboxamides foldamers. Molecular models revealed that the charge transfer 
through the foldamers backbone occurred through multiple pathways where through space 
coupling played more important role than through bond coupling. The horizontal charge 
transfer through the self-assembled monolayer was not effective and was found to be almost 
completely insulating. 
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Figure 1-6: a) chemical structures of thiol functionalized oligo-quinolinecarboxamides; b) carton 
representation of MOM junction prepared using conductive AFM; c) molecular length dependence of 
vertical resistance (Ω) of Q9-Q33. 
 
The conductance through other types of foldamers was also measured with C-AFM 
technique. The electron transfer across oligourea foldamer was investigated using the same 
method.
26
 The oligourea foldamers adopt a 2.5-helix structure as indicated by circular 
dichroism in solution. Electron transfer across oligourea foldamers showed similar small 
length depended transfer rate. The distance decay constant (𝛽) is 0.92-0.95 nm-1 which 
indicates electron transport through oligourea via hopping mechanism. Rectification effect, 
which is the dependence of the electron transfer on the direction of the electron flow in the 
helix, was observed in oligourea foldamers. Rectification effect normally associates with 
permanent dipole moment aligned along the direction of electron transfer, i.e. long axis of the 
helix foldamer. The residue dipole moment of a urea is ~4.7-4.9 D which is bigger than the 
amide in peptides (~3.5 D). The bigger residue dipole moment is probably the origin of 
rectification effect observed.  
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Figure 1-7: a) Chemical structures of thiol functionalized oligourea foldamers; b) cartoon 
representation of conductivity measurement with C-AFM; c) rectification effect of conductivity 
through oligourea foldamers. 
 
The effect of copper ion complexation on the conductivity of self-assembled monolayer 
of tripeptide Gly-Gly-His (glysine-glysine-histidine) was found to be dependent on the 
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density of the monolayer used.
27
 The conductivity of high density monolayer decreased after 
complexation with copper ions. On the other hand, the conductivity of low density monolayer 
increased after copper binding. The observation of two different trends was explained by the 
different conformation changes after copper binding. In the case of high density monolayer, 
little space was left for any substantial conformational changes of the Gly-Gly-His tripeptide 
and an insulating layer was formed after binding with copper ions. The formation of this 
insulating layer caused the decrease of conductivity. On the other hand, the low density 
monolayer has enough space to allow conformational changes of the tripeptide. The tripeptide 
in the monolayer changes its conformation to wrap around the copper ion after complexation 
which changes the work function and increased the conductivity of the monolayer.  
 
Figure 1-8: The representation of high and low density monolayer of tripeptide Gly-Gly-His and the 
different conformational changes after complexation with copper ions. 
 
Chirality dependent electron transfer was observed in D/L-12mer peptide 
Cya-[(D/L-Ala)3-Aib]3-(D/L-Ala)2 (Cya = cysteamine; Ala = alanine and Aib = 
aminoisobutyric acid).
28
 Ferrocene was attached at the N-terminus of the peptide as an 
electron donor or acceptor depending on the potential applied. When a magnetic field was 
applied to the self-assembled monolayer of D/L peptide on gold, opposite dependence of the 
conductivity on the magnetic field was observed. For the D-peptide, the conductivity is about 
four times smaller when the magnetic field is up than the magnetic field is down. While for 
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the L-peptide, it is the opposite. The observation of the magnetic dependence on the rate of 
electron transfer was explained by the magnetization of the system and the spin selective 
electron transfer through the chiral peptide. The magnetization of the system was confirmed 
by a ferromagnetic response of the SAM on gold. The spin dependent electron transfer of a 
chiral molecule is called chiral induced spin selectivity (CISS)
29
 which allows the electron 
with preferred spin to be transferred faster while the electron with opposite spin is transferred 
slower. In this system, both the magnetic moment of the gold substrate and the ferrocene are 
parallel to the molecule axis and therefore the electron injected into the peptide has the spin 
orients to the same direction. Because of the CISS effect, the L-peptide prefers the electron to 
be transfer through one direction while the D-peptide prefers the opposite direction.  
 
Figure 1-9: Cartoon representation of the asymmetric electron transfer of chiral peptides when 
magnetic field is applied. The gold is magnetized by the magnetic field which caused the electron with 
one spin is injected preferentially to the molecule than with the other spin. A) In the case of 
L-oligopeptide (right handed helix) the electron injected from the gold has a spin aligned parallel to the 
electron’s velocity, which is the preferred spin for the electron transfer. As a result, the electron transfer 
in this direction (reduction process) is faster than backward. B) In the case of D-oligopeptide (left 
handed helix), the preferred spin orientation is antiparallel to the electron’s velocity; therefore the 
preferred rate is for the oxidation process. 
 
1.3 Self-assembled nano/macro-materials 
1.3.1 Organization in the solid (bulk) 
Virus usually has a shell formed by tightly assembled proteins at the surface which served 
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as protection for the inner nucleic acids. Tobacco mosaic virus, for instance, has a rod like 
appearance with a capsid made by self-assembly of 2130 copies of proteins. The proteins of 
the capsid form a helical rod which wrap around the nucleic acid inside.
30
 Inspired by the 
fascinating nano-structures/materials formed by self-assembly of proteins, it is interesting to 
use self-assembly of proteins/peptides or foldamers to obtain novel nanomaterials. The 
self-assembly of foldamers to form various types of architectures has been extensively studied 
by Hee-Seung Lee and co-workers that they named foldectures.
31
 Different shapes of 
nano/micro-objects were obtained by self-assembly of foldamers. Windmill-shaped 
supramolecular architectures were formed by self-assembly of ACPC7 (ACPC = 
trans-(S,S)-2-aminocyclopentanecarboxylic acid) heptameric foldamer in distilled water alone. 
And the shape can be tuned by addition of a nonionic surfactant P123 (Pluronic P123, 
(ethylene glycol)20-(propylene glycol)70-(ethylene glycol)20). The size distribution of the 
formed structures was very narrow which is interesting for preparation of homogeneous 
nano/micro sized materials. Other foldamers such as BocNH-ACPC6-OBn (4),
32
 
BocNH-ACPC6-OH (5),
33
 BocNH-(Aib-ACPC)3-Aib-OBn (6),
34
 BocNH-(Aib-ACPC)3-OBn 
(7)
35
 and BocNH-ACPC6Leu2-OBn (8)
36
 were also found to form specific structures as 
showed in the bellow figure. Detailed analysis of the structures revealed the foldamers formed 
pseudo-continues packing along the long axis of the helix or formed zigzag alignment along 
the long axis. Noncovalent interactions between the helices allow the foldamers to align at the 
same plane in an antiparallel organization.  
 
Figure 1-10: Various microstructures formed by self-assembly of foldamers; a)-e) Chemical structures 
of the foldamers 4-8 and the SEM images of the structures formed.  
 
The nano/micro structures formed by self-assembly of foldamers were found to be able to 
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respond to magnetic field. Usually diamagnetic molecules do not show any effects under 
magnetic field due to thermal relaxation and random Brownian motion that cancelled the 
overall magnetic dipole. In order to observe magnetic effects of diamagnetic molecules, 
ordered alignments of the molecules are necessary to preserve the diamagnetic anisotropy of 
the materials. Peptide 9 (BocNH-ACPC6-OH) forms rhombic rods and peptide 10 
(BocNH-ACPC8-OBn) forms rectangular plates upon injection of the peptide solutions in 
THF into water containing surfactant P123. When static magnetic field was applied to the 
aqueous suspensions of these two foldectures, the alignments of the foldectures were 
observed. The longitudinal axis of rhombic rods of peptide 9 aligned parallel to the magnetic 
field (Fig. 1-11c) while the rectangular plates of peptide 10 aligned parallel to the magnetic 
field along their minor axes (Fig. 1-11d). The alignments of the foldectures were due to 
ordered organization of the diamagnetic dipole moment along the crystalline axes that the 
overall magnetic moment was not cancelled. Macroscopic movement was achieved also by 
incorporation of the foldectures into hydrogels as a potential application of those materials. 
 
Figure 1-11: a) Chemical structures of ACPC peptides 9 and 10; b) illustration of magnetic field 
directed alignments of foldectures; c) SEM images of rhombic rod foldectures deposited on Si 
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substrates under (left) in-plane magnetic field and (right) out-of-plane magnetic field; d) SEM images 
of rectangular plate foldectures deposited on Si substrates under (left) in-plane magnetic field and 
(right) out-of-plane magnetic field. Arrows and circles indicate direction of magnetic field. Scale bars, 
5 μm. 
 
1.3.2 Organization on surface 
A triaxial supramolecular weave was achieved by self-assembly of perylene-monoimide 
(PMI) functionalized oligoprolines reported by H. Wennemers and co-workers.
37
 
Oligoprolines forms a helical structure of three units per turn with a increment of 9 Å along 
the axis. Perylene-monoimide forms strong aggregates due to large flat aromatic surface 
which enables π-π interactions. The compound was designed to have the PMIs separated by 
seven monomers so that the two PMIs are on the same side of the helix of oligoproline. The 
distance between the PMIs is estimated to be 18 Å based on the helical structure of 
oligoproline. The self-assembly of this system occurred when water was added into the 
solution in THF. Highly ordered flat hexagonal structures were formed as observed by 
transmission electron microscopy (TEM) and atomic force microscopy (AFM). The diameters 
of the hexagonal structures exceed 1 μm and the heights exceed 100 nm. A regular mesh-like 
superstructure was observed under higher magnification TEM which has regular hexagonal 
holes with diameters around 3.0 nm. Detailed analysis of the self-assembled structures reveals 
that the molecules form head-to-tail π-stacking. It was found out that CH-π interaction in 
additional to the π-π interactions between the PMIs was important factor to form 60o 
intercalation of two strands of oligoprolines. Due to the weaving, the structures were quite 
robust as indicated by Young’s modulus (~1.7 Gpa was found).  
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Figure 1-12: a) Chemical structure of the perylene-monoimide functionalized oligoprolines and 
estimated molecular dimensions and expected mode of self-assembly; b) TEM image of the woven 
structure and superimposition of proposed molecular organization; c) carton representation of triaxial 
weave to form the hexagonal structures.  
 
1.4 Foldamer based artificial channels 
In nature, the maintenance of ions’ concentration inside cell is controlled by groups of 
membrane pore forming proteins which are able to selectively transport ions out or into the 
cells. These proteins usually have asymmetric structures with respect to the axis of cell 
membrane which is essential for governing the direction of ions transport. Inspired by the 
membrane protein channels as well as the need to develop membranes for practical 
applications such as seawater desalination, developing water channels and selective ions’ 
channels are interesting. Many foldamers have helical structure with an interior space 
stabilized by hydrogen bonds which makes them as suitable candidates of channel molecules. 
Zeng developed extensively oligo-pyridine carboxylic amides foldamers based water 
channels.
38
 In order to avoid labor consuming and low yield synthesis of long oligomers with 
length over 3.4 nm to across the membrane, “sticky-end” guided stacking of short helical 
foldamers to form long assembly of helix and to form channels was found to be useful.
39
 
Oligomer 11 formed nicely assembled 1D channel and a chain of water molecules were 
aligned inside the channel. Water transporting ability of this channel was supported by size 
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expansion of large unilamellar vesicles. Osmotic pressure created by pH gradient across the 
membrane allowed transportation of water though the channel. Alkali metal ions such as Na
+
 
and K
+
 were not transported which might be due to the channels diameter was only around 
2.8 Å and lack of interactions to free these ions from their hydration shells.  
 
Figure 1-13: a) Chemical structure of foldamer 12; b) H-bonded “sticky ends” of 12; c) crystal 
structure of 12 with water molecules encapsulated in the cavity; d) crystal structure of self-assembled 
channel of 12 and a chain of water molecules aligned inside the channel.  
 
Similar alignments of helical foldamers were also observed with 
Indolocarbazole-pyridine (IP) oligomers. These oligomers were also found to form channels 
with water molecules aligned inside the channels.
40
 The IP oligomers formed helical folded 
structure due to opposite dipoles of the neighboring units and π-stacking interactions. In the 
crystal structures of hexamer and heptamer, water molecules were found to be enclosed inside 
the channels of the helices. In the case of heptamer 14, the stacks of the helices were not 
aligned and offsets were observed between helices. The helices were packed by alternating P 
and M helices along the helix axis. An interesting observation was that the hexamer 13 
formed a pseudo-continuous helix by aligning one helix on top of another. The water 
molecules inside the helices were also aligned. The packing of the helices were continuous P 
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or M of each line of channel. The water or ions transportation performance of this channel 
was not reported.  
 
Figure 1-14: a) conformation preference of indolocarbazole−pyridine (IP) conjugates; b) chemical 
structures of indolocarbazole−pyridine (IP) oligomers 13 and 14; c) crystal structure of 13 and the 
channel stacking of single P or M helices in one line with water molecules aligned inside the channels; 
d) crystal structure of 14 and the channel stacking of alternating P/M helices with water molecules 
inside the helices. 
 
Helically folded polymers 15 and 16 were also found to form channels.
41
 The preparation 
of these polymers was achieved by post-cyclization of linear polymer precursors. Two 
polymers with estimated length of 13 and 30 units were tested. The diameter of the polymer 
channels was estimated to be 5.5 Å which was big enough for hydrated ions to pass through. 
The ion transport ability were about the same level following the Eisenman sequence III of 
the ions selectivity (Rb
+
>K
+
>Cs
+
>Na
+
>Li
+
). Another type of oligomers 17 and 18 were also 
reported to form channels by the same group.
42
 Oligomers 17 and 18 use pyridine instead of 
10-methyl-pyrido[3,2-g]quinoline in 15 and 16 as one of the repeating units. The ions 
selectivity of those oligomers was different to that of polymer 13 and 14. The following order 
Cs
+
~Rb
+
>K
+
>>Na
+
>Li
+
 of selectivity was found. It is worth mentioning that the selectivity of 
K
+
 over Na
+
 was high (up to 22.5).  
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Figure 1-15: Chemical structures of a) helical folded 15 and 16; b) oligomers 17 and 18. 
 
1.5 Foldamer catalyst 
Enzymes are a class of highly efficient catalysts usually made of proteins and nucleic 
acids. It is known that multiple interactions with the substrates and specific catalytic pockets 
are essential for the activity of enzymes. Foldamers are considered to mimic the structures of 
proteins; it would be interesting to know if foldamers are also able to be designed as catalysts 
in order to mimic enzymes. Recently, G. Guichard and co-worker reported an excellent 
example of foldamer-based catalyst (Fig. 1-16).
43
 The foldamer catalysts were made from 
oligoureas which are known to form helical folded structures. The active site of the oligourea 
catalyst is the urea group at the terminus which is not completely involved in the endo-helical 
hydrogen bonds networks that stabilize the helical structure of the oligomers. In order to 
improve the activity of this terminus urea, 3,5-bis(trifluoromethyl)phenyl group was attached 
at the terminus. Thiourea counterpart was also prepared due to better hydrogen bonding 
ability. The catalytic activity of the oligourea catalysts was tested for Michael reaction. In the 
presence of suitable base (DIEA), the oligourea catalysts were able to catalyze Michael 
reaction with high yields and enantioselectivites. It is remarkable that the turn over number of 
oligourea catalyst is also very high (over 10
4
) which means very small quantity of catalyst is 
necessary to catalyze the reaction. More importantly, the catalytic activity of the oligourea 
catalyst can be fine-tuned by structure variations of the oligoureas. The length and sequences 
of the oligomers can be changed to tune the activity of the catalyst. The ability to fine tune the 
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foldamers structures offers a unique way to improve and design catalysts. 
 
Figure 1-16: Oligourea based highly reactive and enantioselctive catalyst and the model reaction 
catalyzed by oligourea catalyst.  
 
Another example of foldamer based catalyst was reported by Gellman which also 
showed the strength of structural modifications of the foldamers to tune the catalytic 
activities.
44
 A serial of oligomers of trans-2-aminocyclopentanecarboxylic acid (ACPC) and 
4-amino pyrrolidine-3-carboxylic acid (APC) showed catalytic activity towards aldol reaction 
(Fig. 1-17). By systematic variation of the positions of the APC residues in the sequences and 
also inserting α-aminoacids, the catalytic activities were found to vary above 100 times. The 
APC residue is the catalytic active residue. The distance and angles between two APC 
residues are tuned by separating them by different units. The catalytic activity of the 
foldamers is then modulated because the best outcome needs two APC residues to work 
synergistically to activate the two reactants. The foldamer catalyst with best efficiency was 
found to be α/β-peptides (1:2 ratio of α and β-peptides) where the two APC residues were 
separated by 3 residues (peptide 22). The two active sites (APC residues) are separated by 5.5 
Å in space and an angle of 10
o
. As pointed by the author, the ability of foldamers to access 
various spatial arrangements of reactive diad will accelerate the searching for optimal 
arrangements of cooperative catalytic sites. Compared to enzymes which contain hundreds of 
amino acid residues, foldamer catalysts are simple, yet, they might be a step to understand the 
origin of enzymes in the prebiotic period.  
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Figure 1-17: a) scheme of the active site of oligo-α/β-peptide catalysts; b) chemical structures of 
variations of position of active monomer of the oligo-α/β-peptide catalysts and the relative reactivity; c) 
the crossed aldol reaction catalyzed by these foldamers. 
 
1.6 Some other applications 
1.6.1 Foldamer based guest binding 
Molecular capsules based on helically folded aromatic amides have been extensively 
developed in the group.
45
 The “capsules” were designed based on the length and angles of 
different monomers which generate curvature with different diameters. Usually, the 
monomers that generate small diameters are placed at the terminus position of the oligomers 
and serve as “caps” to close the capsules. Monomers that generate large diameters are in the 
middle to create a cavity inside the capsules. Monomers that are able to interact with guest 
molecules, sugars for instance, are also organized in the middle of the capsule. Those 
monomers usually form strong hydrogen bonds with the guest molecules. Over the years, 
capsules of various sizes, binding strengths and selectivity have been prepared. Also structure 
based design allows for optimizing the capsules for selective binding of one sugar among 
many others.
46
 A very recent example demonstrated the ability to prepare capsules with inner 
cavity large enough to accommodate disaccharide.
47
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Figure 1-18: a) Capsule like foldamers and binding with guest molecules; b) some typical monomers 
used in construction of foldamer capsules. 
 
1.6.2 Circularly polarized luminescence of foldamer 
Circularly polarized luminescence (CPL) is the emission of light that the intensity of left 
and right circularly polarized light is different.
48
 The difference between left and right 
circularly polarized light is characterized by anisotropy factor 𝑔𝑙𝑢𝑚 which can be obtained 
by the intensities of left (𝐼𝐿) and right-handed (𝐼𝑅) circularly polarized emissions. 
𝑔𝑙𝑢𝑚 =
2(𝐼𝐿 − 𝐼𝑅)
(𝐼𝐿 + 𝐼𝑅)
⁄  
The range of allowed values of 𝑔𝑙𝑢𝑚 is from -2 to +2. The 𝑔𝑙𝑢𝑚 of organic compounds falls 
in the range of 10
-5
-10
-3
 which is very small compared to lanthanide complexes (usually 
within the range of 0.05-0.5). Hence, intense researches were focused on improving the 
anisotropy factor of chiral organic dyes. Helical folded aromatic foldamers adopt P or M 
helical structures which might give CPL if enantiomeric pure helices are provided. Indeed, the 
enantiomeric pure P or M handed foldamers induced by oxazolylanilines showed nice CPL 
signals.
49
 The anisotropy factor was found to be 0.015 which is about one order magnitude 
higher than usual chiral organic compounds. The |glum| values of longer oligomers were found 
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to be higher than the shorter oligomers which might be because of the increased helical 
aromatic stacks in the longer oligomers.  
 
Figure 1-19: a) chemical structures of one handed oligo-quinoline carboxamides 23-25; b) CD and CPL 
spectra of oligomers 23-25.  
1.7 Conclusions 
The foldamers are inspired by nature. Many abiotic monomers were developed and their 
oligomers form various types of folded structures such as helix, sheet and turns. Higher 
structures such as tertiary and quaternary structures of foldamers were also obtained. The 
developments of new foldamers with functions demonstrate its ability to mimic the structures 
of proteins. It should not be forget that in proteins, only α-amino acids are used, while a much 
bigger pool of monomers can be used and developed by chemist. It would be natural to use 
foldamers beyond what has been seen in proteins and nucleic acids. As described in above the 
examples of some applications of foldamers, they can play roles in much broader areas such 
as materials. Predicable structures and structural based designs are among various advantages 
of foldamers that make them unique candidates of vast applications. Structural based design 
paves a way to endow functions and also optimizations. Although great developments have 
been achieved in the foldamers discoveries and applications, still many more questions are 
pending. How can we achieve large and sophisticated foldamers structures and aggregates 
akin to the size of proteins through segments assembly? How can the backbone of existing 
foldamers be modified to endow new functions? How can the foldamers be applied as novel 
materials? With those questions in mind, we try to develop quinoline carboxamide based 
foldamers towards materials and new self-assemblies through main chain and side chain 
modifications.  
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II Quinolylene-vinylene as oligo-Quinoline Carboxamide Foldamer 
Isostere 
2.1 Introduction 
The foldamer chemistry
1,2
 has long been inspired by the naturally occurring higher order 
structures prevailing through the biomacromolecules, such as proteins and nucleic acids. The 
structure features noted other than the chemical compositions like helix, sheet and β-turn are 
the structural basis of the functions that those biomacromolecules preform. The evolution 
allows nature to choose the building blocks and molecules that form precisely the required 
structures and thus the functions they play. However, novel building blocks that beyond those 
found in nature can be developed by the ever new synthetic techniques and unlimited designs. 
The foldamer chemistry is such an example that expands the scopes and possibilities of the 
nature’s inspirations.  
The aromatic foldamers stand out among other biomimetic compounds that they are not 
only resemblance to the structures of biomolecules but also their functions. For example, 
different types of structures such as helix,
3
 double helix
4,5
 and β-sheets6,7 have been reported 
by several groups. Also, several functions, such as sugar recognition
8
 and information 
communication
9
, have also been proved. Nevertheless, those foldamers were mostly based on 
the oligoamides which were found in proteins. The ease of synthetic efforts and the abilities 
of acting as both hydrogen bond donor and acceptor to stabilize the folded conformation are 
among the advantages of using amide as propagation linkage group. However, in order to 
achieve more diverse structures and functions, the sole use of amide linkage might be a 
limitation. The efforts of using different connecting groups which served as isosteres of 
peptides
10,11
 have been proven as interesting and promising methods to probe the structures of 
peptides
12-14
 as well as the mechanism
15
 behind their functions. Also, the potential abilities to 
resist enzyme degradation makes them suitable candidates as small peptide drugs which may 
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have long term efficiency.
16,17
  
Many type of isosteres for 
peptides have been proposed in 
the last few decades. Wipf 
18,19
 
and Fujii
16,17,20,21
 have 
developed extensively 
tri-substituted E-alkene peptide 
isosteres. Other types of peptide bond mimetics such as ketomethylene
22,23
, 
(di)hydroxyethylene
24-27
, hydroxyethylamine
28
 and methyleneamine
29-31
 have also been 
proposed. The vinyl bond is one of the most studied surrogates of amide bond because of 
structural similarities between them. On the other hand, vinyl can improve the conjugation 
between the adjacent moieties which may affect the electron orbital energy levels and the 
photophysical properties. In recent years, large π-conjugated compounds have been 
extensively studied in the field of optical-electronic organic materials.
32-34
  
The oligo-quinoline carboxamides forms a stable helical folded structure in solution and 
in the solid state. The helical structure of the oligo-quinoiline carboxamides are stabilized by 
the endo-helical H-bond chains and electron repulsion of the adjacent polar groups as well as 
the π-π stacking effects of the aromatics of quinoline rings. What will happen if the amide 
bonds which play a central role to stabilize the structures are replaced with bonds that are not 
able to form H-bonds? What will be the preferred conformation? In order to answer those 
questions, we prepared a serie of aromatic foldamers using vinyl bond as linkage which 
replaced the amide bond and a detailed structure analysis of these oligomers was conducted.  
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Figure 2-1: Chemical structure of the parts of quinoline amide oligomers and vinylene isotere. 
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2.2 Compounds design 
Vinylene double bond has been long considered as a good choice of isosteres for peptide 
bond. The amide and vinylene double bond are similar in the geometry and spatial 
arrangements of substituents attached to them. There is only one atom difference (nitrogen 
atom in the amide changed to carbon atom in vinylene double bond) in the main chain 
between these two bonds. Only small structural differences are then expected by replacing the 
amide bond to vinylene double bond. As showed in above figure 2-1, the amide bond of 
8-aminoquinoline-2-carboxamide is replaced with vinylene double bond as an isostere. It 
should be noted that the intermolecular interactions between vinylene double bond and amide 
bond are different. The amide bond is good hydrogen bond donor and acceptor while vinylene 
double bond is only a very week hydrogen bond donor. The electrostatic interaction of 
vinylene double bond is also very weak compared to amide. So, it is interesting to know how 
the vinylene isostere behaves and what the preferred structures of those isosteres are. The 
vinylene isostere will also bring us some additional physical properties because of the 
enhanced conjugation compared to the amide bonds. For example, fluorescence which is 
weak in the oligo-quinolinecarboxylamides might become strong in the vinylene isostere. 
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Figure 2-2: Chemical structure of quinolylene-vinylene oligomers (A) and quinoline 
carboxamide-quinolylene-vinylene hybrid-oligomers (B). 
 
The quinolylene-vinylene oligomers (A in figure 2-2) are the isosteres of oligo-quinoline 
carboxamides that the amide bonds are replaced by vinylene double bond. A hexyl side chain 
is selected over isobutyl side chain to avoid possible solubility issue during synthesis. An 
oligomer length of quinolylene-vinylenes of seven is targeted which is long enough to know 
the structure preferences of those oligomers. On the other hand, in order to combine the amide 
oligomer and vinylene oligomer together, a hybrid oligomers composed of both sequences 
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were synthetized. (B in figure 2-2) The hybrid oligomers are composed of two short amide 
oligomers at both ends and in the middle a segment of vinylene oligomers of different length. 
A quinoline carboxamide tetramer is used for the oligoamide segments which form stable 
helical folded structure and it is simple to obtain. The hybrid oligomers allowed us to know if 
the vinylene oligomers maintain the similar helical structure inside the quinoline amide 
oligomers. Also, in the case that the vinylene oligomers alone did not form stable helically 
folded structures, it is interesting to know how the amide oligomers affect the structure of the 
vinylene oligomer part and induce its folding.  
 
2.3 Results and discussions 
2.3.1 Compounds synthesis 
The synthesis of quinolylene-vinylene oligomers were achieved according to the route 
showed in scheme 2-1. The monomer 1 was prepared from o-toluidine according to our 
previous procedures
35
 with minor changes. Selective transformation of 1 resulted in two key 
intermediates, the aldehyde 3 and phosphonate ester 5. The aldehyde 3 was obtained via two 
steps transformations. The monomer 1 was first reduced to alcohol 2 which was then 
re-oxidized to corresponding aldehyde 3 by using SIBX
36
 as a selective oxidation reagent. 
The phosphonate ester 5 was also synthesized via two steps’ transformations. A Br-substituted 
intermediate 4 was obtained by free radical bromination using N-bromosuccinimide (NBS). A 
subsequent nucleophilic substitution reaction yielded the desired phosphonate ester 5. The 
subsequent Horner-Wadsworth-Emmons (HWE) reaction furnished the formation of vinylene 
bond using NaH as the base. However, under the condition used, saponification of 
methylester of 5 occurred as a major unwanted side reaction due to trace of moisture. An 
additional step of re-esterification was performed to obtain the desired oligomers. The 
elongation of the oligomers was achieved by stepwise addition of one monomer each time 
under similar conditions. The longest oligomer we prepared was the heptamer 11a. Further 
elongation of the oligomers according to this method was not trivial due to formation of side 
products (partial transformation of aldehyde reagent to corresponding carboxylic acid of 
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unknown reason) during the HWE reaction which hampered efficient purification of the 
products. Another serie of oligomers (15a-19a) bearing Boc-amide terminal functional group 
was also prepared according to the same procedures. (Scheme. 2-1) These oligomers allowed 
them to be inserted into amide analogs 
 
a: 1) dimethyl acetylenedicarboxylate, MeOH, 2) Ph2O, 260 °C; 3) DIAD, THF, PPh3, 2-ethylbutanol; 
b: NaBH4, THF, 60 °C; c: SIBX, THF, 60 °C; d: NBS, CCl4, reflux; e: P(O
i
Pr)3, 70 °C; f: 1) NaH, 
15-crown-5, THF; 2) K2CO3, MeI, acetone. 
 
Scheme 2-1: Synthesis of the quinolylene-vinylene oligomers. 
 
The hybrid amide and vinylene oligomers were prepared by acid chloride activation of 
the proper acid and coupled with the amine functionalized oligomers. The synthetic scheme 
was displayed in scheme 2-2. Briefly, the Boc-protected vinylene oligomers of different 
lengths (dimer, tetramer and hexamer) were treated with sodium hydroxide to obtain the 
carboxylic acids which were activated to their corresponding acid chlorides with 
1-chloro-N,N,2-trimethyl-1-propenylamine (Ghosez’s reagent) and coupled with quinoline 
oligo-carboxamide tetramer amine. This intermediate was then treated with TFA to afford the 
free amine and then coupled with quinoline oligo-carboxamide tetramer acid chloride to 
afford the designed hybrid oligomers. Compound 21 (scheme 2-2) which has only one double 
bond and one short amide oligomer at one end was prepared as a short model compound. 
Compounds 27, 28, and 29 all have a tetramer oligoamide at both ends differing with the 
number of central vinylene linkers which are 1, 3 and 5 double bonds respectively. Another 
hybrid oligomer 30 was also prepared which shared the same central units of 27 with a single 
double bond in the middle and a longer amide segments (quinoline oligo-amide octamer). 
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g: TFA, DCM, r.t.; h: 1) oxalyl chloride, DCM, 2) DIEA, CHCl3; i: 1) 
1-chloro-N,N,2-trimethyl-1-propenylamine, DCM, 2) DIEA, CHCl3. 
 
Scheme 2-2: Synthesis of the quinolylene-vinylene amide hybrid oligomers. 
 
2.3.2 Conformation study of the oligomers 
The proton NMR spectra of the oligomers (6a-11a and 15a-19a) are shown in figure 2-3 
and 2-4 and reflected their conformations in solution. For the oligomers 6a-11a, the proton 
signals of the -CH3 and -COOCH3 were separated from others and hence were easily 
recognized. The chemical shifts of those two groups can be useful to indicate the possible 
conformations of the oligomers in solution due to dramatic changes of the chemical shifts 
between different conformations. The observed evolution of those two signals showed, first, 
an upfield shift caused by the deshielding effect of the aromatic rings and then downfield shift 
when oligomer length exceeding four (from 8a to 11a). The chemical shift differences 
between 10a and 11a was actually negligible (about 0.001 ppm for -CH3 and 0.006 ppm for 
-OCH3). The two stage evolution of chemical shifts indicates that multiple effects might take 
places. The downfield shifting of the –CH3 signal from 8a to 11a indicate that the folding is 
weak in chloroform solution otherwise dramatic upper field shifts of the signals should be 
observed. The upfield shift from 6a to 8a might be caused by increased conjugation in those 
oligomers. In the aromatic region, the H
3
 protons (Figure 2-3) of the quinoline rings did not 
shift to upper field which is also consistent with the fact that helical folding is not the major 
conformation in solution. In the helical folded conformation, the H
3
 proton should 
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consistently shifts to upper field due to the enhancement of π-π stacking upon increase of the 
oligomer length.
3
 One of the vinylene protons (H
α
 in figure 2-5) was separated from the other 
signals and could clearly be identified, because of its large coupling constant (around 16.6 
Hz). The overlapping of this signal in 10a and 11a also reflect a similar environment of these 
protons. The trend of evaluation of the chemical shifts of the ester protons in the Boc-amide 
functionalized oligomers 15a-19a was similar to the previous oligomers and two stage shifts 
were observed (figure 2-4). 
 
Figure 2-3: Parts of the 
1
H NMR spectra (300 MHz) of 1 and 6a-11a showing the vinyl (green), 
aromatic and terminal groups of –OCH3 (red) and –CH3 (blue) at 298 K for a) 1, b) 6a, c) 7a, d) 8a, e) 
9a, f) 10a, g) 11a. 
 
 
Figure 2-4: Parts of the 
1
H NMR spectra (300 MHz) of 12 and 15a-19a showing the vinyl (blue), 
aromatic and terminal groups –OCH3 (red) and BocNH- (green) at 298 K for a) 12, b) 15a, c) 16a, d) 
17a, e) 18a, f) 19a. 
 
The dimer 6a which has only one vinylene bonds was used as a model compound to 
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analyze the possible conformations of this type of oligomers. By subsequently flipping the 
orientation of the double bonds, four possible conformations can be drawn as shown in the 
figure 2-5. Among the four conformations, two of them (B and D) were compatible with 
structure of helical folding, while the other two (A and C) gave a sheet structure upon 
extending the segments. For each double bond, the same number of possible conformation 
can be generated. If we count the number of double bond in a given oligomer as n, the 
number of conformations will be 4
n
. In order to find out the conformations of those oligomers 
in solution, we measured the NOESY spectrum of 6a. The four possible conformations of 6a 
gave four sets of correlations between H
3
, H
7
 and H
α
, H
β
 protons as summarized in figure 2-5. 
For example, in the conformation of A, only H
3
-H
β
, H
7
-H
α
 correlations were expected. As 
showed in figure 2-5, the observed NOESY spectrum of 6a in CDCl3 showed strong 
correlations between H
3
-H
α
 and H
7
-H
β
 which correspond to the conformation C in figure 2-5. 
However, a set of weaker correction was also observed (H
3
-H
β
 and H
7
-H
α
) which indicated 
the presence of other conformations. The observation of four correlations can be explained by 
coexistence of the four possible conformations which underdo fast exchange in solution. The 
relative intensity of the different sets of corrections reflected the relative population of the 
possible conformations which in our case implied that conformation C was the major one in 
chloroform solution. We also checked the NOESY spectrum in CD2Cl2 which gave similar 
results. The similar conformation behavior also holds for the longer oligomers as indicated by 
the NOESY spectrum of 8a in CDCl3 (Fig. 2-6). 
 
Figure 2-5: The four possible conformations of the 6a and the expected 
1
H-
1
H NOESY correlations and 
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excerpt from 
1
H-
1
H NOESY spectrum of 6a in CDCl3 at 298 K (400 MHz). 
 
Figure 2-6: Excerpt from 
1
H-
1
H NOESY spectrum of 8a in CDCl3 at 298 K (400 MHz) indicating the 
correlations between vinyl protons and aromatic protons. 
 
The extended conformation of the quinolylene-vinylene oligomers in solution reflected 
the conformational flexibility of those oligomers. In order to favor the helical folded 
conformation, a segment of quinoline carboxamide oligomers may be helpful to induce the 
helical shape of vinylene segments. As a starting point, we tried to elucidate the conformation 
of tetramer 21 in solution which is composed of only two amides and one vinylene bonds. 
The signal of the two vinylene protons of 21 were greatly shifted to upper field compared to 
the dimer 6a. The shifts are in agreement with a shielding effect of the aromatic rings that 
come from the quinoline carboxylamide trimer segments. However, the vinylene bond is still 
capable to cause different conformations similar to those depicted in figure 2-5. The part of 
oligoamide trimer was known to adopt a helically folded conformation in solution.
3
 The 
quinoline that connected though vinylene bond with the oligoamide trimer could have four 
possible positions related to the helical shaped trimer. Among them, two are compatible with 
the helically folded conformation while the other two are not. Nevertheless, the vinylene 
protons of all four possible conformations are positioned at the deshielding region of the helix 
trimer as observed in our energy minimized models of four conformations. (Figure 2-9) The 
dynamic behavior of the vinylene bond was also reflected by the proton NMR spectra. The 
signal of –OCH2- on the iso-butyoxyl side chain (δ 3.09 ppm, side chain of N-terminus 
II Quinolylene-vinylene as oligo-Quinoline Carboxamide Foldamer Isostere 
 
- 32 - 
 
quinoline) is broad at 298 K which became a sharp doublet at 323 K. This signal became 
broader upon cooling and at 238 K, the signal almost disappeared and splits as two broad 
peaks at 228 K. (Figure 2-7) Those changes reflected the dynamic exchange rates of these 
signals are fast at elevated temperature and slow at low temperature at the NMR time scale. 
This behavior can be caused by the slow dynamics of P/M handedness exchange of the helical 
folded 21 which also known as anisochronous signals. The 2D NOESY spectrum of 21 in 
chloroform showed similar pattern as compound 6a that is a set of strong correlations which 
correspond to the linear conformation of the vinylene part, together with a set of minor 
correlations that could indicate the helically folded conformation in solution. As showed in 
figure 2-8, a major set of correlations between H
3
-H
α
 and H
7
-H
β
 was observed while a minor 
set of correlation between H
3
-H
β
 and H
7
-H
α
 was also observed. The dynamic conformation 
behavior and especially the major unfolded conformation indicated that amide oligomer at 
only one end might not be sufficient to template the folding the vinylene segments. 
 
Figure 2-7: parts of the variable temperature 
1
H NMR spectra of 21 showing the amide, aromatic and 
side chain region, a) 228 K, b) 248 K, c) 258 K, d) 278 K, e) 298 K and f) 323 K. 
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Figure 2-8: Excerpt from 
1
H-
1
H NOESY spectrum of 21 in CDCl3 at 25 °C (400 MHz) indicating the 
correlations between vinyl protons and aromatic protons. 
 
Figure 2-9: Energy minimized molecular models of four conformations of 21. The models were 
produced with Maestro software package, using MFFS force field, chloroform as solvent and PRCG as 
minimization method. 
 
The lack of sufficient induced folding effect of only one oligoamide segment at one end 
of the vinylene oligomers guide us to add another segment of oligoamide at the other end of 
the vinylene oligomers. The compounds, 27, 28 and 29 were prepared and all shared the same 
oligo-tetrameric quinoline carboxamide segments at both end of the quinolylene-vinylene 
oligomers. Complicated NMR spectra are observed for all three compounds in CDCl3 
showing more than one set of signals. The coexistence of different sets of signals reflected 
that different conformations are in slow exchange at the NMR time scale. As showed in the 
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figure 2-10, the proportion of conformers of 27 and 28 are solvent dependent. In CDCl3, 27 
which has one vinyl bond gives two sets of signals at 298 K in which one is the major. We 
attributed the major set of signals to the helically folded conformation. The minor set of 
signals, on the other hand, was difficult to assign. The proportion of the two set of signals 
were dependent on the solvents. The minor set of signals almost disappeared in CD2Cl2, and 
observable but tiny in acetone-d6. Upon addition of ten percent of methanol in chloroform, 
the minor set of signals decrease which indicated that methanol as a solvent favors the major 
helical conformation. The proton NMR of 28 which possess three vinyl bond in chloroform is 
much more complicated than 27. The solvent dependent NMR is similar to 27 except that 
proportion of the minor set of signals are higher than 27. As showed in figure 2-10, two sets 
of signals of similar intensity coexist in CDCl3. One set of signals became smaller upon 
addition of large amount of methanol (up to 40 vol%). In dichloromethane, there is a major 
set of signals that coexist with some small signals while two sets of similar intensity signals 
coexist in acetone-D6. The proton NMR spectroscopy of 29 is too complicated to allow 
interpretation of NMR data. However, several sets of signals reflecting coexistence of more 
than two conformations are observed.  
 
Figure 2-10: Parts of the 
1
H NMR spectra (300 MHz) of  27 and 28 showing the amide in different 
solvents at 25 °C for a) 27 in CDCl3, b) 27 in CDCl3/CD3OD (9/1), c) 27 in CD2Cl2, d) 27 in 
acetone-D6, e) 28 in CDCl3, f) 28 in CDCl3/CD3OD (6/4), g) 28 in CD2Cl2, h) 28 in acetone-D6; j) 29 
in CDCl3; k) 29 in CD2Cl2; m) 29 in CD2Cl2/CD3OD (8/2) and n) 29 in acetone-d6.  
 
The conformations of the aforementioned compounds were further analyzed with 
multiple techniques. The variable temperature proton NMR of 27 in dichloromethane showed 
that a different conformation appeared upon cooling to 253 K (Figure 2-11). Upon cooling, 
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the minor signals which came from a minor conformation at room temperature did not change 
significantly until the temperature decreased to 253 K and then disappeared in favor to a new 
set of minor signals. This change is attributed to a conformation change upon cooling. We 
suspect that the new set of peaks could belong to another conformation that is compatible 
with a helical folding. The new set of signals was independent to the concentration which 
implied that this set of peaks is not caused by aggregation behavior. We also checked the 
variable temperature proton NMR of 27 at high temperature in C2D2Cl4. Upon heating the 
sample from 268 K to 343 K, we observed changes of the chemical shifts of most of the 
signals. The interesting part is that at higher temperature, some of the signals which were 
difficult to observe at room temperature became sharper. Especially the most important 
signals of one of the vinylene proton could only be observed at higher temperature at 4.72 
ppm at 343 K (figure 2-12). The other vinylene proton was identified by COSY spectrum to 
be at 7.80 ppm (343 K). The substantial upfield shifts of those two peaks compared to 6a 
could be explained by the shielding of quinoline rings from both upper and lower side in the 
helix. After identification of the vinylene protons, we performed 2D NOESY experiment 
which gives only the correlation of one vinylene proton with both H
3
 and H
7
 proton in the 
aromatics which correspond to the folded conformation B in figure 2-5. (Figure 2-13) Herein, 
we showed that the addition of two short oligoamide segments at both end of the vinylene 
oligomers could induce the folding of the vinylene oligomers.  
 
 
Figure 2-11: Part of the 
1
H NMR spectra (700 MHz) of 27 in CD2Cl2 showing the amide and aromatic 
at different temperature for a) 233 K, b) 238 K, c) 253 K, d) 263 K, e) 268 K, f) 283 K and g) 298 K. 
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Figure 2-12: Part of the 
1
H NMR spectra (300 MHz) of  27 in C2D2Cl4 showing the amide and 
aromatic at different temperature for a) 268 K, b) 283 K, c) 303 K, d) 323 K, e) 343 K. 
 
Figure 2-13: Excerpt from 
1
H-
1
H NOESY spectrum of 27 in C2D2Cl4 at 333 K (400 MHz) indicating 
the correlations between vinyl protons and aromatic protons. 
 
This observation is also confirmed by the X-ray single crystal structures. We obtained 
single crystals suitable for X-ray analysis for 6a, 27 and 28. All structures show the helical 
conformation of the vinylene segment (conformation B in figure 2-5). The structure of 6a, 
whose crystal was obtained by slow diffusion of methanol into dichloromethane solution, 
showed different conformation compared with the solution data. This is probably reflecting 
that different conformations coexist in solution in which the one compatible with folding were 
easier than the others to crystallize in the mixture of dichloromethane/methanol. The structure 
of 6a was almost flat on the side view, the dihedral angle of the two aromatic ring is only 8.6° 
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which was expected due to the maximum conjugation of the two aromatic rings. However, in 
the structure of 27 and 28, the two consecutive quinoline rings connected with vinylene bonds 
are no longer coplanar and have large dihedral angles of 17.5° in 27 and 18.3°, 15.5° and 14.1° 
in 28 respectively. The distortion of the conjugation was a result of the steric effect from the 
helical structure. From a top view of 28, a triangular shape of the central vinylene tetramer 
part could be observed in which the fourth quinoline ring sit on the top of the first one. This 
shape will give a helix structure of three units per turn which is slightly larger than the 2.5 
units per turn of quinoline oligoamides.
3
 The slight conformation differences can be also 
observed from the side views of the two different oligomers.  
 
Figure 2-14: The X-ray structure of the 6a, 27 and 28 for a) front and side view of 6a, b) side view of 
27, c) side view of 28, d) front view of the central part of 28 showing the three double bonds, e) side 
view of 28 showing the central part and end part, the double bond was marked as yellow, hydrogen 
atoms and side chains were removed for clarity. 
 
The 
1
H NMR of 27 after immediately dissolving the crystal which was found to have the 
folded conformation displayed two sets of signals in CDCl3 which showed no evolution with 
time at room temperature. This observation implied that the conformation equilibrium was 
completed within few minutes. As discussed above, the two sets of signals are associated with 
two isomers of 27. The compound 27 is composed by two segments of helical oligoamides 
and a central vinylene. The helical oligoamides can be either P or M-helix. The central 
vinylene has four possible conformations as showed in figure 2-5. In order to change from 
one conformation to another, a flipping around the double bond is required. However, this 
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flipping results overlapping of the two helical oligoamides. The change of conformation is 
then possible that the handedness of one of the helical oligoamide segments changes at the 
same time. The rate of handedness inversion is highly dependent on the length of the 
oligomers. The handedness inversion rate of longer oligomers is lower than the shorter 
oligomers. Hence, in order to slow down the kinetics of handedness inversion, similar 
compound 30 with longer oligoamide segments (quinoline carboxylamide octamer in this case) 
was prepared. The crystal structure of 30 showed similar folded conformation as 27. As 
expected, compound 30 showed two sets of signals in CDCl3 similar to 27. However, the 
NMR spectrum after immediately dissolving the crystals showed only one set of signals 
which corresponds to the major set of signals at equilibrium. The proton NMR slowly evolved 
to display another set of minor peaks after standing at room temperature for few hours and the 
proportion stopped changing after about one day. The observation of slowing kinetics of the 
oligomer with longer amide segments also justified our hypothesis about the conformational 
dynamics of the oligomers in solution. 
 
Figure 2-15: Part of 
1
H NMR spectra of 30 of dissolving the crystal measured after a) 6 minutes, b) 5 
hours, c) 21 hours and d) 72 hours, only the amide region and methyl ester region were shown in here. 
 
2.3.3 Absorption and emission 
The absorption and emission spectra of 6a-11a were measured in chloroform. Compared 
to the monomer 1, the UV-Vis absorption spectra of 6a-11a all had a distinct absorbance at 
longer wavelength (around 360 nm) which was attributed to the effect of conjugation through 
the double bonds. The continually bathochromic shift of the absorption band from 6a to 11a 
indicated the elongation of the conjugation which lowering the π–π* transition energies. It is 
interesting to note that the absorbance by the number of double bonds dropped from 6a to 11a. 
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The absorption spectra of 21, 27, 30 and 28 were also measured to compare with 6a and 8a. 
Compared with 6a, the absorption of 21, 27 and 30 all have bigger absorbance and the 
absorption peaks shift to short wavelength. The absorption spectra of 28 and 8a also show 
similar differences. The fluorescence emission spectra of 6a-11a were measured in 
chloroform at the concentration of 10 μM as showed in figure 2-16. The compound 1 was 
measured as a reference which has very weak emission. The intensity of the emission 
increased as the order of 6a < 7a < 11a < 10a < 8a < 9a (measured at the same condition). 
The decreasing of the intensity from 9a to 11a could be attributed to the saturation of 
conjugation effect. The small shifts of emission maximum also reflected the saturation of the 
conjugation as the emission peak shift little form 7a to 11a show in the normalized emission 
spectra.  
 
Figure 2-16: The UV-Vis absorption spectra of 1, 6a-11a, 21, 27, 28 and 30 and fluorescence spectra of 
1 and 6a-11a. a) UV-Vis spectra of 1 and 6a-11a; b) molar extinction coefficients of 1 and 6a-11a 
divided by number of double bonds; c) UV-Vis spectra of 6a and 21, 27, 28 and 30; d) UV-Vis spectra 
of 8a and 28; e) fluorescence spectra of 1 and 6a-11a and f) normalized fluorescence spectra of 1 and 
6a-11a. 
 
2.4 Conclusions and perspectives 
We have successfully synthetized the quinolylene-vinylene oligomers by developing a 
Horner-Wadsworth-Emmons (HWE) reaction strategy. In solution, those oligomers showed 
distinct conformations from their oligoamide analogs. The flexibility of the conformation of 
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those oligomers could be attributed to the lack of stabilizing forces that drive the 
conformation to a preferential one which was rather strong in the carboxamide analogs. The 
quinolylene-vinylene oligomers do not have strong tendency to form helical folded 
conformation alone. Oligo-quinoline carboxamides are necessary to induce the helical 
structures of quinolylene-vinylene oligomers, yet, several conformers exist. The population of 
the helical conformation is solvent dependent and addition of polar solvent such as methanol 
favors it. The lack of stable folding structure might undermine their usability as building 
blocks as foldamers. Also, if we consider that the vinylene is an isostere of amide, the results 
indicated the importance of the amide to maintain the helical folded conformation.  
The flexibility of this type of oligomers might open another avenue to the design 
oligomers where structure rigidity wasn’t necessary. The replacement of the amide bond with 
vinylene bond, itself, changes not only the structure but also the properties. The nature of 
conjugation of the vinylene linkage was sure to affect the nature of the backbone of the 
oligomers in terms of electronic behaviors as already indicated by the absorption and 
emission spectra. The investments of the electron transport properties of the oligomers with 
vinylene bonds are hence very interesting to know. The electron transport properties can be 
studied by attaching electron donor and acceptor. Ultrafast absorption and emission 
spectroscopy is a well suited technique to study the photo-electron transport of 
donor-bridge-acceptor systems. Two proposed compounds are showed in below figure 2-17 
(P1 and P2). Another interesting future plan of the quinolylene-vinylene oligomers is the 
water soluble version of them. A short side chain with amine group (Figure 2-17 P3) is 
proposed which brings the water solubility and also compatible with growing crystals. In 
aqueous phase, the strong hydrophobic effect might force the aromatic rings of quinolines to 
stay close in order to bury as much as possible of hydrophobic surfaces. The aromatic rings 
also form π-π stacking to further stabilize the folded structures. 
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Figure 2-17: Proposed compounds P1 and P2 attached with electron donor (OPV) and electron acceptor 
(PB) for the purpose to study the photo-electron transfer and the proposed oligomers with water soluble 
side chains to investigate the structure in water.  
 
2.5 Experimental section 
2.5.1 General remarks 
All the solvents and reagents were used as received unless otherwise specified. Dry THF 
was obtained from distillation over sodium/benzophenone. 
1
H NMR, 
13
C NMR and 2D NMR 
were recorded on 300 MHz, 400 MHz or 700 MHz Bruker Avance 300, 400 and 700 
spectrometer. Reactions were monitored by thin layer chromatography (TLC) on Merck silica 
gel 60-F254 plates and observed under UV light. Column chromatography purifications were 
carried out on Merck GEDURAN Si60 (40-63 µm). ESI mass spectra were obtained from the 
Mass Spectrometry Laboratory at the European Institute of Chemistry and Biology (UMS 
3033 - IECB), Pessac, France. UV-Vis spectra were recorded on Varian
®
 Cary 300 Scan 
UV-Visible spectrophotometer at room temperature. Fluorescence spectra were recorded on 
HORIBA FluoroMax-4 spectrofluorometer at room temperature. 
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2.5.2 X-ray crystallography 
The single crystals were obtained by slow diffusion of acetonitrile or hexane into the 
stock solution in chloroform. Typically, the crystals were obtained in around 1 to 2 weeks and 
suitable crystals were picked for X-ray diffraction.  
 
2.5.3 Compounds synthesis 
Synthesis of 1: To a 250 mL flask was added triphenylphosphine (7.97 g, 30.4 mmol), S2 
(6.00 g, 27.6 mmol). Then the flask was filled with N2. Dry THF (45 mL) and 2-ethylbutanol 
(3.7 mL, 30.4 mmol) were added through syringe. DIAD (6.0 mL, 30.4 mmol) was slowly 
added into the flask through a dropping funnel during 20 minutes. The resulting mixture was 
then stirred for 17 hours. The reaction mixture was concentrated and 50 mL methanol was 
added in to the resulting slurry and cooled down to form white precipitate. The solid was 
filtrated off and washed with methanol and dried to yield white solid (5.8 g, 69.6%). 
1
H NMR 
(300 MHz, CDCl3): δ 8.09 (d, J = 8.3 Hz, 1 H), 7.60 (d, J = 5.6 Hz, 1 H), 7.56 (s, 1 H), 7.47 (t, 
J = 7.7 Hz, 1 H), 4.17 (d, J = 5.6 Hz, 2 H), 4.06 (s, 3 H), 2.87 (s, 3 H), 1.86 (m, 1 H), 
1.64-1.53 (m, 4 H), 0.99 (t, J = 7.4 Hz, 6 H) ppm; 
13
C NMR (84 MHz, CDCl3): δ 166.8, 163.1, 
148.0, 147.8, 138.3, 130.7, 127.3, 122.6, 119.7, 100.6, 70.9, 53.2, 41.0, 23.7, 18.2, 11.4 ppm, 
HRMS (ESI) m/z: calcd for C18H24NO3 [M+H]
+
 302.1750, found 320.1748. 
Synthesis of oligomers 
General procedure for the synthesis of methylene alcohol: To a 100 mL flask was added 
with methyl ester (1 eq.) and NaBH4 (10 eq.), THF was added and heated at 50 °C, and then 
MeOH was added slowly. After the reaction completed, water was added to quench the 
unreacted NaBH4. Then dichloromethane was added to extract the compound and then 
washed with brine. The organic layer was dried over Na2SO4 and then filtrated and removed 
the solvent to give a white solid. This was used without further purification.  
General procedure for the preparation of aldehydes: To a 50 mL flask was added with 
methylene alcohol (1 eq.) and SIBX (1.2 eq.), then the flask was filled with N2. Dry THF was 
added through syringe. Then the mixture was heated under reflux for 1 hour under N2. 
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Heating was stopped and the mixture was cooled down to room temperature; a saturated 
Na2S2O3 solution was added. Dichloromethane was added to extract the compound and then 
washed three times with saturated Na2CO3 solution. The organic layer was dried over Na2SO4 
and then filtrated and the solvent was removed. Hexane was added to precipitate the 
compound. The precipitate was filtrated off to give the aldehyde. 
Synthesis of 4: To a 100 mL flask was added 1 (2.10 g, 7.0 mmol), NBS (1.37 g, 7.7 
mmol) and AIBN (22 mg, 0.14 mmol). The air inside was replaced with N2 three times. Then 
40 mL of CCl4 was added through a syringe. The mixture was heated under N2 at 75 °C 
overnight. The reaction mixture was cooled down to room temperature and washed with brine 
three times. The organic layer was dried over Na2SO4, filtrated and the solvent was removed. 
Cyclohexane was added to form a white needle like precipitate. The solid was filtrated to 
obtain a white solid (1.85 g, 69.0%). 
1
H NMR (300 MHz, CDCl3): δ 8.21 (dd, J = 8.4, 1.5 Hz, 
1 H), 7.90 (dd, J = 7.2, 1.5 Hz, 1 H), 7.58 (s, 1 H), 7.56 (t, J = 7.7 Hz, 1 H), 5.31 (s, 2 H), 
4.18 (d, J = 5.6 Hz, 2 H), 4.06 (s, 3 H), 1.86 (m, 1 H), 1.64-1.53 (m, 4 H), 0.99 (t, J = 7.4 Hz, 
6 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ 166.5, 163.0, 148.8, 146.0, 137.0, 131.7, 127.2, 
122.6, 101.0, 71.1, 53.1, 40.8, 29.5, 23.6, 11.3 ppm, HRMS (ESI) m/z: calcd for C18H23BrNO3 
[M+H]
+
 380.0856, found 380.0852. 
Synthesis of 5: To a 50 mL flask was added 4 (2.36 g, 6.2 mmol). The air inside was 
replaced with N2 and triisopropanylphosphine (3.0 mL, 12.4 mmol) was added. The mixture 
was heated at 70 °C for 3 hours under N2. The reaction mixture was cooled down to room 
temperature. Toluene was added to remove the excess of triisopropanylphosphine by 
co-evaporating under reduced pressure. The slurry was dried under high vacuum to give a 
white solid (2.52 g, quant). 
1
H NMR (300 MHz, CDCl3): δ 8.13 (d, J = 8.5 Hz, 1 H), 7.93 (dd, 
J = 7.3, 3.4 Hz, 1 H), 7.53 (s, 1 H), 7.54 (t, J = 8.2 Hz, 1 H), 4.74-4.63 (m, 2 H), 4.16 (d, J = 
5.4 Hz, 2 H), 4.06 (d, J = 22.3 Hz, 2 H), 1.84 (m, 1 H), 1.61-1.53 (m, 4 H), 1.22 (d, J = 6.4 Hz, 
6 H), 1.09 (d, J = 6.4 Hz, 6 H), 0.99 (t, J = 7.2 Hz, 6 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ 
163.1, 148.1, 146.9, 146.8, 132.7, 132.6, 131.6, 131.5, 127.2, 127.1, 122.7, 122.6, 120.8, 
120.7, 100.6, 70.7, 52.9, 41.0, 29.2, 27.3, 24.2, 23.9, 23.7, 11.4 ppm; 
31
P NMR ( 121 MHz, 
CDCl3): δ 25.2 ppm, HRMS (ESI) m/z: calcd for C24H37NO6P [M+H]
+
 466.2353, found 
466.2348. 
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General procedure for the coupling: To a 50 mL flask was added with the aldehyde (1 
eq.), 5 (1.1 eq.) and NaH (2 eq.). The flask was then connected with vacuum and then filled 
with N2. Dry THF and 15-rown-5 (1 eq.) were added through syringes. The mixture was 
stirred at room temperature for 2 hours. The reaction was quenched by adding water and 
dichloromethane. The compound was extracted with dichloromethane and dried over Na2SO4. 
The salt was filtrated off and the solvent was removed under vacuum. The residue was dried 
under high vacuum. K2CO3 (1.5 eq.) and acetone was added. The mixture was stirred at room 
temperature for about 10 minutes before adding MeI (2 eq.). The mixture was stirred at room 
temperature for 5 hours. Dichloromethane was added and the solution was washed with brine 
three times. The organic layer was dried with Na2SO4 and then filtrated and the solvent was 
removed. The residue was purified with column. 
2: 
1
H NMR (300 MHz, CDCl3): δ 8.04 (d, J = 8.5 Hz, 1 H), 7.54 (d, J = 8.5 Hz, 1 H), 
6.57 (s, 1 H), 4.96 (s, 1 H), 4.84 (s, 2 H), 4.07 (d, J = 5.5 Hz, 2 H), 2.78 (s, 3 H), 1.85 (m, 1 
H), 1.64-1.53 (m, 4 H), 0.98 (t, J = 7.4 Hz, 6 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ 162.7, 
158.7, 146.4, 136.0, 130.4, 125.1, 121.2, 120.0, 97.0, 70.7, 64.2, 41.0, 23.7, 18.3, 11.4 ppm, 
HRMS (ESI) m/z: calcd for C17H24NO2 [M+H]
+
 274.1802, found 274.1798. 
3: 
1
H NMR (300 MHz, CDCl3): δ 10.16 (s, 1 H), 8.11 (d, J = 8.5 Hz, 1 H), 7.63 (d, J = 
7.2 Hz, 1 H), 7.51 (t, J = 7.7 Hz, 1 H), 7.38 (s, 1 H), 4.17 (d, J = 5.6 Hz, 2 H), 2.87 (s, 3 H), 
1.86 (m, 1 H), 1.64-1.54 (m, 4 H), 0.99 (t, J = 7.3 Hz, 6 H) ppm; 
13
C NMR (75 MHz, CDCl3): 
δ 194.9, 163.1, 153.1, 148.1, 138.5, 130.7, 127.9, 123.3, 120.0, 96.3, 71.1, 40.9, 23.7, 18.3, 
11.3 ppm, HRMS (ESI) m/z: calcd for C17H22NO2 [M+H]
+
 272.1645, found 272.1642. 
6a: 
1
H NMR (300 MHz, CDCl3): δ 9.03 (d, J = 16.8 Hz, 1 H), 8.25 (d, J = 7.6 Hz, 1 H), 
8.21 (d, J = 7.8 Hz, 1 H), 8.04 (d, J = 8.4 Hz, 1 H), 7.74 (d, J = 16.8 Hz, 1 H), 7.64 (t, J = 7.8 
Hz, 1 H), 7.62 (s, 1 H), 7.53 (d, J = 7.4 Hz, 1 H), 7.34 (t, J = 7.6 Hz, 1 H, 7.26 (s, 1 H), 4.23 
(d, J = 5.9 Hz, 2 H), 4.21 (d, J = 5.8 Hz, 2 H), 4.08 (s, 3 H), 2.89 (s, 3 H), 1.93-1.84 (m, 2 H), 
1.68-1.55 (m, 8 H), 1.03 (t, J = 5.5 Hz, 6 H), 1.01 (t, J = 5.7 Hz, 6 H) ppm; 
13
C NMR (75 
MHz, CDCl3): δ 166.7, 163.2, 162.1, 156.4, 148.4, 148.3, 146.4, 137.0, 136.0, 133.0, 130.1, 
129.2, 127.5, 127.2, 124.9, 122.9, 122.0, 121.0, 119.7, 100.8, 98.4, 71.2, 70.4, 53.0, 41.1, 41.0, 
23.8, 23.7, 18.4, 11.4, 11.3 ppm, HRMS (ESI) m/z: calcd for C35H43N2O4 [M+H]
+
 555.3217, 
found 555.3212. 
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6b: 
1
H NMR (300 MHz, CDCl3): δ 9.01 (d, J = 16.5 Hz, 1 H), 8.19 (d, J = 8.2 Hz, 2 H), 
8.03 (d, J = 8.2 Hz, 1 H), 7.56 (d, J = 16.5 Hz, 1 H), 7.58 (d, J = 6.2 Hz, 1 H), 7.52 (t, J = 4.8 
Hz, 1 H), 7.34 (t, J = 7.3 Hz, 1 H), 7.12 (s, 1 H), 6.64 (s, 1 H), 4.91 (s, 2 H), 4.19 (d, J = 5.5 
Hz, 2 H), 4.11 (d, J = 5.6 Hz, 2 H), 2.87 (s, 3 H), 1.90-1.83 (m, 2 H), 1.69-1.55 (m, 8 H), 
1.04-0.98 (m, 12 H) ppm, HRMS (ESI) m/z: calcd for C34H43N2O3 [M+H]
+
 527.3268, found 
527.3266. 
6c: 
1
H NMR (300 MHz, CDCl3): δ 10.26 (s, 1 H), 9.07 (d, J = 16.6 Hz, 1 H), 8.27 (d, J = 
7.8 Hz, 1 H), 8.25 (d, J = 8.2 Hz, 1 H), 8.05 (d, J = 7.8 Hz, 1 H), 7.70 (d, J = 16.6 Hz, 1 H), 
7.68 (t, J = 7.4 Hz, 1 H), 7.55 (d, J = 7.2 Hz, 1 H), 7.43 (s, 1 H), 7.35 (t, J = 8.2 Hz, 1 H), 
7.21 (s, 1 H), 4.22 (d, J = 5.5 Hz, 2 H), 4.20 (d, J = 5.8 Hz, 2 H), 2.88 (s, 3 H), 1.91-1.84 (m, 
2 H), 1.70-1.53 (m, 4 H), 1.06-0.98 (m, 12 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ 194.6, 
163.2, 162.3, 156.2, 153.2, 148.4, 146.8, 137.0, 136.2, 133.0, 130.2, 129.0, 128.1, 127.2, 
125.0, 123.7, 122.3, 121.1, 119.7, 98.4, 96.6, 71.3, 70.4, 41.1, 41.0, 23.9, 23.8, 18.4, 11.5, 
11.4 ppm, HRMS (ESI) m/z: calcd for C34H41N2O3 [M+H]
+
 525.3112, found 525.3108. 
7a: 
1
H NMR (300 MHz, CDCl3): δ 9.12 (d, J = 16.6 Hz, 1 H), 9.08 (d, J = 16.6 Hz, 1 H), 
8.24-8.18 (m, 4 H), 8.03 (d, J = 7.8 Hz, 1 H), 7.80 (d, J = 16.6 Hz, 1 H), 7.70 (d, J = 16.6 Hz, 
1 H), 7.64 (m, 2 H), 7.53 (d, J = 7.4 Hz, 1 H), 7.52 (t, J = 7.4 Hz, 1 H), 7.34 (s, 1 H), 7.33 (t, J 
= 7.8 Hz, 1 H), 7.30 (s, 1 H), 4.26 (d, J = 5.4 Hz, 2 H), 4.21 (d, J = 5.8 Hz, 2 H), 4.14 (d, J = 
5.8 Hz, 2 H), 3.87 (s, 3 H), 2.87 (s, 3 H), 1.85-1.70 (m, 3 H), 1.68-1.43 (m, 12 H), 1.05 (t, J = 
7.5 Hz, 6 H), 1.02 (t, J = 7.6 Hz, 6 H), 0.92 (t, J = 7.5 Hz, 6 H) ppm; 
13
C NMR (75 MHz, 
CDCl3): δ 166.7, 163.2, 162.2, 162.1, 157.1, 156.8, 148.4, 147.0, 146.4, 136.9, 136.1, 134.7, 
133.0, 131.9, 130.2, 130.0, 129.9, 127.5, 127.4, 126.7, 125.2, 124.8, 123.0, 122.2, 121.6, 
121.0, 119.7, 101.0, 98.9, 98.1, 71.2, 70.5, 53.0, 41.1, 41.0, 40.9, 23.9, 23.8, 23.6, 18.5, 11.5, 
11.4, 11.3 ppm, HRMS (ESI) m/z: calcd for C52H62N3O5 [M+H]
+
 808.4684, found 808.4674. 
7b: 
1
H NMR (300 MHz, CDCl3): δ 9.07 (d, J = 16.6 Hz, 1 H), 8.90 (d, J = 16.6 Hz, 1 H), 
8.22-8.16 (m, 4 H), 8.03 (d, J = 7.5 Hz, 1 H), 7.69 (d, J = 16.6 Hz, 1 H), 7.68 (d, J = 16.6 Hz, 
1 H), 7.58-7.49 (m, 3 H), 7.33 (t, J = 7.5 Hz, 1 H), 7.31 (s, 1 H), 7.24 (s, 1 H), 6.67 (s, 1 H), 
4.86 (d, J = 3.6 Hz, 2 H), 4.50 (t, J = 3.6 Hz, 1 H), 4.24 (d, J = 5.4 Hz, 2 H), 4.18 (d, J = 5.6 
Hz, 2 H), 4.12 (d, J = 5.5 Hz, 2 H), 2.86 (s, 3 H), 1.91-1.77 (m, 3 H), 1.70-1.49 (m, 12 H), 
1.06-0.93 (m, 18 H) ppm. 
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7c: 
1
H NMR (300 MHz, CDCl3): δ 10.16 (s, 1 H), 9.11 (d, J = 16.5 Hz, 1 H), 9.08 (d, J = 
16.5 Hz, 1 H), 8.27 (d, J = 8.3Hz, 1 H), 8.25 (d, J = 7.2 Hz, 1 H), 8.19 (d, J = 7.8 Hz, 2 H), 
8.03 (d, J = 7.8 Hz, 1 H), 7.80 (d, J = 16.5 Hz, 1 H), 7.69 (d, J = 16.5 Hz, 1 H), 7.69 (t, J = 
7.6 Hz, 1 H), 7.52 (t, J = 7.3 Hz, 1 H), 7.51 (d, J = 5.8 Hz, 1 H), 7.43 (s, 1 H), 7.33 (t, J = 7.6 
Hz, 1 H), 7.28 (s, 1 H), 7.27 (s, 1 H), 4.26 (d, J = 5.2 Hz, 2 H), 4.21 (d, J = 5.7 Hz, 2 H), 4.15 
(d, J = 5.4 Hz, 2 H), 2.86 (s, 3 H), 1.92-1.78 (m, 3 H), 1.68-1.47 (m, 12 H), 1.05 (t, J = 7.4 Hz, 
6 H), 1.02 (t, J = 7.4 Hz, 6 H), 0.94 (t, J = 7.4 Hz, 6 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ 
194.4, 163.2, 162.3, 162.2, 156.9, 156.7, 153.4, 148.4, 147.1, 146.8, 136.9, 136.3, 134.8, 
133.2, 132.1, 130.2, 130.1, 129.8, 128.1, 127.5, 126.9, 125.3, 124.8, 123.7, 122.5, 122.2, 
121.6, 121.0, 119.7, 98.6, 98.3, 96.7, 71.3, 70.6, 70.5, 41.0, 41.0, 23.9, 23.8, 23.7, 18.5, 11.5, 
11.4 ppm, HRMS (ESI) m/z: calcd for C51H60N3O4 [M+H]
+
 778.4578, found 778.4569. 
8a: 
1
H NMR (300 MHz, CDCl3): δ 9.45 (d, J = 16.6 Hz, 1 H), 9.16 (d, J = 16.8 Hz, 1 H), 
9.02 (d, J = 16.7 Hz, 1 H), 8.22-8.16 (m, 4 H), 7.96 (dd, J = 8.3, 1.1 Hz, 1 H), 7.82 (d, J = 7.4 
H, 1 H), 7.76 (d, J = 5.3 Hz, 1 H), 7.72 (d, J = 16.4 Hz, 1 H), 7.71 (d, J = 16.4 Hz, 1 H), 7.68 
(d, J = 16.4 Hz, 1 H), 7.57 (s, 1 H), 7.53 (dd, J = 7.8, 3.5 Hz, 1 H), 7.50 (dd, J = 7.7, 3.5 Hz, 1 
H), 7.43 (d, J = 6.6 Hz, 1 H), 7.32 (s, 1 H), 7.22 (s, 1 H), 7.23-7.13 (m, 2 H), 4.26 (d, J = 5.5 
Hz, 2 H), 4.19 (d, J = 5.3 Hz, 2 H), 4.17 (d, J = 5.3 Hz, 2 H), 4.05 (d, J = 5.9 Hz, 2 H), 3.74 (s, 
3 H), 2.82 (s, 3 H), 1.94-1.81 (m, 4 H), 1.71-1.51 (m, 8 H), 1.05 (t, J = 7.5 Hz, 6 H), 1.03 (t, J 
= 7.6 Hz, 6 H), 0.97 (t, J = 7.5 Hz, 6 H), 0.84 (t, J = 7.4 Hz, 6 H) ppm; 
13
C NMR (75 MHz, 
CDCl3): δ 166.6, 163.0, 162.2, 161.9, 157.0, 157.0, 156.9, 148.1, 148.0, 147.1, 136.6, 135.4, 
134.6, 134.5, 132.4, 131.8, 131.2, 130.8, 130.3, 130.1, 129.7, 127.2, 127.1, 126.8, 126.6, 
125.1, 125.0, 124.4, 122.6, 122.4, 122.1, 121.8, 121.5, 121.4, 120.8, 119.5, 100.8, 99.6, 99.1, 
97.8, 71.0, 70.6, 70.5, 70.5, 52.8, 41.1, 41.0, 40.9, 40.7, 23.8, 23.7, 23.6, 23.3, 18.5, 11.4, 11.4, 
11.3, 11.2 ppm, HRMS (ESI) m/z: calcd for C69H81N4O6 [M+H]
+
 1061.6151, found 
1061.6142. 
8b: 
1
H NMR (300 MHz, CDCl3): δ 9.45 (d, J = 16.5 Hz, 1 H), 8.66 (d, J = 16.9 Hz, 1 H), 
8.85 (d, J = 16.6 Hz, 1 H), 8.22-8.16 (m, 4 H), 7.91 (dd, J = 8.2, 1.2 Hz, 1 H), 7.70 (d, J = 
16.8 Hz, 1 H), 7.67 (d, J = 16.4 Hz, 1 H), 7.58 (d, J = 16.6 Hz, 1 H), 7.73 (m, 2 H), 7.54-7.47 
(m, 2 H), 7.40 (d, J = 7.0 Hz, 1 H), 7.32 (s, 1 H), 7.19 (s, 1 H), 7.17 (s, 1 H), 7.11 (m, 2 H), 
6.59 (s, 1 H), 4.76 (s, 2 H), 4.51 (w, 1 H), 4.23 (d, J = 5.3 Hz, 2 H), 4.25 (d, J = 5.5 Hz, 2 H), 
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4.08 (d, J = 5.5 Hz, 2 H), 4.02 (d, J = 5.9 Hz, 2 H), 2.80 (s, 3 H), 1.89-1.83 (m, 4 H), 
1.68-1.54 (m, 8 H), 1.04 (t, J = 7.05 Hz, 6 H), 1.02 (t, J = 6.6 Hz, 6 H), 0.99 (t, J = 6.9 Hz, 6 
H), 0.81 (t, J = 7.4 Hz, 6 H) ppm. 
8c: 
1
H NMR (300 MHz, CDCl3): δ 9.88 (s, 1 H), 9.64 (d, J = 16.2 Hz, 1 H), 9.17 (d, J = 
16.9 Hz, 1 H), 9.14 (d, J = 16.5 Hz, 1 H), 8.22-8.14 (m, 4 H), 7.82 (dd, J = 8.3, 1.1 Hz, 1 H), 
7.72-7.61 (m, 4 H), 7.56-7.48 (m, 4 H), 7.36 (d, J = 6.6 Hz, 1 H), 7.31 (s, 1 H), 7.14 (s, 1 H), 
7.09 (s, 1 H), 7.12-7.05 (m, 3 H), 4.24 (d, J = 5.4 Hz, 2 H), 4.19 (d, J = 6.0 Hz, 2 H), 4.17 (d, 
J = 5.9 Hz, 2 H), 3.94 (d, J = 6.0 Hz, 2 H), 2.71 (s, 3 H), 1.94-1.83 (m, 4 H), 1.71-1.56 (m, 8 
H), 1.06 (t, J = 6.8 Hz, 6 H), 1.03 (t, J = 7.9 Hz, 6 H), 1.01 (t, J = 7.5 Hz, 6 H), 0.76 (t, J = 7.4 
Hz, 6 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ 194.5, 162.8, 162.4, 162.3, 161.6, 156.8, 156.6, 
1156.5, 153.0, 147.9, 147.4, 147.1, 146.3, 136.6, 135.1, 134.9, 134.3, 131.8, 131.6, 131.4, 
130.4, 130.3, 130.0, 129.5, 127.2, 126.9, 126.8, 126.5, 125.1, 125.0, 124.2, 123.1, 122.3, 
122.2, 121.8, 121.5, 121.4, 120.7, 119.4, 100.3, 99.6, 97.6, 96.4, 71.1, 70.6, 41.1, 41.0, 41.0, 
40.6, 23.9, 23.8, 23.7, 23.2, 18.4, 11.5, 11.4, 11.4, 11.1 ppm, HRMS (ESI) m/z: calcd for 
C68H79N4O5 [M+H]
+
 1031.6045, found 1031.6037. 
9a: 
1
H NMR (300 MHz, CDCl3): δ 9.46 (d, J = 16.4 Hz, 1 H), 9.36 (d, J = 16.6 Hz, 1 H), 
9.10 (d, J = 16.8 Hz, 1 H), 8.89 (d, J = 16.6 Hz, 1 H), 8.21-8.17 (m, 2 H), 8.07 (d, J = 6.8 Hz, 
1 H), 8.01 (d, J = 8.3 Hz, 1 H), 7.96 (d, J = 7.9 Hz, 1 H), 7.94 (d, J = 5.9 Hz, 1 H), 7.92 (d, J 
= 6.0 Hz, 1 H), 7.87 (d, J = 16.6 Hz, 1 H), 7.77 (d, J = 7.3 Hz, 1 H), 7.67-7.48 (m, 7 H), 7.35 
(s, 1 H), 7.24-7.14 (m, 5 H), 4.25 (d, J = 5.5 Hz, 2 H), 2.20-4.15 (m, 6 H), 4.06 (d, J = 5.7 Hz, 
2 H), 3.84 (s, 3 H), 2.85 (s, 3 H), 1.95-1.37 (m, 15 H), 1.06 (t, J = 7.4 Hz, 6 H), 0.99 (t, J = 
7.4 Hz, 12 H), 0.92 (t, J = 7.5 Hz, 6 H), 0.89 (t, J = 7.5 Hz, 6 H) ppm; 
13
C NMR (75 MHz, 
CDCl3): δ 166.7, 163.0, 162.3, 162.0, 162.0, 161.9, 157.1, 157.0, 157.0, 156.9, 148.3, 148.0, 
147.3, 147.0, 146.8, 146.1, 136.7, 135.4, 134.5, 134.4, 134.2, 132.9, 131.7, 131.5, 131.4, 
131.2, 130.2, 130.1, 129.8, 129.7, 127.2, 127.1, 126.4, 126.2, 124.8, 124.7, 124.5, 122.6, 
122.3, 122.1, 121.8, 121.7, 121.4, 121.3, 120.9, 119.7, 100.7, 100.0, 99.2, 98.6, 97.9, 71.1, 
70.6, 70.5, 70.4, 53.6, 52.8, 41.2, 41.0, 40.9, 40.9, 40.8, 23.8, 23.7, 23.6, 23.6, 23.5, 18.6, 11.5, 
11.4, 11.3, 11.2 ppm, HRMS (ESI) m/z: calcd for C86H100N5O7 [M+H]
+
 1314.7617, found 
1314.7641. 
9b: 
1
H NMR (300 MHz, CDCl3): δ 9.44 (d, J = 16.5 Hz, 1 H), 9.37 (d, J = 16.5 Hz, 1 H), 
II Quinolylene-vinylene as oligo-Quinoline Carboxamide Foldamer Isostere 
 
- 48 - 
 
9.08 (d, J = 16.5 Hz, 1 H), 8.75 (d, J = 16.5 Hz, 1 H), 8.20 (t, J = 7.3 Hz, 2 H), 8.06 (d, J = 
7.3 Hz, 1 H), 8.00 (d, J = 8.8 Hz, 1 H), 7.92 (d, J = 8.6 Hz, 2 H), 7.85 (d, J = 16.5 Hz, 1 H), 
7.76 (d, J = 8.8 Hz, 1 H), 7.64-7.45 (m, 5 H), 7.34 (s, 1 H), 7.26-7.14 (m, 4 H), 7.05 (t, J = 8.0 
Hz, 1 H), 6.6 (s, 1 H), 4.82 (s, 2 H), 4.22 (d, J = 4.7 Hz, 2 H), 4.21 (d, J = 5.3 Hz, 2 H), 4.16 
(d, J = 5.3 Hz, 2 H), 4.06 (d, J = 5.3 Hz, 2 H), 4.04 (d, J = 5.9 Hz, 2 H), 2.85 (s, 3 H), 
1.89-1.41 (m, 15 H), 1.05 (t, J = 7.5 Hz, 6 H), 1.01 (t, J = 7.5 Hz, 6 H), 0.99 (t, J = 7.7 Hz, 6 
H), 0.92 (t, J = 7.6 Hz, 6 H), 0.88 (t, J = 7.8 Hz, 6 H) ppm. 
9c: 
1
H NMR (300 MHz, CDCl3): δ9.98 (s, 1 H), 9.61 (d, J = Hz, 1 H), 9.39 (d, J = Hz, 1 
H), 9.01 (d, J = Hz, 1 H), 8.21 (d, J = Hz, 1 H), 8.14 (d, J = Hz, 1 H), 8.01 (d, J = Hz, 1 H), 
7.96 (d, J = Hz, 1 H), 7.93 (d, J = Hz, 2 H), 7.86 (d, J = Hz, 1 H), 7.76 (d, J = Hz, 1 H), 7.67 
(d, J = Hz, 1 H), 7.59-7.45 (m, 6 H), 7.29-7.24 (m, 2 H), 7.21-7.08 (m, 4 H), 7.06 (s, 1 H), 
7.05 (s, 1 H), 4.23 (d, J = Hz, 2 H), 4.19 (d, J = Hz, 2 H), 4.17 (d, J = Hz, 2 H), 4.09 (d, J = 
Hz, 2 H), 3.95 (d, J = Hz, 2 H), 2.83 (s, 3 H), 1.96-1.35 (m, 15 H), 1.06 (t, J = Hz, 6 H), 1.02 
(t, J = Hz, 6 H), 0.94 (t, J = Hz, 6 H), 0.92 (t, J = Hz, 6 H), 0.86 (t, J = Hz, 6 H) ppm; 
13
C 
NMR (75 MHz, CDCl3): δ 194.7, 162.8, 162.4, 162.1, 161.8, 161.7, 157.0, 156.7, 156.6, 
156.5, 152.9, 148.2, 147.4, 147.1, 146.6, 146.3, 136.7, 135.2, 134.3, 134.3, 132.1, 131.7, 
131.4, 131.3, 130.0, 129.8, 129.8, 129.7, 127.5, 127.2, 126.7, 126.2, 124.8, 124.7, 124.4, 
124.3, 123.1, 122.4, 122.0, 121.8, 121.7, 121.4, 121.2, 121.1, 120.9, 100.7, 99.3, 99.2, 97.8, 
96.3, 71.2, 70.5, 70.4, 41.1, 41.0, 40.8, 40.8, 40.7, 23.8, 23.8, 23.5, 23.5, 23.4, 18.6, 11.5, 11.4, 
11.3, 11.2, 11.2 ppm, HRMS (ESI) m/z: calcd for C85H98N5O6 [M+H]
+
 1284.7512, found 
1284.7537. 
10a: 
1
H NMR (300 MHz, CDCl3): δ 9.36 (d, J = 16.4 Hz, 1 H), 9.30 (d, J = 16.4 Hz, 1 
H), 9.29 (d, J = 16.4 Hz, 1 H), 9.13 (d, J = 16.4 Hz, 1 H), 8.94 (d, J = 16.5 Hz, 1 H), 8.14 (d, 
J = 5.9 Hz, 1 H), 8.08 (d, J = 7.1 Hz, 1 H), 8.04-7.90 (m, 7 H), 7.84-7.70 (m, 5 H), 7.66 (d, J 
= 6.8 Hz, 1 H), 7.60-7.54 (m, 2 H), 7.49 (d, J = 6.6 Hz, 1 H), 7.37- 7.29 (m, 4 H), 7.24-7.16 
(m, 4 H), 4.22 (d, J = 5.8 Hz, 2 H), 4.17-4.10 (m, 10 H), 3.84 (s, 3 H), 2.87 (s, 3 H), 1.91-1.44 
(m, 18 H), 1.03 (t, J = 7.3 Hz, 6 H), 0.99 (t, J = 7.4 Hz, 12 H), 0.96 (t, J = 7.4 Hz, 6 H), 0.93 
(t, J = 7.4 Hz, 6 H), 0.90 (t, J = 7.4 Hz, 6 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ 166.7, 163.0, 
162.0, 157.1, 157.0, 156.8, 148.1, 147.1, 146.9, 146.1, 163.7, 135.5, 134.4, 134.2, 134.1, 
133.0, 131.6, 131.4, 131.3, 131.1, 131.0, 130.8, 130.2, 129.8, 129.6, 127.3, 127.1, 126.7, 
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126.5, 126.2, 124.9, 124.5, 122.7, 122.0, 121.8, 121.4, 120.9, 119.7, 100.8, 99.5, 99.3, 99.0, 
98.5, 98.0, 71.1, 70.6, 70.5, 52.9, 41.0, 40.9, 40.8, 23.7, 23.7, 23.6, 23.5, 18.6, 11.4, 11.3, 11.3 
ppm, HRMS (ESI) m/z: calcd for C103H119N6O8 [M+H]
+
 1568.9118, found 1568.9151. 
10b: 
1
H NMR (300 MHz, CDCl3): δ 9.38 (d, J = 16.4 Hz, 1 H), 9.33 (d, J = 16.4 Hz, 1 
H), 9.23 (d, J = 16.4 Hz, 1 H), 9.13 (d, J = 16.4 Hz, 1 H), 8.81 (d, J = 16.4 Hz, 1 H), 8.14 (d, 
J = 7.8 Hz, 1 H), 8.07 (d, J = 7.8 Hz, 1 H), 8.02-7.86 (m, 4 H), 7.79-7.72 (m, 2 H), 7.69-7.47 
(m, 3 H), 7.33 (s, 1 H), 7.22-7.11 (m, 5 H), 6.63 (s, 1 H), 4.83 (s, 2 H), 4.22-4.07 (m, 12 H), 
2.86 (s, 3 H), 1.89-1.43 (m, 18 H), 1.05-0.85 (m, 36 H) ppm. 
10c: 
1
H NMR (300 MHz, CDCl3): δ 10.00 (s, 1 H), 9.31 (d, J = 16.1 Hz, 1 H), 9.36 (d, J 
= 16.4 Hz, 1 H), 9.18 (d, J = 16.4 Hz, 1 H), 9.11 (d, J = 16.4 Hz, 1 H), 9.02 (d, J = 16.4 Hz, 1 
H), 8.13 (d, J = 7.8 Hz, 1 H), 8.05-7.88 (m, 6 H), 7.82-7.80 (m, 2 H), 7.75-7.64 (m, 3 H), 
7.59-7.49 (m, 3 H), 7.37 (t, J = 7.9 Hz, 1 H), 7.32 (s, 2 H), 7.25-7.15 (m, 5 H), 7.10 (s, 1 H), 
7.08 (s, 1 H), 4.20-4.09 (m, 10 H), 4.02 (d, J = 5.8 Hz, 2 H), 2.88 (s, 3 H), 1.89-1.40 (m, 18 
H), 1.04-0.86 (m, 36 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ 194.6, 162.9, 162.2, 162.1, 
161.9, 161.8, 157.1, 157.0, 156.7, 156.5, 153.0, 148.3, 147.2, 147.1, 147.0, 146.4, 136.7, 
135.4, 134.4, 134.0, 132.4, 131.6, 131.3, 131.1, 130.9, 130.5, 129.8, 129.7, 127.6, 126.8, 
126.7, 126.5, 126.3, 124.8, 124.5, 124.3, 123.2, 122.0, 121.4, 121.2, 120.9, 119.7, 100.0, 99.6, 
99.0, 98.9, 98.1, 96.4, 71.3, 70.5, 41.1, 41.0, 40.9, 40.8, 40.7, 31.7, 23.8, 23.7, 23.6, 23.5, 22.8, 
18.6, 14.2, 11.4, 11.4, 11.3, 11.2, HRMS (ESI) m/z: calcd for C102H117N6O7 [M+H]
+
 
1538.9012, found 1538.9036. 
11a: 
1
H NMR (300 MHz, CDCl3): δ 9.34-9.26 (m, 4 H), 9.23 (d, J = 16.4 Hz, 1 H), 9.14 
(d, J = 16.4 Hz, 1 H), 8.95 (d, J = 16.6 Hz, 1 H), 8.15 (m, 2 H), 8.07-1.96 (m, 5 H), 7.92-7.36 
(m, 16 H), 7.20-7.02 (m, 3 H), 4.24-4.15 (m, 14 H), 3.85 (s, 3 H), 2.86 (s, 3 H), 1.90-1.77 (m, 
7 H), 1.62-1.43 (m, 28 H), 1.12-0.93 (m, 42 H) ppm, HRMS (ESI) m/z: calcd for 
C120H138N7O9 [M+H]
+
 1822.0584, found 1822.0619. 
13: 
1
H NMR (300 MHz, CDCl3): δ 8.72 (s, 1 H), 8.43 (d, J = 7.8 Hz, 1 H), 7.80 (d, J = 
7.8 Hz, 1 H), 7.44 (t, J = 8.0 Hz, 1 H), 6.66 (s, 1 H), 4.87 (s, 2 H), 3.95 (d, J = 6.4 Hz, 2 H), 
3.66 (w, 1 H), 2.27 (m, 1 H), 1,58 (s, 9 H), 1.13 (d, J = 6.6 Hz, 6 H) ppm; 
13
C NMR (75 MHz, 
CDCl3): δ 162.7, 158.9, 153.0, 137.7, 134.4, 126.0, 120.9, 115.7, 114.7, 98.0, 80.7, 77.6, 77.2, 
76.7, 75.0, 65.0, 28.6, 28.3, 19.4 ppm. 
II Quinolylene-vinylene as oligo-Quinoline Carboxamide Foldamer Isostere 
 
- 50 - 
 
14: 
1
H NMR (300 MHz, CDCl3): δ 10.17 (s, 1 H), 9.00 (s, 1 H), 8.49 (d, J = 7.8 Hz, 1 H), 
7.84 (d, J = 7.8 Hz, 1 H), 7.59 (t, J = 7.8 Hz, 1 H), 7.36 (s, 1 H), 4.04 (d, J = 6.5 Hz, 2 H), 
2.28 (m, 1 H), 1.60 (s, 9 H), 1.13 (d, J = 6.6 Hz, 6 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ 
193.7, 163.1, 152.8, 151.7, 138.7, 136.0, 129.2, 123.1, 115.7, 114.5, 96.9, 81.0, 77.6, 77.2, 
76.7, 75.4, 28.5, 28.3, 19.4 ppm. 
15a: 
1
H NMR (300 MHz, CDCl3): δ 9.15 (s, 1 H), 8.81 (d, J = 16.6 Hz, 1 H), 8.39 (d, J = 
7.8 Hz, 1 H), 8.25-8.23 (m, 2 H), 7.80 (d, J = 16.6 Hz, 1 H), 7.78 (d, J = 7.8 Hz, 1 H), 7.66 (t, 
J = 7.8 Hz, 1 H), 7.62 (s, 1 H), 7.42 (t, J = 8.0 Hz, 1 H), 7.34 (s, 1 H), 4.21 (d, J = 5.6 Hz, 2 
H), 4.11 (d, J = 6.4 Hz, 2 H), 4.09 (s, 3 H), 2.40-2.26 (m, 1 H), 1.93-1.81 (m, 1 H), 1.69-1.54 
(m, 2 H), 1.60 (s, 9 H), 1.18 (d, J = 6.3 Hz, 6 H), 1.01 (t, J = 7.2 Hz, 6 H) ppm; 
13
C NMR (75 
MHz, CDCl3): δ 166.6, 163.2, 162.1, 155.8, 153.1, 148.3, 146.3, 139.0, 135.7, 135.0, 132.8, 
129.6, 127.6, 127.5, 126.0, 123.0, 122.3, 120.8, 115.0, 114.4, 100.9, 98.2, 80.4, 74.8, 71.2, 
53.1, 41.0, 28.6, 28.4, 23.8, 19.5, 11.4 ppm, HRMS (ESI) m/z: calcd for C37H46N3O6 [M+H]
+
 
628.3381, found 628.3380. 
15b: 
1
H NMR (300 MHz, CDCl3): δ 9.14 (s, 1 H), 8.82 (d, J = 16.7 Hz, 1 H), 8.39 (d, J = 
7.5 Hz, 1 H), 8.21-8.17 (m, 2 H), 7.78 (d, J = 8.3 Hz, 1 H), 7.56 (d, J = 16.7 Hz, 1 H), 7.55 (t, 
J = 7.8 Hz, 1 H), 7.41 (t, J = 8.0 Hz, 1 H), 7.17 (s, 1 H), 6.67 (s, 1 H), 4.91 (s, 2 H), 4.11 (d, J 
= 5.6 Hz, 2H), 4.07 (d, J = 6.4 Hz, 2 H), 2.35-2.26 (m, 1 H), 1.88-1.81 (m, 1 H), 1.60 (s, 9 H), 
1.65-1.52 (m, 4 H), 1.16 (d, J = 6.7 Hz, 6 H), 1.00 (t, J = 7.4 Hz, 6 H) ppm; 
13
C NMR (75 
MHz, CDCl3): δ 162.7, 162.3, 159.8, 155.6, 153.1, 145.3, 139.0, 134.9, 134.0, 131.6, 129.8, 
127.0, 126.0, 125.4, 122.7, 121.7, 120.8, 115.0, 114.4, 98.5, 97.6, 80.4, 74.7, 70.9, 64.7, 41.0, 
28.6, 28.4, 23.8, 19.5, 11.4 ppm. 
15c: 
1
H NMR (300 MHz, CDCl3): δ 10.27 (s, 1 H), 9.19 (s, 1 H), 9.08 (d, J = 16.7 Hz, 1 
H), 8.42 (d, J = 7.32 Hz, 1 H), 8.28-8.25 (m, 2 H), 7.79 (d, J = 8.4 Hz, 1 H), 7.70 (t, J = 7.8 
Hz, 1 H), 7.66 (d, J = 16.7 Hz, 1 H), 7.43 (t, J = 8.1 Hz, 1 H), 7.43 (s, 1 H), 7.16 (s, 1 H), 4.21 
(d, J = 5.6 Hz, 2 H), 4.08 (d, J = 6.33 Hz, 2 H), 2.37-2.28 (m, 1 H), 1.93-1.83 (m, 1 H), 1.61 
(s, 9 H), 1.64-1.61 (m, 4 H), 1.18 (d, J = 6.6 Hz, 6 H), 1.01 (t, J = 7.4 Hz, 6 H) ppm; 
13
C 
NMR (75 MHz, CDCl3): δ 194.5, 163.2, 162.4, 155.2, 153.3, 153.1, 146.7, 139.1, 135.9, 
135.0, 131.9, 129.3, 128.1, 127.1, 126.1, 123.8, 122.6, 120.8, 115.1, 114.4, 99.3, 96.7, 80.5, 
74.8, 71.3, 40.9, 28.6, 28.4, 23.7, 19.5, 11.4 ppm, HRMS (ESI) m/z: calcd for C36H44N3O5 
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[M+H]
+
 598.3276, found 598.3275. 
16a: 
1
H NMR (300 MHz, CDCl3): δ 9.20 (s, 1 H), 9.11 (d, J = 16.6 Hz, 1 H), 9.07 (d, J = 
16.6 Hz, 1 H), 8.38 (d, J = 7.6 Hz, 1 H), 8.27-8.18 (m, 4 H), 7.82-7.76 (m, 2 H), 7.69 (d, J = 
16.8 Hz, 1 H), 7.65 (t, J = 7.6 Hz, 1 H), 7.63 (s, 1 H), 7.53 (t, J = 7.7 Hz, 1 H), 7.40 (t, J = 8.1 
Hz, 1 H), 7.34 (s, 1 H), 7.31 (s, 1 H), 4.27 (d, J = 5.3 Hz, 2 H), 4.21 (d, J = 5.5 Hz, 2 H), 3.99 
(d, J = 6.5 Hz, 2 H), 3.84 (s, 3 H), 2.22-2.11 (m, 1 H), 1.96-1.84 (m, 2 H), 1.75-1.55 (m, 8 H), 
1.55 (s, 9 H), 1.05 (t, J = 7.6 Hz, 6 H), 1.02 (t, J = 7.3 Hz, 6 H), 1.01 (d, J = 7.1 Hz, 6 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ 166.6, 163.2, 162.3, 162.1, 157.0, 156.1, 153.2, 148.4, 146.4, 
139.0, 136.0, 134.9, 134.4, 132.7, 131.2, 130.6, 130.1, 127.5, 127.4, 126.9, 125.8, 125.2, 
123.0, 122.5, 122.3, 121.6, 120.7, 115.0, 114.4, 101.0, 98.9, 98.7, 80.3, 74.7, 71.2, 70.6, 53.0, 
41.1, 41.0, 28.6, 28.3, 23.8, 23.7, 19.3, 11.5, 11.4 ppm, HRMS (ESI) m/z: calcd for 
C54H65N4O7 [M+H]
+
 881.4849, found 881.4847. 
16b: 
1
H NMR (300 MHz, CDCl3): δ 9.19 (s, 1 H), 8.99 (d, J = 16.8 Hz, 1 H), 8.92 (d, J = 
16.6 Hz, 1 H), 8.37 (d, J = 7.2 Hz, 1 H), 8.21-8.16 (m, 4 H), 7.77 (dd, J = 8.3, 1.2 Hz, 1 H), 
7.69 (d, J = 16.6 Hz, 1 H), 7.67 (d, J = 16.8 Hz, 1 H), 7.54 (t, J = 7.1 Hz, 1 H), 7.52 (t, J = 7.1 
Hz, 1 H), 7.39 (d, J = 16.1 Hz, 1 H), 7.30 (s, 1 H), 7.24 (s, 1 H), 6.67 (s, 1 H), 4.83 (s, 2 H), 
4.24 (d, J = 5.4 Hz, 2 H), 4.11 (d, J = 5.5 Hz, 1 H), 4.04 (d, J = 6.4 Hz, 2 H), 2.32-1.98 (m, 2 
H), 1.74-1.54 (m, 12 H), 1.53 (s, 9 H), 1.07 (d, J = 6.8 Hz, 6 H), 1.03 (t, J = 7.9 Hz, 6 H), 1.00 
(t, J = 7.4 Hz, 6 H) ppm.  
16c: 
1
H NMR (300 MHz, CDCl3): δ 10.13 (s, 1 H), 9.19 (s, 1 H), 9.12 (d, J = 16.5 Hz, 1 
H), 9.03 (d, J = 16.7 Hz, 1 H), 8.38 (d, J = 7.4 Hz, 1 H), 8.27 (d, J = 8.3 Hz, 1 H), 8.28 (d, J = 
7.1 Hz, 1 H), 8.21 (d, J = 6.9, 1 H), 8.18 (d, J = 7.6 Hz, 1 H), 7.80 (d, J = 16.8Hz, 1 H), 7.78 
(d, J = 4.7 Hz, 1 H), 7.70 (d, J = 16.7 Hz, 1 H), 7.69 (t, J = 7.9, 1 H), 7.53 (t, J = 15.6 Hz, 1 
H), 7.41 (t, J = 8.0 Hz, 1 H), 7.42 (s, 1 H), 7.29 (s, 1 H), 7.28 (s, 1 H), 4.02 (d, J = 6.4 Hz, 2 
H), 4.27 (d, J = 5.5 Hz, 2 H), 4.21 (d, J = 5.6 Hz, 2 H), 2.27-2.19 (m, 1 H), 1.94-1.84 (m, 2 H), 
1.68-1.51 (m, 8 H), 1.51 (s, 9 H), 1.08 (d, J = 6.7 Hz, 6 H), 1.06 (t, J = 7.4 Hz, 6 H), 1.01 (t, J 
= 7.4 Hz, 6 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ 194.3, 163.2, 162.3, 162.2, 156.9, 156.0, 
153.3, 153.1, 147.1, 146.8, 139.0, 136.1, 134.9, 134.6, 132.9, 131.4, 130.7, 129.8, 128.1, 
127.4, 127.1, 125.8, 125.3, 123.7, 122.6, 122.5, 121.6, 120.7, 115.0, 114.4, 98.8, 98.6, 96.7, 
80.2, 74.7, 71.3, 70.6, 41.1, 40.9, 28.5, 28.4, 23.9, 23.7, 19.4, 11.5, 11.3 ppm, HRMS (ESI) 
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m/z: calcd for C53H63N4O6 [M+H]
+
 851.4742, found 851.4741. 
17a: 
1
H NMR (300 MHz, CDCl3): δ 9.48 (d, J = 16.5 Hz, 1 H), 9.13 (s, 1 H), 9.10 (d, J = 
17.9 Hz, 1 H), 8.97 (d, J = 16.9 Hz, 1 H), 8.29 (d, J = 7.3 Hz, 1 H), 8.22-8.18 (m, 4 H), 7.95 
(d, J = 8.1 Hz, 1 H), 7.75-7.70 (m, 4 H), 7.54-7.50 (m, 4 H), 7.42 (d, J = 7.9 Hz, 1 H), 7.29 (s, 
1 H), 7.22-7.15 (m, 3 H), 4.27 (d, J = 5.1 Hz, 2 H), 4.18-4.16 (m, 4 H), 3.89 (d, J = 6.2 Hz, 2 
H), 3.77 (s, 3 H), 2.17-2.07 (m, 1 H), 1.94-1.80 (m, 3 H), 1.74-1.51 (m, 12 H), 1.57 (s, 9 H), 
1.05 (t, J = 7.5 Hz, 6 H), 1.02 (t, J = 7.4 Hz, 6 H), 0.98 (t, J = 7.4 Hz, 6 H), 0.90 (d, J = 6.6 
Hz, 6 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ 166.6, 163.0, 162.3, 161.9, 157.1, 157.0, 156.0, 
153.2, 148.0, 146.1, 138.8, 135.2, 134.7, 132.4, 131.4, 131.2, 130.5, 127.4, 127.1, 126.7, 
125.4, 125.1, 125.0, 122.6, 122.5, 122.4, 122.0, 121.6, 121.5, 120.5, 114.8, 113.4, 100.7, 99.8, 
99.0, 98.4, 80.2, 74.4, 71.2, 70.7, 70.6, 52.8, 41.1, 41.0, 40.9, 28.6, 28.2, 23.8, 23.7, 23.7, 19.2, 
11.4, 11.4 ppm, HRMS (ESI) m/z: calcd for C71H84N5O8 [M+H]
+
 1134.6314, found 
1134.6331. 
17c: 
1
H NMR (300 MHz, CDCl3): δ 9.91 (s, 1 H), 9.61 (d, J = 16.3 Hz, 1 H), 9.10 (d, J = 
16.7 Hz, 1 H), 9.04 (d, J = 19.8 Hz, 1 H), 8.25-8.13 (m, 4 H), 7.85 (d, J = 7.8 Hz, 1 H), 
7.71-7.50 (m, 5 H), 7.33 (d, J = 7.8 Hz, 1 H), 7.29 (s, 1 H), 7.18-7.10 (m, 4 H), 4.25 (d, J = 
5.5 Hz, 2 H), 4.20 (d, J = 5.6 Hz, 2 H), 4.16 (d, J = 5.9 Hz, 2 H), 3.80 (d, J = 6.7 Hz, 2 H), 
2.06-1.84 (m, 4 H), 1.70-1.54 (m, 12 H), 1.56 (s, 9 H), 1.06 (t, J = 7.4 Hz, 6 H), 1.02 (t, J = 
7.4 Hz, 6 H), 1.01 (t, J = 7.4 Hz, 6 H), 0.83 (d, J = 6.7 Hz, 6 H) ppm; 
13
C NMR (75 MHz, 
CDCl3): δ 194.6, 162.9, 162.4, 162.3, 161.6, 156.7, 155.9, 153.1, 153.0, 147.4, 147.1, 146.4, 
138.6, 135.0, 134.8, 134.7, 134.0, 131.8, 131.5, 131.1, 130.6, 130.4, 130.2, 127.4, 127.0, 
126.9, 126.6, 125.2, 125.1, 124.9, 123.2, 122.5, 122.4, 122.0, 121.5, 120.4, 114.6, 114.2, 
100.4, 99.4, 98.2, 96.4, 80.2, 74.2, 71.4, 70.6, 70.6, 41.0, 41.0, 40.7, 28.6, 28.2, 23.9, 23.8, 
23.7, 23.6, 19.2, 19.1, 11.5, 11.4, 11.4, 11.3 ppm, HRMS (ESI) m/z: calcd for C70H82N5O7 
[M+H]
+
 1104.6209, found 1104.6226. 
18a: 
1
H NMR (300 MHz, CDCl3): δ 9.42 (d, J = 16.6 Hz, 1 H), 9.35 (d, J = 16.4 Hz, 1 
H), 9.18 (s, 1 H), 9.02 (d, J = 16.8 Hz, 1 H), 8.88 (d, J = 16.7 Hz, 1 H), 8.36 (d, J = 7.2 Hz, 1 
H), 8.21-8.18 (m, 2 H), 8.05 (d, J = 7.3 Hz, 1 H), 8.02 (d, J = 8.4 Hz, 1 H), 7.96 (d, J = 8.2 Hz, 
1 H), 7.90-7.80 (m, 3 H), 7.72-7.60 (m, 5 H), 7.56 (s, 1 H), 7.51 (t, J = 7.8 Hz, 1 H), 7.35-7.18 
(m, 9 H), 4.24 (d, J = 5.6 Hz, 2 H), 4.19 (d, J =5.6 Hz, 2 H), 4.15 (d, J = 5.7 Hz, 2 H), 4.07 (d, 
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J = 5.8 Hz, 2 H), 4.02 (d, J = 6.5 Hz, 2 H), 3.83 (s, 3 H), 2.25-2.17 (m, 1 H), 1.96-1.54 (m, 20 
H), 1.58 (s, 9 H), 1.08-0.83 (m, 30 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ 166.7, 163.0, 
162.3, 162.1, 162.0, 157.2, 157.1, 156.9, 156.2, 153.2, 148.0, 147.3, 147.0, 146.8, 146.1, 
138.9, 135.4, 134.8, 134.4, 134.2, 134.1, 132.9, 131.5, 131.3, 130.9, 130.7, 130.4, 129.9, 
127.3, 127.2, 126.6, 126.4, 125.5, 124.8, 124.5, 122.6, 122.4, 122.2, 122.1, 121.8, 121.5, 
121.3, 120.6, 114.8, 114.4, 100.7, 99.9, 99.3, 98.7, 98.4, 80.2, 74.6, 71.1, 70.7, 70.6, 52.8, 
41.0, 41.0, 40.9, 40.8, 28.6, 28.3, 23.8, 23.7, 23.7, 23.5, 19.3, 11.4, 11.4, 11.3, 11.3 ppm, 
HRMS (ESI) m/z: calcd for C88H103N6O9 [M+H]
+
 1387.7781, found 1387.7816. 
18b: 
1
H NMR (300 MHz, CDCl3): δ 9.40 (d, J = 16.5 Hz, 1 H), 9.38 (d, J = 16.5 Hz, 1 
H), 9.18 (s, 1 H), 9.01 (d, J = 16.8 Hz, 1 H), 8.74 (d, J = 16.6 Hz, 1 H), 8.34 (d, J = 7.7 Hz, 1 
H), 8.20 (d, J = 8.2 Hz, 1 H), 8.19 (d, J = 7.5 Hz, 1 H), 8.03 (d, J = 5.4 Hz, 1 H), 8.01 (d, J = 
6.9 Hz, 1 H), 7.93 (d, J = 8.2 Hz, 1 H), 7.88 (d, J = 5.5 Hz, 1 H), 7.84 (d, J = 16.5 Hz, 1 H), 
7.81 (d, J = 8.1 Hz, 1 H), 7.67-7.47 (m, 6 H), 7.32 (t, J = 8.1 Hz, 1 H), 7.27 (s, 1 H), 
7.23-7.16 (m, 5 H), 7.10 (t, J = 7.8 Hz, 1 H), 6.61 (s, 1 H), 4.81 (s, 2 H), 4.21 (d, J = 5.5 Hz, 4 
H), 4.07 (d, J = 5.3 Hz, 2 H), 4.05 (d, J = 4.7 Hz, 2 H), 4.00 (d, J = 6.6 Hz, 2 H), 2.27-2.18 (m, 
1 H), 1.92-1.49 (m, 20 H), 1.07-0.96 (m, 24 H), 0.89 (t, J = 7.4 Hz, 6 H) ppm. 
18c: 
1
H NMR (300 MHz, CDCl3): δ 9.98 (s, 1 H), 9.54 (d, J = 16.3 Hz, 1 H), 9.34 (d, J = 
16.6 Hz, 1 H), 9.15 (s, 1 H), 8.99 (d, J = 16.6 Hz, 1 H), 8.92 (d, J = 16.8 Hz, 1H), 8.35 (d, J = 
7.0 Hz, 1 H), 8.22 (d, J = 8.2 Hz, 1 H), 8.14 (d, J = 6.5 Hz, 1 H), 7.99 (d, J = 7.9 Hz, 2 H), 
7.90 (d, J = 6.3 Hz, 1 H), 7.87 (d, J = 7.2 Hz, 1 H), 7.78 (d, J = 16.4 Hz, 1 H), 7.73 (d, J = 8.2 
Hz, 1 H), 7.64-7.48 (m, 6 H), 7.33 (t, J = 8.0 Hz, 1 H), 7.31 (s, 1 H), 7.26-7.13 (m, 3 H), 7.11 
(s, 1 H), 7.09 (s, 1 H), 7.07 (s, 1 H), 4.22 (d, J = 5.9 Hz, 2 H), 4.20 (d, J = 5.9 Hz, 2 H), 4.09 
(d, J = 5.8 Hz, 2 H), 4.02 (d, J = 6.6 Hz, 2 H), 3.98 (d, J = 5.8 Hz, 2 H), 2.28-2.17 (m, 1 H), 
1.94-1.38 (m, 20 H), 1.59 (s, 9 H), 1.08-0.99 (m, 18 H), 0.95 (t, J = 7.4 Hz, 6 H), 0.87 (t, J = 
7.4 Hz, 6 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ 194.6, 162.8, 162.4, 162.2, 161.9, 161.8, 
157.0, 156.8, 156.5, 156.2, 153.2, 153.0, 147.4, 147.1, 146.6, 146.4, 138.9, 135.9, 135.3, 
134.8, 134.3, 134.0, 132.2, 131.7, 131.4, 131.2, 130.7, 130.6, 130.1, 129.8, 127.5, 127.3, 
127.0, 126.4, 125.7, 125.4, 124.8, 124.3, 123.2, 122.5, 122.2, 122.0, 121.9, 121.5, 121.3, 
121.2, 120.6, 114.8, 114.4, 100.4, 99.4, 99.2, 98.3, 96.4, 80.2, 74.6, 71.3, 70.6, 41.0, 40.9, 
40.8, 34.4, 30.5, 29.6, 28.6, 28.4, 23.8, 23.5, 23.4, 21.3, 19.3, 11.4, 11.4, 11.3, 11.2 ppm, 
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HRMS (ESI) m/z: calcd for C87H101N6O8 [M+H]
+
 1357.7675, found 1357.7717. 
19a: 
1
H NMR (300 MHz, CDCl3): δ 9.34 (d, J = 16.6 Hz, 1 H), 9.31 (d, J = 16.2 Hz, 1 
H), 9.28 (d, J = 16.4 Hz, 1 H), 9.19 (s, 1 H), 9.06 (d, J = 16.7 Hz, 1 H), 8.93 (d, J = 16.7 Hz, 1 
H), 8.36 (d, J = 6.5 Hz, 1 H), 8.13 (d, J = 6.8 Hz, 1 H), 8.09 (d, J = 6.7 Hz, 1 H), 8.03-7.99 (m, 
4 H), 7.94-7.56 (m, 12 H), 7.39 (d, J = 15.7 Hz, 1 H), 7.34-7.15 (m, 12 H), 4.23 (d, J = 5.8 Hz, 
2 H), 4.17 (d, J = 5.5 Hz, 6 H), 4.12 (d, J = 5.6 Hz, 2 H), 3.98 (d, J = 6.4 Hz, 2 H), 3.84 (s, 3 
H),2.21-2.12 (m, 1 H), 1.93-1.77 (m, 5 H), 1.66-1.44 (m, 29 H), 1.08-0.86 (m, 36 H) ppm; 
13
C 
NMR (75 MHz, CDCl3): δ 166.6, 162.1, 157.2, 156.9, 156.2, 153.2, 148.1, 147.0, 146.2, 
134.8, 134.3, 131.5, 130.9, 127.2, 127.1, 126.7, 125.5, 124.7, 122.4, 122.1, 121.8, 121.2, 
120.7, 114.8, 114.4, 100.8, 99.4, 98.4, 80.2, 74.6, 71.2, 70.7, 52.9, 40.9, 28.6, 28.3, 23.7, 23.6, 
22.8, 19.3, 11.4, 11.3 ppm, HRMS (ESI) m/z: calcd for C105H122N7O10 [M+H]
+
 1641.9281, 
found 1641.9285. 
15e: 
1
H NMR (300 MHz, CDCl3): δ 8.92 (d, J = 16.Hz, 1 H), 8.22 (d, J = 8.2 Hz, 1 H), 
8.21 (d, J = 7.2 Hz, 1 H), 7.69 (d, J = 16.7Hz, 1 H), 7.64 (t, J = 7.7 Hz, 1 H), 7.62 (s, 1 H), 
7.52 (d, J = 8.2 Hz, 1 H), 7.25 (t, J = 8.7 Hz, 1 H), 7.22 (s, 1 H), 6.93 (d, J = 7.4 Hz, 1 H), 
4.21 (d, J = 5.6 Hz, 2 H), 4.08 (d, J = 6.1 Hz, 2 H), 4.08 (s, 3 H), 2.36-2.27 (m, 1 H), 
1.90-1.84 (m, 1 H), 1.66-1.54 (m, 4 H), 1.17 (d, J = 6.7 Hz, 6 H), 1.01 (t, J = 7.4 Hz, 6 H) 
ppm. 
21: 
1
H NMR (300 MHz, CDCl3): δ 12.41 (s, 1 H), 12.29 (s, 1 H), 9.05 (d, J = 7.7 Hz, 1 
H), 8.98 (d, J = 7.7 Hz, 1 H), 8.25 (d, J = 8.32 Hz, 1 H), 8.24 (d, J = 7.9 Hz, 1 H), 8.14 (d, J = 
16.8 Hz, 1 H), 8.09 (d, J = 8.4 Hz, 1 H), 7.94 (d, J = 8.3 Hz, 1 H), 7.94 (s, 1 H),  7.71-7.58 
(m, 5 H), 7.58 (s, 1 H), 7.34 (t, J = 7.9 Hz, 1 H), 7.16 (s, 1 H), 6.73 (d, J = 16.7 Hz, 1 H), 6.54 
(s, 1 H), 4.22 (d, J = 5.6 Hz, 2 H), 4.19 (d, J = 6.4 Hz, 2 H), 3.93 (d, J = 6.4 Hz, 2 H), 3.81 (s, 
3 H), 3.09 (d, J = 6.9 Hz, 2 H), 2.40-2.24 (m, 2 H), 1.95-1.85 (m, 1 H), 1.69-1.58 (m, 5 H), 
1.21 (d, J = 6.7 Hz, 6 H), 1.18 (d, J = 6.8 Hz, 6 H), 1.04 (t, J = 7.4 Hz, 6 H), 0.78 (d, J = 6.7 
Hz, 6 H) ppm.  
15d: 
1
H NMR (300 MHz, CDCl3): δ 9.12 (s, 1 H), 8.76 (d, J = 16.4 Hz, 1 H), 8.43 (d, J = 
7.8 Hz, 1 H), 8.29 (d, J = 9.5 Hz, 1 H), 8.26 (d, J = 7.2 Hz, 1 H), 7.80 (d, J = 8.3 Hz, 1 H), 
7.71 (t, J = 7.9 Hz, 1 H), 7.71 (s, 1 H), 7.55 (d, J = 16.4 Hz, 1 H), 7.44 (t, J = 8.1 Hz, 1 H), 
7.08 (s, 1 H), 4.25 (d, J =5.6 Hz, 2 H), 4.07 (d, J = 6.4 Hz, 2 H), 2.34-2.28 (m, 1 H), 1.94-1.82 
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(m, 1 H), 1.68-1.51 (m, 13 H), 1.17 (d, J = 6.7 Hz, 6 H), 1.02 (t, J = 7.4 Hz, 6 H) ppm, HRMS 
(ESI) m/z: calcd for C36H42N3O6 [M-H]
-
 612.3068, found 612.3063. 
23a: 
1
H NMR (300 MHz, CDCl3): δ 11.91 (s, 1H), 11.82 (s, 1 H), 11.72 (s, 1 H), 11.49 (s, 
1 H), 8.64 (s, 1 H), 8.50 (d, J = 6.7 Hz, 1 H), 8.36 (d, J = 7.8 Hz, 1 H), 8.32 (d, J = 8.6 Hz, 1 
H), 8.28 (d, J = 7.4 Hz, 1 H), 8.23 (d, J = 7.3 Hz, 1 H), 8.09 (d, J = 8.5 Hz, 1 H), 8.06 (d, J = 
7.6 Hz, 1 H), 7.85 (d, J = 6.8 Hz, 1 H), 7.80 (d, J = 8.5 Hz, 1 H), 7.67 (d, J = 7.6 Hz, 1 H), 
7.62 (d, J = 7.5 Hz, 2 H), 7.47 (d, J = 16.2 Hz, 1 H), 7.40-7.19 (m, 6 H), 7.09-6.98 (m, 2 H), 
6.87 (s, 1 H), 6.82 (s, 1 H), 6.62 (d, J = 16.6 Hz, 1 H), 6.47 (s, 1 H), 6.20 (s, 1 H), 4.54-4.49 
(m, 1 H), 4.51 (d, J = 9.0 Hz, 2 H), 4.33-4.27 (m, 2 H), 4.11-3.93 (m, 5 H), 3.68 (d, J = 6.6 Hz, 
2 H), 3.17 (s, 3 H), 2.57-2.07 (m, 6 H), 1.85-1.71 (m, 4 H), 1.59 (s, 9 H), 1.34-1.07 (m, 30 H), 
0.70 (d, J =6.6 Hz, 3 H), 0.59 (d, J = 6.7 Hz, 3 H) ppm, HRMS (ESI) m/z: calcd for 
C93H102N11O14 [M+H]
+
 1597.7636, found 1597.7646. 
23b: 
1
H NMR (300 MHz, CDCl3): δ 11.93 (s, 1 H), 11.89 (s, 1 H), 11.76 (s, 1 H), 11.58 
(s, 1 H), 8.54 (d, J = 8.0 Hz, 1 H), 8.40 (d, J = 7.6 Hz, 1 H), 8.29 (d, J = 7.6 Hz, 1 H), 8.24 (d, 
J = 8.1 Hz, 1 H), 8.08 (d, J = 8.4 Hz, 1 H), 8.05 (d, J = 8.5 Hz, 1 H), 7.83 (d, J = 6.0 Hz, 1 H), 
7.81 (d, J = 7.1 Hz, 1 H), 7.74 (d, J = 16.8 Hz, 1 H), 7.64 (t, J = 7.9 Hz, 1 H), 7.48 (t, J = 7.9 
Hz, 1 H), 7.40 (t, J = 8.1 Hz, 1 H), 7.39 (s, 1 H), 7.36-7.28 (m, 2 H), 7.23 (s, 1H), 7.20-7.10 
(m, 1 H), 7.02 (t, J = 7.9 Hz, 1 H), 6.85 (s, 1H), 6.81 (s, 1H), 6.74 (d, J = 7.4 Hz, 1 H), 6.50 (d, 
J = 16.5 Hz, 1 H), 6.48 (s, 1 H), 6.22 (s, 1H), 4.55-4.47 (m, 3 H), 4.35-4.27 (m, 2 H), 
4.12-3.92 (m, 5 H), 3.68 (d, J = 6.3 Hz, 2 H), 3.18 (s, 3 H), 2.57-2.08 (m, 6 H), 1.87-1.70 (m, 
4 H), 1.37-1.23 (m, 18 H), 1.19-1.13 (m, 6 H), 1.10 (t, J = 6.3 Hz, 6 H), 0.70 (d, J = 6.7 Hz, 3 
H), 0.60 (d, J = 6.7 Hz, 3 H) ppm. 
27: 
1
H NMR (400 MHz, CDCl3): δ 11.30 (s, 1 H), 11.20 (s, 1 H), 11.14 (s, 1 H), 11.01 (s, 
1 H), 10.97 (s, 1 H), 10.84 (s, 1 H), 10.78 (s, 1 H), 10.72 (s, 1 H), 8.24 (d, J = 8.2 Hz, 1 H), 
8.19 (d, J = 7.5 Hz, 1 H),  8.15 (d, J = 7.7 Hz, 1 H), 8.14 (d, J = 7.5 Hz, 1 H), 8.07 (d, J = 
7.5 Hz, 1 H), 7.96 (d, J = 8.3 Hz, 1 H), 7.91 (d, J = 7.5 Hz, 1 H), 7.84 (d, J = 8.2 Hz, 1 H), 
7.53 (d, J = 7.9 Hz, 1 H), 7.40 (d, J = 7.7 Hz, 1 H),  7.38 (d, J = 7.9 Hz, 1 H), 7.30 (t, J = 7.8 
Hz, 1 H), 7.01 (s, 1 H), 6.63 (s,1 H), 6.61 (s, 1 H), 6.50 (s, 1 H),    6.27 (s, 1 H), 5.88 (s, 1 
H), 5.40 (s, 1 H), 5.08 (s, 1 H), 2.94 (s, 3 H), 1.04 (t, J = 7.9 Hz, 6 H) ppm; 
13
C NMR (200 
MHz, CDCl3): δ 163.9, 163.5, 163.3, 163.2, 163.2, 163.0, 162.9, 162.4, 162.1, 161.8, 161.6, 
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161.0, 161.0, 160.8, 160.8, 160.6, 160.2, 159.8, 159.8, 153.4, 150.6, 150.4, 150.0, 149.2, 
148.8, 148.6, 148.2, 145.4, 145.0, 144.6, 139.9, 139.1, 139.1, 139.0, 138.6, 138.4, 138.3, 
137.9, 137.8, 137.2, 134.6, 133.9, 133.8, 133.8, 133.7, 133.7, 133.5, 133.3, 132.6, 128.3, 
127.6, 127.3, 127.2, 126.8, 126.7, 126.2, 126.1, 125.3, 124.6, 124.4, 124.0, 123.3, 122.6, 
122.4, 122.1, 121.9, 121.8, 121.6, 121.3, 120.7, 117.4, 117.4, 117.3, 117.2, 116.9, 116.8, 116.5, 
116.4, 116.4, 116.3, 116.1, 115.6, 115.2, 114.8, 100.4, 100.4, 100.0, 99.5, 98.8, 98.1, 98.0, 
97.9, 97.8, 76.0, 75.8, 75.7, 75.6, 75.5, 75.2, 75.0, 74.9, 71.8, 52.0, 41.6, 28.8, 28.8, 28.8, 28.7, 
28.7, 28.6, 28.5, 28.5, 24.2, 24.1, 19.6, 19.6, 19.6, 19.6, 19.5, 19.5, 19.4, 19.4, 19.3, 19.3, 19.2, 
19.2, 11.6 ppm, HRMS (ESI) m/z: calcd for C144H148N19O22 [M+H]
+
 2496.1074, found 
2496.1087. 
17d: 
1
H NMR (300 MHz, CDCl3): δ 9.68 (d, J = 16.2 Hz, 1 H), 9.10 (d, J = 16.9 Hz, 1 
H), 8.93 (s, 1H), 8.79 (d, J = 16.1 Hz, 1 H), 8.21 (d, J = 7.2 Hz, 4 H), 8.13 (d, J = 7.4 Hz, 1 
H), 7.81 (d, J = 8.3 Hz, 1 H), 7.65 (d, J = 16.3 Hz, 1 H), 7.60-7.49 (m, 6 H), 7.43 (d, J = 16.3 
Hz, 1 H), 7.30 (d, J = 8.1 Hz, 1 H), 7.13-7.02 (m, 6 H), 4.24-4.19 (m, 6 H), 3.73 (d, J = 6.7 
Hz, 2 H), 1.97-1.88 (m, 4 H), 1.68-1.58 (m, 12 H), 1.07-0.99 (m, 18 H), 0.78 (d, J = 6.7 Hz, 6 
H) ppm, HRMS (ESI) m/z: calcd for C70H82N5O8 [M+H]
+
 1120.6158, found 1120.6208. 
19d: 
1
H NMR (300 MHz, CDCl3): δ 9.38 (d, J = 16.5 Hz, 1 H), 9.36 (d, J = 16.3 Hz, 1 
H), 9.16 (d, J = 16.2 Hz, 1 H), 9.18 (s, 1 H), 8.99 (d, J = 16.8 Hz, 1 H), 8.72 (d, J = 16.4 Hz, 1 
H), 8.35 (d, J = 6.8 Hz, 1 H), 8.11 (d, J = 6.6 Hz, 1 H), 7.97 (d, J = 6.7 Hz, 4 H), 7.87 (d, J = 
7.4 Hz, 1 H), 7.82 (d, J = 6.5 Hz, 1 H), 7.74 (d, J = 7.8 Hz, 1 H), 7.68-7.30 (m, 11 H), 
7.22-7.07 (m, 5 H), 7.00 (s, 1 H), 6.97 (s, 1 H), 6.91 (s, 1 H), 4.19-4.12 (m, 8 H), 3.96 (d, J = 
6.0 Hz, 4 H), 2.20-2.11 (m, 1 H), 1.92-1.82 (m, 5 H), 1.66-1.37 (m, 31 H), 1.02-0.83 (m, 36 H) 
ppm, HRMS (ESI) m/z: calcd for C104H120N7O10 [M+H]
+
 1627.9125, found 1627.9177. 
24a: 
1
H NMR (300 MHz, CDCl3): δ 11.62 (s, 1 H), 11.60 (s, 1 H), 11.47 (s, 1 H), 11.36 
(s, 1H), 8.82 (s, 1 H), 8.70 (d, J = 16.3 Hz, 1 H), 8.50 (d, J = 16.7 Hz, 1 H), 8.33 (d, J = 7.4 
Hz, 1 H), 8.22-8.08 (m, 4 H), 8.01-7.91 (m, 3 H), 7.84 (d, J = 7.3 Hz, 1 H), 7.74-7.60 (m, 3 
H), 7.54-7.34 (m, 6 H), 7.24-7.06 (m, 6 H), 6.98 (t, J = 7.9 Hz, 1 H), 6.87 (s, 1 H), 6.80 (d, J 
= 6.1 Hz, 1 H), 6.75 (d, J = 7.9 Hz, 1 H), 6.67 (s, 1 H), 6.58 (s, 1 H), 6.40 (s, 1 H), 6.22 (s, 1 
H), 6.07 (s, 1 H), 4.47-4.42 (m, 1 H), 4.24-3.68 (m, 12 H), 3.66-3.62 (m, 2 H), 3.46-3.41 (m, 
1 H), 3.02 (s,3 H), 2.52-2.12 (m, 7 H), 1.92-1.56 (m, 15 H), 1.37-1.34 (m, 6 H), 1.29-0.98 (m, 
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42 H), 0.56 (d, J = 6.4 Hz, 3 H), 0.34 (d, J = 6.3 Hz, 3 H), HRMS (ESI) m/z: calcd for 
C127H140N13O16 [M+H]
+
 2104.0569, found 2104.0586. 
28: HRMS (ESI) m/z: calcd for C178H186N21O24 [M+H]
+
 3003.4041, found 
3003.4087. 
25a: HRMS (ESI) m/z: calcd for C161H178N15O18 [M+H]
+
 2610.3502, found 
2610.3562. 
29: HRMS (ESI) m/z: calcd for C212H224N23O26 [M+2H]
2+
 1755.3524, found 
1755.3685. 
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III Copper (II) Loaded Quinoline Carboxamide Foldamers 
3.1 Introduction 
Helices are extensively observed in nature such as in proteins and nucleic acids.
1-3
 Those 
helical structures serve not only as structural components but also as functional units. Inspired 
by the helices found in bio-macromolecules, mimics of those helical structure motifs are 
pursued. Among all different kinds of mimics, helicates, which were introduced by Lehn to 
describe helical metal coordination complexes,
4
 stand out as a very important and interesting 
class of compounds. Usually, helicates are composed with multiple metal centers (at least 2 
metal centers) and various number strand ligands. Based on the number of strands, 
single/double/triple-stranded helicates are produced.
5
 There are many advantages to prepare 
helicates such as many metal ions can be chosen and the geometry requirements of each metal 
ions are well established which allow bottom-up design based on those knowledge. The 
helical structure is governed by the coordination of the metal center which results in the 
helical arrangement of the ligand that surround the metal. A great number of helicates has 
been prepared before, such as double stranded helicates,
4-7
 triple stranded helicates.
8,9
 The 
nature of ligands and the metals are varied, nevertheless, they all share a common feature that 
the ligands are oligomers composed of several monomers that have the site for coordination. 
By changing the metal and ligand, literally infinite number of helicates can be made which 
allows design of different kinds of functions such as muscle like extension/contraction 
movements.
10,11
 However, limitations are also found such as the difficulty to synthesize very 
long ligands.
12
 One possible solution to that problem is the spontaneous polymerization of the 
ligand and coordination which was elegantly demonstrated recently by Nitschke et al. by 
taken advantage of imine condensation and metal coordination.
9,13
 Although, this method can 
reach very long helicate, the control of the exact length is less powerful.  
In our group, metal helicates were prepared by the coordination of copper (II) ions and 
with oligopyridine dicarboxamide previously.
14
 In these helicates, the coordination was 
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between metal ions and the nitrogen atoms of pyridine rings and the deprotonated amide 
bonds. Two molecules of oligopyridine dicarboxamide were wrapped around multiple copper 
(II) ions to form a double helix. The coordination geometry of Cu (II) ions inside the double 
helix is pseudo-square planar (with distortion). The metal centers are not completely aligned 
inside the double helix.  
 
Figure 3-1: a) Chemical structures of oligopyridine dicarboxamides; b) expected metal coordination 
modes of 2,6-bis(carbonylamino)pyridines and 2,6-pyridinedicarboxamides; c) top view and d) side 
view of crystal structure of helicate. 
 
Metal coordination was also used to help the formation of closed molecular capsules and 
guest binding.
15-17
 Pyridazine-pyridine-pyridazine (Pyz-Pyr-Pyz) prefers the anti-anti 
conformation over syn-syn conformation in its native state. The conformation preference of it 
can be altered to syn-syn by coordination with suitable metal ions, such as copper and silver.
17
 
The conformation switching of Pyz-Pyr-Pyz was successfully used to construct molecular 
container by connecting two units of conical segments with it. The two conical segments were 
separated due to the preferred anti-anti conformation of Pyz-Pyr-Pyz unit. After complexation 
with metals such as Cu (I), Cu (II), Silver (I)
17
 and even alkali/alkaline-earth metals such as 
Na
+
, K
+
, Ca
2+
 and Mg
2+
,
15,16
 a closed capsule like molecules formed by switching the 
conformation of Pyz-Pyr-Pyz to syn-syn conformation. Strong binding with carbohydrate 
guests was found with the metal containing capsules which the binding of guests was 
mediated with the coordination.
15
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Figure 3-2: a) Conformation preferences of Pyz-Pyr-Pyz before and after metal coordination; b) 
representation of helical-capsule folding upon metal coordination and guest binding; c) crystal structure 
of helical-capsule before metal coordination and d) crystal structure of helical-capsule after metal 
coordination.  
 
Quinoline carboxamide oligomers are studied extensively and are found to form stable 
helical structure both in solution and in the solid state.
18
 The outside of the helices are 
surrounded by aliphatic side chains which allowed good solubility in organic solvents, 
whereas inside the helices, well organized hydrogen bonding network ensured the stability of 
helical structure. The diameter of the inner cavity of the helices is small which does not allow 
any organic molecules to be encapsulated as this segment is used as end cap in the design of 
capsules.
19
 However, the small cavity may allow single atom such as metal ion to reside in. 
The quinoline as well as amide upon deprotonation is suitable coordination sites for metal 
ions. The coordination of de-protonated amide was also proved previously.
14,20-22
 Herein, we 
tried to load metal ions into the helices which will replace the hydrogen bonds to coordination 
bonds as the major stabilization factors while maintaining the helical structure.  
N
N
O
N
N
O
N
H H
H
N
N
O
N
N
O
N
M
1) base
2) M2+
 
Figure 3-3: Expected metal coordination mode of 8-aminoquinoline-1-carboxamide.  
 
3.2 Results and discussions 
The quinolinecarboxylate amide oligomers have been reported before and were prepared 
accordingly.
18,23
 Here, we choose oligomers with odd number of monomers in length in order 
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to fulfil the requirement of coordination numbers determined by the metal ions (chemical 
structures of the oligomers showed below in scheme 3-1). For each oligomer with length of 
2n+1, the available coordination sites are 4n+1 in which 2n comes from the deprotonated 
amide bonds and 2n+1 from the quinolines. The total number of coordination sites is suitable 
for a number of n metal ions to complete their coordination spheres (4 coordination sites are 
necessary for each metal center). Hence, n metal ions are expected if all the coordination sites 
of the oligomer with length of 2n+1 are occupied. For example, Q3 can accommodate one 
copper ion and Q5 can accommodate two copper ions and so on.  
N
O
O2N
N
NH
O
O
OMe
O
n Cu
Cu salt
N
O
O2N
N
N
O
O
OMe
O2n 2n
n = 1, 2, 3, 4 
       8, 16  
Scheme 3-1: The reaction scheme to load copper ions inside the quinolinecarboxylate amide oligomers. 
 
We started testing our hypothesis by mixing quinolinecarboxylate amide trimer (Q3) with 
copper (II) acetate in the mixture of chloroform and methanol (1/1, v/v) at room temperature. 
After mixing the solution of Q3 and Cu(OAc)2, the color of the solution immediately changed 
from light yellow to green. The immediate color changing serves as a good indication of the 
formation of complex which might be a result of the metal-to-ligand charge transfer (MLCT). 
Since, copper acetate was able to form complex with Q3 immediately, UV-Vis titration of Q3 
with Cu (II) at room temperature was performed in chloroform/methanol mixture (1/1, v/v) 
which allowed us to extract a binding constant of 9.7×105 L/mol (Fig. 3-4b) based on 1 to 1 
binding stoichiometry. As showed in figure 3-4a of the titration curve, the two absorption 
peaks at 323 nm and 355 nm of the Q3 gradually decreased and shifted to longer wavelength. 
New peaks appeared at 345 nm at the end of titration which might be a result of red shift of 
the 323 nm absorption of Q3. The gradually increasing shoulder peak above 420 nm was 
attributed to metal to ligand charge transfer absorption which is a clear evidence of the 
complexation. Isosbestic point at 348 nm was clearly observed which indicated two species 
equilibrium during titration. The high binding constant extracted from the titration curve 
indicated strong binding between Cu (II) ion and Q3 which proved our assumption that 
quinolinecarboxylate amide oligomer can serve as ligand for suitable metal ions.  
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Figure 3-4: a) UV-Vis titration of Cu(OAc)2 into Q3, [Q3] = 5×10
-5
 M, solvent: CHCl3/MeOH (1/1, v/v), 
the inset was the evolution of absorbance at 440 nm upon addition of Cu(OAc)2; b) nonlinear fitting 
curve of the absorbance at 440 nm, the fitting equation was based on the 1 to 1 binding model. 
 
Other metal acetates salts, including Co (II), Zn (II), Ni (II), Pd (II), were also tested, 
however, the color changing were not obvious shortly after mixing at room temperature. This 
might be because of slow complexation or not at all or complexation with those metals did 
not cause any color changing. Nevertheless, for Zn (II) and Pd (II), it is possible to check 
NMR as a method to follow the complex formation because they are diamagnetic metal ions. 
As showed in Fig. 3-5, after mixing Q3 with Zn(OAc)2 (1 to 1 ratio) at room temperature in 
CHCl3/MeOH, a new set of peaks corresponding to the complex slowly appeared. After 16 
hours at room temperature, the complex formed was calculated to be around 1/3 conversion of 
the starting Q3 by integrating the peaks in the 
1
H NMR spectrum (Fig. 3-5b). Luckily, after 
standing the mixture at room temperature for about 2 to 3 days, crystal slowly grows in the 
mixture of chloroform/methanol which was the pure complex as indicated by the proton NMR 
after dissolving the crystal (Fig. 3-5c). The complex was stable in chloroform solution at 
room temperature as followed by 
1
H NMR spectroscopy (data not shown). Compared to the 
1
H NMR spectrum of Q3, the resonances from amide protons completely disappear in the 
complex which indicates complete deprotonation of the amides in the complex. The 
1
H NMR 
spectrum of the complex show broadness of some peaks while others are relatively sharp 
which indicated small structural dynamics at room temperature in chloroform. The resonances 
in the aromatic region are shifted to upper field region compared to Q3. In the region of side 
chains (3.5 to 4.5 ppm), anisochronous signals were observed (Fig. 3-5c) indicating slow 
exchanging of those signals at the NMR time scale. 
300 400 500 600
0
1
2
3
A
b
s
wavelength (nm)
0.0 1.0x10
-4
2.0x10
-4
0.1
0.2
A
b
s
.
[Cu] (mol/L)
440 nm
0.05 0.10 0.15 0.20
0
1
2
[C
u
] 
m
o
l/
L
A
Equation y = (x/b) + x / (k*b*(0.00005 - (x/b) ) )
Adj. R-Squar 0.91575
Value Standard Err
B k 971698.7522 241547.3007
B b 4285.37541 12.49777
X 10
- 4
III Copper (II) Loaded Quinoline Carboxamide Foldamers 
 
- 64 - 
 
 
Figure 3-5: Part of 
1
H NMR (300 MHz) spectra of a) Q3, b) Q3 mixed with 1 equivalent of Zn(OAc)2 at 
room temperature after 16 hours, c) redissolve crystal of Q3-Zn complex, the solvent is CDCl3 for all 
three spectra. 
 
The complex formation between Q3 and Pd(OAc)2 was also tested in the same manner as 
zinc. The Q3 and Pd(OAc)2 were mixed in chloroform/methanol (8/2, v/v) at a 1 to 1 ratio. 
After 4 hours at room temperature, a small new set of peaks was observed in 
1
H NMR 
spectrum (Fig. 3-6b) and this new set of peaks kept growing until almost complete conversion 
of starting Q3 after 7 days at room temperature (Fig. 3-6c). This clearly showed the formation 
of complex between Q3 and Pd(OAc)2, however, as indicated by the NMR spectra, the 
conversion was not exclusive and some small peaks can be spotted which might be 
corresponding to other complex than the major one. Also, it is important to note that the 
presence of methanol was necessary to observe the formation of complex. No NMR change 
was observed when pure chloroform was used (data not shown).  
 
Figure 3-6: Part of 
1
H NMR (300 MHz) spectra of a) Q3 and Q3 mixed with 1 equivalent of Pd(OAc)2 
standing at r.t. after b) 4 hours and c) 7 days, [Q3] = 1 mM, the solvent is CDCl3/MeOD (8/2, v/v). 
 
As previously mentioned, the complex formed between Q3 and zinc was successfully 
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crystalized and crystal suitable for X-ray diffraction was obtained. To our surprise, the crystal 
showed dimeric complex between Q3 and zinc as showed in figure 3-7. Two antiparallel 
strands of Q3 wrapped around two zinc cation which formed a double-stranded helicate. The 
Q3 oligomer was partially unfolded and adopted a “Z” conformation which is very different 
from its folded conformation. The unfolding of Q3 was a result of the deprotonation which 
undermine hydrogen bonds of the folded conformation and more importantly as a result of the 
geometry requirement for the zinc coordination. The two zinc cation adopted tetrahedral 
coordination geometry. The bond length between zinc and nitrogen were in the range between 
2.003 to 2.096 Å which indicated strong bonding. The distance between two zinc atoms is 
3.545 Å which is too long to allow interactions between them. The dimeric complex was also 
confirmed by mass spectroscopy where the peak with m/z 1705.533 was exclusively found 
which corresponding to the dimeric complex. The isotope distribution was also matched with 
the calculated one.  
 
Figure 3-7: Crystal structure of Q3Zn, a) side view, b) front view and c) top view; the Zn atoms were 
showed in CPK and all the hydrogens as well as the side chains were removed for clarity. 
 
We next investigated the complexation of different metals with longer oligomers. When 
different metal salts were mixed with Q5 which is two units longer than Q3, we only observed 
nicely formed complex with Cu(OAc)2 as indicated by TLC, with other salts such as 
Zn(OAc)2, Pd(OAc)2, Co(OAc)2 and Ni(OAc)2, we only found partial formation of complex 
or not at all as followed by NMR spectroscopy. Hence, we focused on copper to make 
complexes with longer oligomers. After mixing Cu(OAc)2 with Q5 at the same condition as 
for Q3, we noticed that the kinetics to form the complex was much slower compared to Q3. 
The decreasing of kinetics was expected with increasing the length of oligomers that the 
energy barriers to form the complexes increased with longer oligomers which was also 
indicated by the slowing down of handedness inversion with increasing the oligomer length.
24
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For longer oligomers, the helical conformation is more stable than the shorter ones. The 
deprotonation of the amide bonds inside the helices and insertion of copper ions into the 
helices are also more difficult for the longer oligomers than the shorter ones. The binding 
constant between Q5 and copper was difficult to determine with titration experiment, however, 
we were interested in following the kinetics of complexation with UV-Vis spectroscopy. By 
following the evolution of UV-Vis spectra with time, similar changes of the spectra were 
observed as in the titration of copper with Q3. The absorption peaks of Q5 at 325 and 360 nm 
slowly decreased while new peak above 420 nm increased slowly with time. Isosbestic points 
at 260, 305 and 365 nm were observed. By plotting the absorbance at 472 nm as a function of 
time, we were able to find out that the complete formation of complex requires around 95 
hours at room temperature at 50 μM concentration. The half conversion time was around 26 
hours. The obvious decrease of reaction kinetics upon increasing the length from trimer to 
pentamer suggested harsher conditions might necessary in order to load copper ions into the 
longer oligomers. 
 
Figure 3-8: The kinetics of the formation of complex with Q5 at room temperature followed by UV-Vis 
spectrum, the inset was the changes of absorbance at 472 nm with time, [Q5] = 5×10
-5
 M, [Cu] = 
1×10-4 M, solvent is CHCl3/MeOH (v/v 1/1). 
 
In order to increase the kinetics, we tried to heat the mixture of Q5 and Cu(OAc)2 in 
chloroform/methanol (1/1 V/V) at 60 
o
C. Indeed, by increasing the temperature, the 
complexation of Q5 with Cu(OAc)2 was complete in around 6 hours. The desired complex 
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was confirmed by HRMS that we found m/z 1397.3640 which corresponded to the calculated 
complex of Q5Cu2 (Fig. 3-10b). For longer oligomers, the formation of complexes especially 
the fully loaded complexes that metal ions occupy all the available coordinating sites of the 
quinoline carboxamide oligomers (n metal ions for an oligomer of 2n+1 units) may become 
challenging as the energy barriers of complexation are expected to increase with the length of 
the oligomers. For Q7 and Q9, the complete formation of fully loaded complexes required 
heating at 65 
o
C for about one day. Also, excess of Cu(OAc)2 was required (around 5 
equivalents for loading of one copper) in order to obtain the fully loaded complexes. The 
formation of fully loaded complexes was confirmed by HRMS. For Q7, the peak with m/z 
1942.4888 which corresponded to the expected fully loaded complex Q7Cu3 was found (Fig. 
3-10c); and for Q9, the peak with m/z 1245.3118 (z equal 2) which corresponded to the fully 
loaded complex Q9Cu4 was found (Fig. 3-10d). The observed isotope distributions of both 
complexes were also in agreement with the calculated ones which further confirmed the 
successful formation of the expected fully loaded complexes.  
With the success of above copper fully loaded complexes, we decided to test with more 
ambitious oligomers, Q17 and Q33. The estimated length of the two oligomers is 2.4 nm and 
4.6 nm respectively. Upon completely loading of copper ions, 8 and 16 metal centers are 
expected to insert in the backbone of Q17 and Q33, respectively. We first applied similar 
method used above to load copper ions inside Q17. However, we only obtained complicated 
intermediate complexes with partially loaded oligomers as indicated by HRMS. Peaks 
corresponding to loading of different number of copper ions ranging from 3 to 8 into Q17 were 
observed. Complete conversion to copper fully loaded helices was failed even after long 
reaction time and higher temperature (refluxing temperature). The major product was 
4-copper loaded Q17, with some fully loaded compound (very minor product) and other 
partially loaded compounds. Further heating the reaction was not helpful since degradation of 
the oligomers might happen as indicated by complicated mass spectrum. These observations 
indicated that the energy and kinetic barriers to form the completely loaded complexes with 
Q17 and Q33 were much higher than that of Q9. In order to overcome those barriers, we 
decided to heat the reaction at much higher temperature but below the temperature that 
substantial decomposition happens. We changed the solvent to DMF which is also a solvent 
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that destabilize the helical conformation of the quinoline oligomers which allow us to increase 
the temperature up to around 150 
o
C. However, to our disappointment, after heating at 130 
o
C, 
we only observed a mixture of partially and fully loaded complexes even after few hours of 
heating before decomposition became obvious. Increasing the excess of copper salt 
(Cu(OAc)2 in this case) was also not helpful (up to 80 equivalents used).  
 
Figure 3-9: Representation of error checking process (take Q9 as example) in order to obtain the fully 
loaded Cu (II) complex. 
 
To our surprise, by simply changing the salt from Cu(OAc)2 to Cu(BF4)2, the loading of 
copper was much faster and the fully loaded complexes of Q17 was obtained after heating in 
DMF at 120 
o
C for about 15 minutes. The expected Cu (II) fully loaded Q17 was confirmed 
with HRMS that the expected m/z 2337.0618 (z equals 2) was found to be the major peak 
(Fig. 3-10e). Compared to acetate, tetrafluoroborate was known to be much weaker 
coordinating counter anion which might accelerate the reaction by reducing the energy barrier 
required to dissociate the copper ion from its coordination with counter ions. Another possible 
reason might be the superacidity of the hydrogen tetrafluoroborate which was generated as a 
side product during the reaction. Acid was responsible for reverse reaction that protonate the 
amide bond and removal of copper ions form the helix to restore its original oligomer. The 
small amount of hydrogen tetrafluoroborate acted as an error correcting reagent that catalyze 
the reverse reaction to remove the copper ions that coordinate at wrong positions and allow all 
the copper ions positioned at the right position by fast trial-and-error process (some possible 
intermediates of Cu-coordination at wrong positions are showed in fig. 3-9). This error 
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checking process is important for such a long oligomer which allows many different number 
of possible coordination. If the error checking process is slow, tremendous time is required to 
screen all the possible ways of coordination and find the most stable fully loaded complex. 
The slow error checking process can account for much slower kinetics of longer oligomers. 
The fully loaded Q33 was also obtained with similar conditions as confirmed by HRMS of the 
expected m/z 3014.7144 (z equals 3) was found (Fig. 3-10f). 
 
Figure 3-10：ESI+ HRMS spectra of a) Q3Cu, b) Q5Cu2, c) Q7Cu3, d) Q9Cu4, e) Q17Cu8 and f) Q33Cu16. 
 
The UV-Vis spectra of the copper fully loaded helices were showed in figure 3-11. The 
overall shapes of the spectra of the copper loaded helices were similar which have absorption 
peaks around 385, 335 and 255 nm. From Q3Cu to Q33Cu16, the molar absorption coefficients 
increase as the oligomers become longer. However, the molar absorption coefficients were not 
increasing linearly with the number of quinoline units as showed in the inset figure which was 
attributed to hypochromic effect found also in the oligomers without copper loading. For the 
shortest one, Q3Cu, the peaks at 385 and 335 nm were rather weak and can be barely seen. We 
suspected that this might be results from the lack of Cu-Cu interaction in Q3Cu since there is 
only one copper. Compared with the quinoline oligomers before copper loading, the spectra 
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showed similar changes among all the oligomers that the rising of absorption over 400 nm 
and decreasing the absorption around 350 nm. The rising of absorption over 400 nm might be 
originated from the metal to ligand charge transfer (MLCT) as discussed above.  
 
Figure 3-11: UV-Vis spectra of Q3Cu, Q5Cu2, Q7Cu3, Q9Cu4, Q17Cu8 and Q33Cu16, all the spectra were 
measured in CHCl3 solution at room temperature, inset was the absorbance at 385 nm of the copper 
loaded oligomers against the number of quinoline units. 
 
The FTIR spectra of the copper fully loaded oligomers were shown in figure 3-12. 
Compared with the FTIR spectra of the oligomers without copper loading, the peak at 3400 
cm
-1
 which is the -NH vibration from amide bond was completely disappeared indicating 
deprotonation of the amide bond after formation of the complexes. The carbonyl vibrations of 
the amide bonds shifted from 1700 cm
-1
 to 1600 cm
-1
 in the complexes. The amide I and II 
resonances also changed a lot after copper loading. The clear changes in the FTIR spectra 
confirmed again the formation of complexes.  
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Figure 3-12: FTIR spectra of a) Q5Cu2, b) Q7Cu3, c) Q9Cu4, d) Q17Cu8 and e) Q33Cu16. 
 
Single crystals of Q5Cu2, Q7Cu3 and Q9Cu4 suitable for x-ray diffraction were obtained 
either by slow evaporation of a solution in CHCl3/MeOH mixture (for Q5Cu2 and Q7Cu3) or 
by slow diffusion of methanol to the solution in chloroform (for Q9Cu4). The single helical 
structure of the quinolinecarboxylate amide oligomers was maintained as can be seen in the 
crystal structures, all three compounds were single helical with 2, 3, and 4 copper ions 
coordinated inside a single strand helices of Q5, Q7 and Q9 respectively. By overlapping the 
crystal structure of Q9Cu4 and Q8, we were able to find out that after copper coordination, the 
overall helical shape become tighter than the original helices which have 2.5 units per turn. 
Q5Cu2 spanned more than 2 turns and Q9Cu4 completed almost four turns which require less 
units per turn than the non-copper loaded helices. This reflected the trend that the helices 
became tighter as the oligomers became longer. Unlike similar oligomers made form pyridine 
units that upon complexation with copper, double stranded helicates were formed.
14
 The 
quinoline oligomers forms stable single helical structure even after complexation with metal 
ions reflected its robustness and the space and curvature predefined by the local conformation 
are well suitable for single helical structure.   
III Copper (II) Loaded Quinoline Carboxamide Foldamers 
 
- 72 - 
 
 
Figure 3-13: Single crystal structure of a) Q5Cu2, b) Q7Cu3 and c) Q9Cu4, all the side chain and 
hydrogen were removed for clarity.  
 
In the crystal structures, the principle coordination atoms are nitrogen from quinoline 
rings and the deprotonated amides with bond lengths between 1.87 to 2.11 Å which indicated 
strong binding. Weak coordination was found between the copper ions at the nitro-extremity 
in all cases (bond length around 2.6 Å). The coordination geometries of all copper ions were 
distorted from ideal tetrahedral or octahedral geometry which were caused by the single 
helical structure of the foldamers. If all the weak coordinations are counted, coordination 
numbers of 4, 5 and 6 were found. The formation of stable complexes with copper ion with 
such distorted geometry can be explained with Jahn-Teller effect of d
9
 configuration of Cu (II) 
ions.
25
 The Jahn-Teller effect allows distortion form ideal octahedral yet to have small gain of 
stabilization. The distances between adjacent copper ion in Q5Cu2 is 3.372 Å, whereas in 
Q7Cu3, the distances between adjacent copper ions are 3.242 and 3.322 Å; in Q9Cu4, the 
distances are 3.318, 3.019 and 2.999 Å. The distances between adjacent copper ions decrease 
with the increase of the length of oligomers, which indicates intramolecular stabilization 
forces such as aromatic π-π stacking increased with increasing the oligomer length.  
After carefully checking the coordination of copper ions in the structures, we are now 
able to understand how other metals, such as Pd (II), Co (III), Ni (II) and Zn (II), were failed 
on our hands. In order to form stable complexes, the ligands are better to be positioned 
according to the geometries determined by the metal ions which allows maximum 
overlapping the orbitals of the metals and ligands. In our case, the geometries of the ligands 
are determined by the helical structure of the foldamers which are not suitable for most metal 
ions in a way that they distorted form ideal square planar for Pd (II), tetrahedral for Ni (II) or 
octahedral for Co (III) and Zn (II) and Ni (II). One way to force the adequate positions of the 
coordination atoms of the ligands into ideal geometry is to completely unfold the 
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quinolinecarboxamide oligomers as found in Q3Zn. However, the energy cost for unfolding 
the structures is simply too high to allow coordination happens in the case of longer oligomers. 
Copper, on the other hand, allows a certain flexibility in the coordination geometry and also 
copper normally forms stronger coordination bonds with nitrogen than other metals which 
makes it easier to outcompete the energy lose for structure reorganization.   
As stated above, the copper ions were aligned inside the helices in the crystal. The 
alignments of copper ions were found to be macroscopic also. As showed in figures 3-14 and 
3-15 of the crystal packing of Q7Cu3 and Q9Cu4, the helices were aligned along the long axis 
of the foldamers which formed a pseudo-continuous helical structure. In the case of Q5Cu2, 
similar packing pattern was not found. In the crystal structures of Q7Cu3 and Q9Cu4, the 
helices were sitting on top of each other and form a long stack of helices along c-axis in both 
cases. This organization allows the alignment of the copper ions not only inside the helices on 
the molecular level but also long range alignment on the macroscopic level which spanned to 
the dimension of the crystals. The alignments of copper ions in one dimension allow us to 
form molecular wires on macroscopic level with only relative short oligomers. This type of 
alignment found in Q7Cu3 and Q9Cu4 but not in Q5Cu2 probably indicated the importance of 
aspect ratio in the crystal packing. With even longer oligomer, Q17Cu8, we were unable to 
obtain high resolution diffraction data to solve the structure. Nevertheless, from the electron 
density map, we were able to observe similar pseudo-continues organization of helices and 
alignment of copper ions in long range.  
 
Figure 3-14: Crystal packing pattern of Q7Cu3, a) viewed form a-axis, b) viewed form b-axis and c) 
viewed form c-axis. 
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Figure 3-15: Crystal packing pattern of Q9Cu4, a) viewed form a-axis, b) viewed from b-axis and c) 
viewed form c-axis. 
 
Partial loading of Q7 with copper ions was tried in order to understand the mechanism of 
copper ions insertion into helices. For Q7, three copper ions are necessary to form the fully 
loaded helix. By mixing Q7 and copper acetate at equal mole ratio at room temperature in 
chloroform/methanol, partially loaded oligomers were expected. After heating at 60 
o
C for 3 
hours, oligomers with different loading number of copper ions were obtained as indicated by 
TLC. To our surprise, this mixture could easily give crystals suitable for x-ray diffraction 
analysis. The x-ray structure showed Q7 with 1, 2, and 3 copper ions in the same unit cell with 
partial occupancy of the copper ions. The crystal could grow despite the different number of 
copper loading reflecting that small structural differences arise from different copper loading. 
The copper ions coordinate at the ester end of Q7 of the single copper loaded helix. The 
double copper loaded helix has copper at the ester terminus also and leaves the nitro terminus 
coordination sites open. This probably indicated that the coordination sites at the nitro 
terminus were less stable than the ester terminus. This hypothesis was further supported by 
selectively remove one copper ions from the fully loaded Q7. After completely loading of 
three copper ions into Q7, one copper ion can be selectively removed with trace amount of 
acetic acid. The crystal structure of the one copper removing happened at the nitro terminus of 
the helix as showed in figure 3-16a. The partial loading and removal of copper ions showed 
that the nitro terminus was less favored for copper loading than the ester terminus. The single 
loaded helix showed copper coordinated at the ester terminus indicated that the loading of 
copper form ester terminus might be favored over the nitro terminus. 
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Figure 3-16: a) single crystal structure of Q7Cu2; b) the crystal structure of partially copper loaded Q7 
with 1, 2 and 3 copper ions of partial occupancy in the same unit cell, all side chains and hydrogen 
atoms were removed for clarity. 
3.3 Conclusions and perspectives 
In conclusion, we successfully prepared a new type of Cu (II) ion loaded foldamers 
which is a different form of helicates. We have successfully prepared oligomers containing up 
to 16 copper ions inside a single helix composed of 33 quinoline units. The crystal structures 
clearly showed that the copper ions coordinated inside the helices and the helical structures of 
the foldamers were preserved. The coordination geometries of the copper (II) ions were 
highly distorted due to the helical conformation of the foldamers which was made possible 
due to the Jahn-Teller distortion of the copper (II) ions. The copper (II) ions were aligned not 
only inside the helices but also in the macroscopy level due to pseudo-continues packing of 
the helices. We are expecting the macroscopic molecular wires made from simple oligomers 
will show novel electronic properties.  
For perspectives, pseudo-continues packing of helices and one dimensional alignment of 
copper ions are found in the crystals. It is interesting to directly measure the conductivity of 
the crystals to see if the one dimensional aligned copper ions could be served as molecular 
wires. Another perspective about the copper loaded helices is to use them to form monolayer 
on the surface which will allow us to measure conductivity and other physical properties. A 
cartoon for the monolayer on gold is showed below.  
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Figure 3-17: Cartoon representation of copper loaded helices and the formation of monolayer on gold 
surface. 
 
3.4 Experiments 
3.4.1 General remarks 
All the solvents and reagents were used as received from commercial sources unless 
otherwise specified. Dichloromethane (CH2Cl2) was dried over alumina columns; chloroform 
(CHCl3) and diisopropylethylamine (DIEA) were distilled over calcium hydride (CaH2) prior 
to use. Reactions were monitored by thin layer chromatography (TLC) on Merck silica gel 
60-F254 plates and observed under UV light. Column chromatography purifications were 
carried out on Merck GEDURAN Si60 (40-63 µm). ESI mass spectra were obtained from the 
Mass Spectrometry Laboratory at the European Institute of Chemistry and Biology (UMS 
3033 - IECB), Pessac, France. Preparative recycling Gel Permeation Chromatography (GPC) 
was performed on a JAI LC-9130G NEXT using two JAIGEL 20×600 mm columns (Japan 
Analytical Industry) with 0.5 % NEt3 and 1% ethanol in chloroform (HPLC grade, ethanol 
stabilized), as mobile phase, with a flow rate of 7 mL/min. UV-Vis spectroscopy was recorded 
on Varian
®
 Cary 300 Scan UV-Visible spectrophotometer at room temperature. FTIR 
spectroscopy was recorded on Bruker IRFT IFS 55 infrared spectrometer using KBr to make 
the pallet and the spectrum was recorded at room temperature.  
3.4.2 Oligomer synthesis 
The quinolinecarboxylate amide oligomers (Q3 to Q9) were prepared according to 
previous established methods with minor changes.
26
 The longer oligomers (Q17 and Q33) were 
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prepared by segment doubling methods and purified with GPC.
23
 
3.4.3 Complexation with metals  
For metal ions like Zn (II) and Pd (II) that are diamagnetic, NMR was used as a tool to 
follow the reaction. Typically, an amount of calculated by 1 mM solution of 0.5 mL of the 
quinolinecarboxylate amide oligomers was added into a NMR tube and 1 equivalent amount 
of the metal salts were added. Then 0.5 mL of solvents, typically CDCl3 or mixture of CDCl3 
and MeOD depending on the solubility, was added. Then NMR spectra were taken after 
waiting certain period of time either at room temperature or at elevated temperature 
depending on the reaction kinetics. For metal ions like Cu (II) where NMR was not suitable 
due to the paramagnetic nature of the Cu (II) ion, the reaction was followed by UV-Vis 
spectra where significant differences of absorption were observed. Typically, an amount of 15 
mg of the quinolinecarboxylate amide oligomers (form Q3 to Q9) was added into a flask and 
dissolved in around 2-3 mL of chloroform. Then an amount of Cu(OAc)2 of calculated around 
2-3 equivalents of per copper loading was dissolved in least amount of methanol. The copper 
acetate solution was added into the quinolinecarboxylate amide solution and the resulting 
mixture was stirred either at room temperature (for Q3 and Q5) or at 65 
o
C (for Q5 to Q9). The 
reaction was quenched after completion of full loading of the copper ions by washing with 
water after diluting with dichloromethane. The organic layer was separated and the solvent 
was removed to result a dark green solid. For longer oligomers, like Q17 and Q33, the reaction 
was carried out in dry DMF (for Q17) or dry NMP (for Q33). For both oligomers, the copper 
salt used was copper tetrafluoroborate that was pre-dried under high vacuum. For Q17, an 
amount of 15 mg of Q17 was added in a dry flask and about 30 mg of Cu(BF4)2 was added and 
then 3 mL of dry DMF was added. The mixture was heated at 120 
o
C for 15 minutes and 
cooled down to room temperature. Dichloromethane was added into the mixture and washed 
with water. The organic layer was separated and the solvent was removed to yield a dark solid. 
For Q33, the reaction was similar except the solvent changed to NMP and heated at 150 
o
C for 
about 7 minutes before cooling down.  
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3.4.4 X-ray crystallography 
Single crystals suitable for X-ray diffraction analysis were obtained by either slow 
evaporation of the complexes in co-solvent of chloroform and methanol or by slow diffusion 
of methanol in to the solution of complexes in chloroform.  
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IV Self-assembly of Acridine Functionalized Quinoline Oligoamide 
Foldamers 
4.1 Introduction 
Self-assembly is a powerful technique to form large objects ranging from nanometer to 
micrometer size by using relative small and simple building blocks. Nature is a master of this 
technique. For instance, many proteins are the assembly of several copies of small peptides or 
sub-unit proteins. Even for some small proteins, their structures are an ensemble of multiple 
simple structural motifs such as helix, sheet and turn. The assembly of proteins is governed by 
several type of interactions between the interfaces of sub-units such as hydrophobic effects, 
metal binding and disulfide bond formation.
1
 The formation of intricate and complicated 
assembles of proteins and peptides enable them to perform sophisticated functions.
2
 
Protein engineering and de novo protein design have created numerous assembles of 
proteins beyond the tertiary folds of natural proteins as well as diverse chemical 
functionalities.
3
 Tetrahedron assembly of coiled-coil peptides,
2
 cyclic closed architectures 
from α-helical tandem repeat proteins4 and cages5,6 have been prepared. The self-assembly of 
proteins/peptides has also been used to make nanomaterials such as fibrils, nanotubes and 
nanospheres.
7,8
 Although great progresses have been made in de novo protein design, most of 
the current designs are heavily relied on the structures motifs and folds that found in nature.
2,9
 
Usually, the design was assisted by computation. Modular structural elements have also been 
used extensively to facilitate the design. Coiled-coil is probably one of the most studied and 
well understood structural motifs. Coiled-coil is known to form dimeric or higher assemblies 
characterized by a heptad repeat helix normally designated as abcdefg.
10
 The coiled-coil is 
mostly stabilized by hydrophobic effects of a and d residues as well as electrostatic 
interactions between e and g residues of the heptad repeat. Although coiled-coil has been 
extensively applied in de novo protein design, it has been pointed out that at least three types 
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of coiled-coil elements are required to form two- or three-dimensional assemblies.
2
  
 
Figure 4-1: a) The heptad repeat (abcdefg) of coiled-coil; b) disulfide bond directed helix-helix 
structures; c) covalent linked helix-helix structures; d) dimeric helix bundles and e) trimeric helix 
bundles. 
 
Foldamers, which were inspired by nature, adopt specific folded structures such as helix 
and sheets. It would be naturally to design not only the secondary structures of foldamers but 
also tertiary and higher structures as found in proteins. In the lab, helix-helix structures have 
been prepared based on covalent linkage and non-covalent assembly. Helix-helix motif was 
first made by covalent link through side chains. By connecting two helical foldamers through 
flexible alkyl sidechains, the two helices was found to adopt crossing structure and weak 
chiral communication occurred between the two helices.
11
 Disulfide assisted dynamic 
assembly of helical foldamers has also been reported and remote handedness communication 
was found.
12
 Helix-helix structure was also prepared with covalent linkage through the main 
chain. Different type of helix-helix structures were found such as “U” shape and anti-shape. 
Chiral communication was also found. With proper design of hydrogen bonding motifs, 
helix-helix bundles through non-covalent linkage was achieved. Hydroxyl functional group 
was designed on the same face of oligo-quinolinecarboxamides which was able to form 
hydrogen bonds as hydrogen bond donors with complementary hydrogen bond acceptors such 
as carbonyl of the amide bond. The ratio of dimeric and trimeric bundles was found to be 
solvent dependent.
13
 The complex equilibrium found of the assembly bundles of non-covalent 
interactions indicated complicated behaviors due to the weak and less-directional nature of 
non-covalent interactions. Hydrogen bond was thought to be directional and stronger than 
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other non-covalent interactions in organic solvents such as electrostatic and dispersion 
interactions. However, complete control of those interactions is still challenge.  
Here, we decided to use aromatic interactions to form helix-helix assemblies. Aromatic 
interactions such as π-π stacking, CH-π interaction are commonly encountered in aromatic 
compounds. These interactions can be found in a large variety of solvents ranging from 
nonpolar to polar solvents and water also. Flat π aromatic compounds especially electron poor 
and electron rich pairs are usually found to stack on top of each other. So, we want to take 
advantages of the stacking of flat aromatic moieties to create helix bundles. Acridine 
functionalized quinoline oligoamides are presented and helix-helix organization have been 
achieved by the interactions of acridine units.  
 
4.2 Compounds design 
The oligo-quinolinecarboxamides form stable single helical structure both in solution 
and solid state. The pitch of the helix is about 3.5 nm which spans 2.5 units of monomers. The 
shape of the helix can be represented with a five-star where every corner is a side chain. (Fig 
4-2a) From the five-star model, the possible ways to form helix-helix bundle dimers are 
through interactions of one corner (Fig. 4-2b) or two adjacent corners (Fig. 4-2c). 
Simultaneous contacts with three corners are not feasible unless specifically long armed 
sidechains are made at the two non-adjacent corners. The bundles formed through 
simultaneous contacts with two adjacent corners are more stable because of more contacts are 
presented than the single corner connection if all those interactions are attractive interactions. 
Also, contacts are expected every five units because i and i+5 units have side chains that point 
in the dame direction. Cooperative multidentate interactions can be envisaged by placing 
proper functional groups every five units. The strength of the interaction between two helices 
can be tuned by changing the length of the helices which varies the number of contacts 
between the two helices. Attractive interactions can be designed and placed into the sequence 
to hold the helices closely. The other units that are not responsible for the interactions in the 
sequence are selected to improve the solubility or prevent further non-specific aggregations. 
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Many different types of interactions are available such as hydrogen bonds, halogen bonds, 
electro-static interactions, coordination bonds, etc., and in aqueous solution, hydrophobic 
collapse is an important effect yet difficult to control. Strong, directional and well-understood 
interactions can be chosen as a good starting point to design the bundles. As discussed in the 
introduction, hydrogen bond between hydroxyl and carbonyl was used to design tertiary 
structures of foldamers.  
 
Figure 4-2：a) Five-star representation of the side chain positions of quinocarboxamide oligomers, the 
yellow ball stands for the oxygen of the side chains, an oligomer of abcdefgh follows the order showed 
in the figure to place the side chains, where a and f (b and g, c and h as well) which separated by five 
units have side chains at the same corner of the five star; b) carton representation for two helices 
interact through only one corner; c) carton representation for two helices interact through two adjacent 
corners; d) carton representation of three helices interact through adjacent corners. 
 
Here, we decided to use aromatic interactions to form assembly of foldamers. As a 
choice of interaction units, we have choosed acridine. Acridine is a well-known fluorescent 
dye found to have vast applications in biology. It is probably the first dye molecules found to 
be able to intercalate into double strand DNA.
14-16
 The flat aromatic surface and dipole 
moment caused by the 9-endocyclic nitrogen make acridine attracting functional group which 
may lead to interesting properties. Acetylene was used as linker between acridine and the 
backbone of quinoline oligoamide foldamers. The rigidity and linear shape of acetylene can 
fix the orientation and position of acridine units. The acridine units were connected to 
acetylene at position 9 to avoid complication of free rotation along the connection. Based on 
the five-star model of the oligo-quinolinecarboxamides (Figure 4-2a), different modes of 
interactions between helices can be imaged. As showed in figure 4-2, helix-helix association 
through side chains on single face (Fig. 4-2b); dimeric helix-helix association through side 
chains on two adjacent faces (Fig. 4-2c) and trimeric helix-helix association through side 
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chains on two adjacent faces are possible (Fig. 4-2d). 
The chemical structures of the designed compounds are listed in figure 4-3. Compound 7 
is the key monomer that functionalized with acridine at the 4-position of quionline. The 
acridine is connected to quinoline through a triple bond which reduces the possibility of 
conformational isomers due to the rotation through the connections. Two series of acridine 
functionalized oligomers were designed. One series of the oligomers can be represented as 
(Q2Q
a
Q2)n (n = 1, 2, 3; oligomers 1a-1c in figure 4-3a) which bear acridine side chains at a 
single corner of the surface. The other series of oligomers can be expressed as Q2Q
a
QQ
a
 and 
(Q2Q
a
QQ
a
)nQ2Q
a
Q2 (n = 1, 2; oligomers 2a-2c in figure 4-3a) which bear acridine side chains 
at two adjacent corner of the helices. The oligomers 1a-1c have 1, 2 and 3 acridine side chains 
respectively. This series of oligomers was designed to form helix-helix structure by 
interactions at a single corner of the helical surface. As showed in the molecular model of 1c, 
two molecules of 1c are designed to interact with each other through acridine units which 
form a stack of aromatic rings (Fig. 4-3b and 4-3c). The oligomers 2a-2c bear acridine side 
chains at two corners of the helices. In this case, interactions between three helices are 
possible. As showed in figure 4-3d and 4-3e, a possible trimeric bundle can be imaged 
through stacking of acridine units between these helices. 
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Figure 4-3: a) Chemical structure of acridine functionalized monomer 7 (Q
a
) and quinoline monomer 
(Q) and sequences of two series of oligomers 1a-1c and 2a-2c; Energy minimized molecular model of 
dimer stack by the acridine units of 1c showing b) top view and c) side view; Energy minimized 
molecular model of trimer stack by the acridine units of 2c showing d) top view and e) side view. The 
models were produced with Maestro software package, using MFFS force field, chloroform as solvent 
and PRCG as minimization method. 
 
4.3 Results and discussions 
4.3.1 Compounds synthesis 
The key monomer with acridine side chain was prepared according to scheme 4-1. The 
commercially available 9-chloroacridine was converted to 9-ethynylacridine by first 
Sonogashira coupling with 2-hydroxypropyl-protected acetylene and then deprotection with 
potassium hydroxide and potassium phosphate with moderate yields. The 
4-bromo-8-nitroquinoline 4 was reduced with iron powder and acetic acid which was 
followed by Boc-protection to afford compound 6. The monomer 7 was obtained by 
Sonogashira reaction of precursors 6 and 3 under typical coupling condition with good yield.  
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Scheme 4-1: Synthetic scheme of the acridine functionalized quinoline monomer 7. 
 
Oligomers 1a-1c were prepared according to convergent synthetic route showed in 
scheme 4-2. The short oligomer Q2Q
a
Q2 (1a) was prepared as a precursor block to obtain 
longer oligomers 1b and 1c. Saponification of monomer 7 with sodium hydroxide afford the 
carboxylic acid monomer 8 which was then activated as acid chloride and coupled with 
quinoline dimer amine 9. The product Q
a
Q2 (10) was converted to the free amine compound 
11 by treatment with TFA and was coupled with quinoline dimer acid 12 via acid chloride 
activation. The product of this coupling was the short oligomer 1a. Oligomer 1a was then 
separated into two parts. One part was treated with TFA to afford the free amine 13. The other 
part was reacted with sodium hydroxide which gave the carboxylic acid 14. After converting 
14 to its corresponding acid chloride using Ghosez’s reagent to the corresponding acid 
chloride, this pentamer was coupled with the amine 13, oligomer 1b was obtained after 
column purification. The longest oligomer 1c was obtained similarly by coupling the acid 
chloride of 14 with the free amine of 1b afforded by Boc-deprotection with TFA. The final 
oligomer 1c was purified by GPC and silica gel column chromatography. It is worth 
mentioning that the activation of carboxylic acid 14 with Ghosez’s reagent takes overnight to 
complete. It is not clear why the activation of 14 to corresponding acid chloride takes such a 
long time.  
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Scheme 4-2: Synthetic route for the acridine functionalized oligomers 1a-1c. 
 
The synthesis of oligomers 2a-2c was a bit more complicated. The convergent synthetic 
route was displayed in scheme 4-3. Oligomer Q2Q
a
QQ
a
 (2a) was prepared as a segment to 
synthesis the longer oligomers. Quinoline monomer carboxylic acid 15 was activated as acid 
chloride with Ghosez’s reagent which was then coupled with the Qa amine 16 to afford QQa 
dimer 17. The 17 was then treated with TFA to remove the Boc-protecting group and then 
coupled with Q
a
 acid chloride to obtain Q
a
QQ
a
 trimer 18. After Boc-deprotection of 18 and 
then coupled with Q2 acid chloride, oligomer Q2Q
a
QQ
a
 (2a) was obtained. The corresponding 
carboxylic acid of 2a was obtained by saponification with sodium hydroxide. The carboxylic 
acid 19 was then activated to corresponding acid chloride and coupled with amine 13 to 
afford the oligomer Q2Q
a
QQ
a
Q2Q
a
Q2 (2a). The activation of carboxylic acid 19 to the 
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corresponding acid chloride was again slow and required overnight reaction. However, the 
reaction between the acid chloride of 19 and the amine 13 was complicated which gave the 
desired product with several side products. It was difficult to identify the side products 
generated during the reaction. Nevertheless, it was possible to obtain small amount of pure 
oligomer 2a. However, it was difficult to continue the synthesis of longer oligomer 2c which 
only leaded to complicated mixtures.  
 
Scheme 4-3: The synthetic route for oligomers 2a and 2b. 
 
In order to obtain the long oligomer 2c, linear synthetic route was tried which is showed 
in scheme 4-4. In order to reduce synthetic steps, Q
a
Q dimer 21 was made as a carboxylic 
acid 22 and used as a building block. The whole synthesis was started from Q2Q
a
Q2 amine 
(13). The final compound was obtained by sequencing coupling with appropriate acid 
chloride and boc-deprotection. To be short, Q
a
 acid 8, Q
a
Q acid 22, quinoline monomer acid 
15, Q
a
Q acid 22, Q
a
Q acid 22 and quinoline dimer acid 12 were subsequently activated as 
acid chloride and couple to the corresponding amine to afford the oligomer 2c. The final 
compound was purified by cyclic repeating GPC. 
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Scheme 4-4: Linear synthetic route for the acridine functionalized oligomers 2c. 
 
4.3.2 Aggregation of oligomers with acridine units on one face 
All three compounds 1a-1c showed sharp single set of peaks in chloroform which 
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indicated well defined species presented for those compounds in solution at room temperature. 
The proton NMR spectra of these oligomers with acridine side chain on one side of the 
helices were well defined and could be separated into different regions similar to the 
oligo-quinolinecarboxamides.
17
 As showed in Fig. 4-4, the 
1
H NMR spectra of 1a-1c showed 
separated amide region (12 - 10 ppm), aromatic region (9 - 6 ppm) and aliphatic region 
(below 4.5 ppm). Those peaks spaced into large chemical shift area which clearly indicate 
helical folding of the oligomers. From 1a to 1c, signals are consistently shifted to upper field 
which is caused by the increased helical stacks with the oligomer length. The amide 
resonances are all well-resolved and the number of peaks can be clearly counted as the 
expected number even for the longest oligomer 1c. In the aromatic region, the peaks were 
well resolved except for 1c which showed overlapping of signals. Signals from acridine units 
were mostly hidden in the aromatic region except one signal which appeared at the lowest 
field part of the aromatic region. This signal was attributed to the acridine based on its 
coupling constants. Those acridine signals were clearly shifted to the upper field form 8.76 
ppm in 1a to 8.54 ppm in 1b and 8.46 ppm in 1c. The upper field shift of acridine signals 
were consistent with increasing the strength of pi-pi interactions as the length increased even 
outside of the helix. In the aliphatic region, diastereotopic proton signals (4.5 – 3.5 ppm) were 
observed for all three oligomers which were due to right and left handedness of the helical 
conformation. Methyl ester signals clearly distinguished from other signals and undergo upper 
field shift as expected for helical folding of the oligomers.  
 
Figure 4-4: Part of 
1
H NMR (300 MHz, CDCl3) of acridine functionalized oligomers a) 1a, b) 1b and c) 
1c. 
IV Self-assembly of Acridine Functionalized Quinoline Oligoamide Foldamers 
 
- 91 - 
 
 
Concentration dependent NMR spectra were measured in chloroform, which is an 
informative method to demonstrate the aggregation behavior of a compound in solution. As 
showed in figures 4-5 and 4-6, the concentration dependent 
1
H NMR spectra of 1b and 1c 
were recorded from 10 mM solution to 0.1 mM. As observed in the figure, from low 
concentration to high concentration, both compounds displayed only one set of peaks which 
indicated that either there is only one species in solution or there is fast exchange between 
different possible species. Chemical shifts variations were observed in both cases. Upon 
increasing the concentration, upper field shifts of signals were observed which was consistent 
with aggregation formation at higher concentration. In the case of 1b, the peaks 
corresponding to protons from acridine at 8.62 ppm at 0.1 mM concentration shifted to 8.61 
ppm at 10 mM which accounted for very small chemical shifts variations. The longer 
oligomer 1c showed bigger chemical shifts variations than 1b. In the amide region, obvious 
shifting of some of the signals was observed as marked in the figure 4-6. Also, the resonances 
corresponding to protons on acridines shifted form 8.51 ppm at 0.1 mM concentration to 8.37 
ppm at 15 mM concentration which was more obvious than 1b. Upon increasing the 
concentration, some broadening of the signals was also noticed which indicated nonspecific 
aggregation behavior at higher concentration. Comparing 1b to 1c, 1c has a higher propensity 
to aggregate in solution. This result is not surprising since 1c has one more acridine side chain 
than 1b. The lack of major chemical shifts variations or appearance of another set of signals 
observed in both 1b and 1c upon changing concentration in CDCl3 indicated that weak or 
only nonspecific aggregation of those two oligomers in chloroform.  
 
Figure 4-5: Part of the concentration dependent 
1
H NMR spectra of 1b showing the aromatic region, a) 
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0.1 mM, b) 0.5 mM, c) 1 mM, d) 2.5 mM, e) 5 mM and f) 10 mM in CDCl3. 
 
Figure 4-6: Part of the concentration dependent 
1
H NMR spectra of 1c showing the amide and aromatic 
region, a) 0.1 mM, b) 0.5 mM, c) 1 mM, d) 2.5 mM, e) 5 mM and f) 15 mM in CDCl3. 
 
Single crystals suitable for X-ray diffraction of both 1b and 1c were obtained by slow 
diffusion of acetonitrile into a stock solution of 1b or 1c in chloroform. As showed in figures 
4-7 and 4-8, the acridine side chains of both oligomers are indeed positioned at single face of 
the helices as designed. The acridine side chains are almost parallel with each other although 
small angles between them are observed. In the case of 1b, the two acridine planes had an 
angle of 8.5
o 
and both of the two acridines are not perpendicular to the axis of the helix. 
Similar arrangements of the acridine with respect to the axis of helix are found in 1c too. The 
angles between the acridine planes are 9.3
o
, 0.5
o 
(measured between the acridines at the ester 
end and middle ones; Boc-amide end and middles ones respectively). The distances between 
the acridines planes is 7.1 Å in the case of 1b (Fig. 4-7), and 6.8 Å and 7.2 Å in the case of 1c 
(Fig. 4-8). The distances between 4-position of the quinolines which acridine side chains are 
attached are 6.9 Å in 1b and 6.7 Å, 6.9 Å in 1c which are all slightly shorter than the 
distances between the acridines. It was noticed that in 1c, the triple bond connecting the 
acridine and quinoline at the Boc-amide end was severely distorted from ideal 180
o
 bond 
angle (155
o
 was found which was 25
o
 less than the ideal bond angle). The extreme distortion 
of this triple bond was an indication of some steric hindrance might exist in the crystal. Other 
triple bond linkages also showed slight bending (bond angles around 172
o
 were observed) 
which are in the normal deviation range.  
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Figure 4-7: Single crystal x-ray structure of 1b, a) side view form the helix axis; b) top view form the 
helix axis; c) side view to show relative orientation of the acridine rings with respect to the axis of helix; 
CPK view of acridine rings of d) side view; e) top view and f) side view to show the relative 
orientations. 
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Figure 4-8: Single crystal x-ray structure of 1c, a) side view form the helix axis, in the blue box is the 
zoom of the acetylene that have significant distortion; b) top view form the helix axis; c) side view to 
show relative orientation of the acridine rings with respect to the axis of helix; CPK view of acridine 
rings of d) side view; e) top view and f) side view to show the relative orientations. 
 
In the crystal structures of 1b and 1c, interactions between helices were observed. As 
showed in figure 4-9, two molecules of 1b interacted with each other through acridine units. A 
P-helix of 1b interacts with another antiparallel M-helix of 1b in the crystal (Fig. 4-9a). The 
acridine units of the two helices form π-stacks to associate these helices. Several aromatic 
CH-π interactions of 3.26 Å to 3.34 Å between acridines have been observed. The distance 
between an acridine unit to acridine unit of another helix is about 3.4 Å which indicated 
strong π-stacking effect between them (Fig. 4-9e). From the side view of the acridine stacks 
(Fig. 4-9b and 4-9e), these acridine units have offsets between adjacent acridine units which 
are distinct from the design that all acridine units are stacked on top of each other. From the 
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top view (Fig. 4-9a, 9c and 9d), substantial overlapping of aromatic surfaces of the acridine 
units can still be observed.  
 
Figure 4-9: The interactions of 1b in the solid state. a) Side view of two helices that interact with each 
other through acridine units, the two helices are P and M in an antiparallel orientation; b) side view to 
show the angle of acridine rings with respect to the axis of helices; c) top view of the two helices that 
associated together; d) top view to highlight the overlapping of acridine surfaces; e) side view of 
acridine rings to show the stacking pattern of them, the blue and red color indicate those acridines are 
belong to the same helix. 
 
In the crystal of 1c, the interactions between helices are quite similar to 1b. The two 
helices that interact with each other are P and M helices. The orientation of the two helices is 
antiparallel (Fig. 4-10c). The acridine units form moderate π-stacks with distance around 3.6, 
3.7 and 3.6 Å (Fig. 4-10f). Strong aromatic CH-π interactions with distance of 3.10 Å was 
observed. The middle acridines (H
2
 proton) also form hydrogen bond with amide carbonyl 
oxygen (3.17 Å) of the other helix. Significant offset between acridine rings were observed 
instead of piling up of acridine units as showed in the design (Fig. 4-10b, 10d and 10e). In the 
top view (Fig. 4-10a), the acridine units of two helices do not intercalate into each other. In 
the side view (Fig. 4-10d), adjacent acridine units have some overlapping of the aromatic 
surfaces which indicate aromatic interactions between them. A clear ladder of stacks of 
acridine rings can be observed in the side view (Fig. 4-10f). Those observations indicate π-π 
interactions through acridine units play important role to bring two helices together. Although 
intercalating of acridine rings are not observed, the interactions between acridine rings 
already able to guide the association of helices.  
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Figure 4-10: The interactions of 1b in the solid state. a) top view through the helices; b) side view to 
show the angle of acridine rings with respect to the axis of helices; c) Side view of two helices that 
interact with each other through acridine units, the two helices are P and M in an antiparallel 
orientation; d) side view of acridine rings to show the overlapping of aromatic surfaces of adjacent 
acridine rings; e) top view of the two helices that associated together; f) side view of acridine rings to 
show the stacking pattern of them, the blue and red color indicate those acridines are belong to the 
same helix. 
 
4.3.3 Aggregation of oligomers with acridine units on two faces 
The proton NMR of oligomers 2a-2c with acridine side chains at two corners of the 
helices are presented in figure 4-11. NMR of these three oligomers displayed sharp proton 
NMR spectra with separated regions for amide, aromatic and aliphatic spaced on large 
chemical shift range similar as the oligomers 1a-1c in agreement with the helical folded 
structures. The proton NMR spectra of 2a-2c had some over-lapping of signals especially for 
2c in the amide and aromatic regions. In 2a, parts of the acridine proton signals can be found 
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at 8.74 and 8.37 ppm. In 2b, the signals at 8.55 and 8.44 ppm were attributed to acridine units. 
In 2c, signals at 8.43 and 8.23 ppm were assigned to acridine units. All three compounds 
showed only one set of signals same as 1a-1c. 
 
Figure 4-11: Parts of the 
1
H NMR spectra (300 MHz) of 2a-2c in CDCl3, a) 2a, b) 2b and c) 2c, stars 
indicate those signals are from acridine units. 
 
Concentration dependent NMR spectra of oligomer 18 (Q
a
QQ
a
) and 2a (Q2Q
a
QQ
a
) were 
checked from 0.1 mM to 10 mM concentration. For both compounds, the NMR spectra were 
sharp at all concentrations and only minor chemical shifts variations were observed. Both 
oligomers showed more obvious chemical shifts variation than 1b which have the same 
acridine side chains. In the case of 18, the two amide peaks shifted from 12.52 ppm and 12.50 
ppm at 0.1 mM to 12.47 ppm and 12.45 ppm at 10 mM respectively. The peaks of the 
aromatic region also shifted, for example, the doublet at 8.32 ppm shifted to 8.26 ppm by 
increasing the concentration from 0.1 mM to 10 mM. One interesting feature was that the 
doublet at 8.38 ppm (two of the acridine proton signals) at 0.1 mM concentration shifted 
slightly to upper field and separated as two doublets of at 10 mM. Other acridine protons did 
not show much chemical shift variations, the doublets of acridines at 8.77 and 8.69 ppm at 0.1 
mM shifted only slightly to 8.75 and 8.66 ppm at 10 mM respectively. 
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Figure 4-12: Parts of the concentration dependent 
1
H NMR spectra of 18 (QaQQa) in chloroform, a) 
0.1 mM; b) 0.5 mM, c) 1 mM, d) 2.5 mM, e) 5 mM and f) 10 mM. 
 
In the case of oligomer 2a, the chemical shifts variations were smaller than 18 upon 
increasing concentration from 0.1 mM to 10 mM. In the amide region, all four amide peaks 
show around 0.02 to 0.03 ppm of upper filed chemical shifts variations. Similar upper field 
shifts of the signals in aromatic region also observed. For example, the singlet at 6.91 ppm 
(0.1 mM concentration) shifted to 6.87 ppm (10 mM concentration). One of the acridine 
proton signals at 8.74 ppm (0.1 mM concentration) shifted to 8.71 ppm (10 mM 
concentration). Another acridine proton signal shifted from 8.39 ppm to 8.37 ppm upon 
increasing concentration from 0.1 mM to 10 mM. Minor chemical shifts variation observed in 
both 18 and 2a indicated weak association of these two oligomers in solution.  
 
Figure 4-13: Parts of the concentration dependent 
1
H NMR spectra of 2a in chloroform, a) 0.1 mM; b) 
b) 0.5 mM, c) 1 mM, d) 2.5 mM, e) 5 mM and f) 10 mM. 
 
The oligomer 2c which bears 5 acridine side chains out of 15 side chains was designed to 
have higher propensity to aggregate. Unlike oligomer 2a and 18 for which almost all proton 
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NMR signals displayed upper field shift upon increasing concentration, in oligomer 2c, 
showed some proton signals undergo upper field shift and others lower field shift. In the 
amide region, for example, the peaks at 11.21 ppm (0.1 mM concentration) shifted to 11.23 
ppm (10 mM concentration), the peaks at 10.37 ppm and 10.32 ppm all shifted to lower field 
and almost converged at 10.39 ppm. Three peaks around 10.24 ppm also shifted to lower field 
and converged as a broad peak at 10.28 ppm at 10 mM concentration. In the region between 
5.8 to 6.5 ppm, the singlets of the H
3
 proton of quinoline units all shifted to lower field upon 
changing concentration from 0.1 mM to 10 mM. The doublet at 8.43, 8.28 and 8.08 ppm 
which are acridine proton signals all showed significant upper field shifts. Chemical shifts 
variations of 0.17, 0.16 and 0.10 ppm were observed for those three signals respectively. Due 
to overlapping of signals and some broadening of the peaks, some chemical shifts variations 
were difficult to follow. The observed chemicals variations and changes in the NMR spectra 
in 2c are much bigger than 1a-1c and 2a which indicated strong propensity to aggregate for 
2c.  
 
Figure 4-14: Parts of concentration dependent 
1
H NMR spectra of 2c in chloroform showing the amide 
and aromatic region, a) 0.1 mM; b) 0.5 mM, c) 1 mM, d) 2.5 mM, e) 5 mM and f) 10 mM. 
 
The single crystal of 2b suitable for X-ray diffraction was obtained by layer diffusion of 
hexane to the stock solution in chloroform. As clearly showed in the top view, the acridine 
side chains were indeed at two faces of the helices as designed. The angle between the two 
arms is around 60
o
 as we wanted. The two acridines (acr1 and acr3 in Fig. 4-15) at the same 
side of the helix were not parallel. The angle between the two acridine planes was 36.4
o
 which 
was much bigger than was found in 1b and 1c. Two acridine planes (acr2 and acr3) were not 
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perpendicular to the helix axis as observed in 1b and 1c. These two acridine rings have an 
angle about 55
o
 to the axis of the helix. The acr1 is almost perpendicular to the axis of helix.  
 
Figure 4-15: The crystal structure of 2b, a) top view through the helix; b) side views to show the 
relative position of acr2 and acr3; c) side view to show the relative position of acr1 to the other two 
acridine units; CPK view of acridine units of d) top view; e) and f) side view. Red color indicate that 
those two acridines are on the same face of the helix, blue color indicate the face of a single acridine 
unit. The name of acridine units are followed from the ester end to the Boc-amide terminus of the helix. 
 
The interactions of helices in the crystal of 2b were different compared to 1b and 1c. As 
showed in figure 4-16, substantial overlapping of the aromatic surfaces can be observed 
among the acridine units. A P-helix interacts with an antiparallel M-helix similar to 1b and 1c 
(Fig. 4-16b). From the side view (Fig. 4-16d), a nice stack of four acridine rings can be 
observed. These four acridine units are the acr2 (acr2’) and acr3 (acr3’) from both helices. 
The two acr1 (acr1’) units did not form parallel stacks with acr2 and acr3 as showed in side 
view (Fig. 4-16d, 16e, 16f). The surfaces of the four acridine rings that stack with each other 
have an angle around 55
o
 with respect to the helix axis (Fig. 4-16d). The distances between 
these four acridine rings are about 3.4 Å, 3.3 Å and 3.4 Å (Fig. 4-16e). The acr3 and acr3’ 
form strong π-stacking interactions with each other. Several aromatic CH-π interactions with 
distance from 3.32 Å to 3.37 Å have been observed between these two acridine rings. The 
acr2 (acr2’) only forms weak π-stacking interaction with acr3’ (acr3). Only partial surface 
overlapping between acr2 (acr2’) and acr3’ (acr3) has been observed (Fig. 4-16f). The 
overall interactions observed between acridine rings indicate those helices are able to 
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associate together in the solid state. 
 
Figure 4-16: The interactions between two helices of 2b, a) top view through the helices; b) Side view 
of two helices that interact with each other through acridine units, the two helices are P and M in an 
antiparallel orientation; c) side view of acridine rings to show the overlapping of aromatic surfaces of 
adjacent acridine rings; d) side view to show the angle of acridine rings with respect to the axis of 
helices; e) and f) side view of acridine rings to show the stacking pattern of them, the purple and red 
color indicate those acridines are belong to the face of helices that have two acridine rings. The names 
of acridine units are the same as in figure 15. 
 
The packing pattern of 2b in the crystal structures are displayed in figure 4-17. The 
acridine units form a continuous ladder of π-stacks in between two lines of helices. From the 
top view (Fig. 4-17a), a line of P helices standing outward the surface interact with a line of 
M helices of opposite orientation. The acridine units in between the two lines of helices form 
a zigzag shaped ladder (Fig. 4-17a). From the side view (Fig. 4-17b), the acridine units that 
stack with each other are (-acr3-acr3’-acr2-acr2’’-)n. For any given helix of 2b in the crystal, 
its acr3 interacts with acr3 of an antiparallel helix at left (right) opposite line, and its acr2 
interacts with acr2 of another antiparallel helix at right (left) opposite line. Propagating this 
arrangement forms the continuous stacking of acridine units as showed in figure 4-17. This 
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packing pattern is different from the design showed in figure 4-2d. A chain like arrangement 
was observed instead of a cyclic closed ring as designed.  
 
Figure 4-17: The packing pattern of 2b in the crystal, a) top view through helices, P and M indicate the 
handedness of the helices, the black dot indicate the helices are standing outward toward the surface 
(from Boc-amide terminus to ester terminus), the empty circle indicate the helices are standing inward 
toward the surface; b) side view across the helices.  
 
4.4 Conclusions and perspectives 
In conclusion, we have successfully synthesized oligo-quinolinecarboxamide foldamers 
bearing different numbers of acridine units on the side chains. Due to the interactions of 
acridine side chains, the oligomers showed weak association in solution especially the 
oligomers with five acridine side chains. However, the association was weak and probably 
nonspecific in solution. Nevertheless, in the solid state, interactions between helices through 
acridine units were found. Aromatic interactions such as π-π stacking and CH-π interactions 
have been observed in the solid state. A continuous ladder of acridine stacking has been 
observed in 2b. These observations suggested that the assemblies of these oligomers are 
strongly guided by the interactions of acridines.  
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As for perspectives, the acridine guided self-assembly of helical foldamers is weak but 
probably sufficient to be used to guide the formation of nicely self-organized helices on the 
surface of solid supports. Pyrene functionalized oligomers (Fig.14-8A) are designed. The 
pyrene unit attached at the N-terminus of the helical foldamers is used for attaching on 
surfaces such as highly oriented graphite. Another perspective is to change acridine unit to 
other functional groups that have stronger π-π stacking ability than acridine such as porphyrin 
as showed in Fig.4-18B. The ability of porphyrin to form π-stacks may allow formation of 
intercalated assembly of helical foldamers. A third perspective is the methylation of acridine 
units to acridium (Fig. 4-18C). The positive charge on acridium may allow it to intercalate 
with electron rich aromatic compounds.  
 
Figure 4-18: Proposed chemical structures for organization of helices on surface (A); self-assembly 
using porphyrin as functional groups (B); and methylation of acridine to methyl-acridine (C). 
 
4.5 Experimental section 
4.5.1 General remarks 
All the solvents and reagents were used as received unless otherwise specified. Dry 
dichloromethane was obtained passing the solvent through a alumina column of solvent 
drying system. Dry chloroform and DIEA were obtained by refluxing with CaH2 and the dry 
solvent was collected after distillation before using. 
1
H NMR, 
13
C NMR and 2D NMR were 
recorded on 300 MHz and 400 MHz Bruker Avance 300 and 400 spectrometer. Reactions 
were monitored by thin layer chromatography (TLC) on Merck silica gel 60-F254 plates and 
observed under UV light. Column chromatography purifications were carried out on Merck 
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GEDURAN Si60 (40-63 µm). ESI mass spectra were obtained from the Mass Spectrometry 
Laboratory at the European Institute of Chemistry and Biology (UMS 3033 - IECB), Pessac, 
France. 
 
4.5.2 X-ray crystallography 
The single crystals were obtained by slow diffusion of poor solvents such as acetonitrile, 
hexane or methanol into the stock solution in chloroform. Typically, the crystals were 
obtained in around 1 to 2 weeks and suitable crystals were picked for x-ray diffraction.  
 
4.5.3 Monomer synthesis 
Compound 3 was prepared according to the known procedure
18
 with minor changes. 
Compound 5: To a 100 mL flask charged with 4 (1.56 g, 5 mmol), then 10 mL of AcOH 
and 20 mL of MeOH was added. The mixture was stirred with magnetic stirring bar and was 
equipped with condenser. Iron powder (1.4 g, 25 mmol) was added slowly in portions to 
avoid vigorous generation of gases. After completion of addition of iron powder, the reaction 
was allowed to slowly heat at 65 ℃ for about 40 minutes. The reaction mixture was cooled 
down to room temperature after the complete conversion of the starting material by check 
TLC. The resulting slurry was filtrated through celite and washed thoroughly with 
dichloromethane. The organic layer was then dried over sodium sulfate, filtrated and the 
solvent was removed with rotatory evaporation. The resulting orange solid (1.2 g) was not 
purified and used directly for the next step. 
1
H NMR (300 MHz, CDCl3) δ: 8.40 (s, 1H), 
7.54-7.45 (m,2 H), 6.98 (dd, J = 7.0, 1.7 Hz, 1 H), 5.24 (bs, 2 H), 4.04 (s, 3 H) ppm. 
 
Compound 6: The crude starting material of compound 5 (1.2 g, 4.27 mmol) and Boc2O 
(5.45 g, 25 mmol) were added into a 100 mL flask. Dioxane (15 mL) and DIPEA (5.6 mL) 
were added and the reaction mixture was then heated at 80 ℃ for 5 days under N2 with 
magnetic stirring. After cooling down to room temperature, solvent was evaporated and the 
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resulting sluggish mixture was directly applied on a column. The product was eluted with 
dichloromethane/ethyl acetate (v/v 20/1). Some of the unreacted 5 was recovered from the 
column and recycled for the reaction. Yield 1.4 g (75% over two steps). 
1
H NMR (300 MHz, 
CDCl3) δ: 9.00 (s, 1H), 8.56 (d, J = 8.0 Hz, 1 H), 8.46 (s, 1 H), 7.80 (dd, J = 8.4, 1.3 Hz, 1 H), 
7.71 (t, J =8.0 Hz, 1 H), 4.07 (s, 3 H), 1.59 (s, 9 H) ppm. 
 
Compound 7: To a 50 mL dry flask was added with 6 (1.22 g, 3.21 mmol), 3 (0.85 g, 
4.18 mmol), PdCl2(PPh3)2 (120 mg, 0.16 mmol), CuI (61 mg, 0.32 mmol) and PPh3 (84 mg, 
0.32 mmol). Then the flask was equipped with condenser and was connected with vacuum 
line and exchanged with N2 for three times. A mixture of degassed THF and Et3N (12 mL, v/v 
2/1, THF was from solvent drying system and Et3N was distilled over CaH2 before degassing) 
was added into the flask. The resulting mixture was heated at 75 ℃ for overnight. After 
cooling down to room temperature, the precipitate was filtrated and washed with methanol. 
The solid was dried under vacuum. (yield 1.1 g, 68%). 
1
H NMR (300 MHz, CDCl3) δ: 9.08 (s, 
1H), 8.63 (d, J = 8.4 Hz, 2 H), 8.60 (s, 1 H), 8.32 (d, J = 8.6 Hz, 2 H), 8.16 (d, J = 8.4 Hz, 1 
H), 7.89 (d, J = 8.6, 1 H), 7.86 (d, J = 8.6 Hz, 1 H), 7.81 (t, J =8.2 Hz, 1 H), 7.75 (d, J = 8.4 
Hz, 1 H), 7.72 (d, J = 8.4 Hz, 1 H), 4.14 (s, 3 H), 1.62 (s, 9 H) ppm; 
13
C NMR (75 MHz, 
CDCl3) δ: 165.2, 152.8, 148.6, 148.6, 145.0, 137.7, 137.0, 131.2, 130.6, 130.6, 130.4, 130.4, 
130.2, 128.5, 127.6, 127.5, 126.6, 126.4, 126.3, 125.8, 124.7, 117.8, 115.9, 99.4, 93.7, 81.2, 
53.3, 28.5 ppm.  
 
4.5.4 Oligomer synthesis 
Compound 8: To a 25 mL flask added 7 (200 mg, 0.4 mmol), NaOH (40 mg, 1 mmol), 
then 4 mL THF and 1 mL MeOH was added. The resulting mixture was stirred at room 
temperature for about 2 hours. Then the pH was adjusted to around 3 with 5% citric acid. The 
precipitate was filtrated and washed with water and MeOH. The resulting yellow solid (180 
mg, yield 91%) was not purified further and used directly for next step. 
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General procedure for the coupling: To a dry flask added corresponding acid (1 
equivalent), the flask was sealed with septum and filled with N2. Then 10 mL of dry 
dichloromethane was added through a syringe. Ghosez reagent (1.5 equivalents) was added 
slowly with a syringe. The resulting mixture was stirred at room temperature under N2 for 2 
hours. Solvent was removed under high vacuum and the residue solid was further dried under 
high vacuum for 3 hours. The resulting acid chloride was not purified and no further 
purification process applied and used directly. The amine (1 equivalent) was added into 
another dry flask and filled with N2. Freshly distilled diisopropylehthylamine (2.5 equivalent) 
was added into the flask with amine compound through a syringe. The acid chloride was then 
dissolved with appropriate amount of dry chloroform and added into the amine with a syringe. 
Upon complete transfer of the acid chloride into the amine, the resulting mixture was stirred 
at room temperature overnight. After completion of the reaction, the solvent was removed and 
the product was purified either by precipitation with dichloromethane/methanol mixing 
solvent or silica gel column chromatography or GPC. 
 
Compound 10: The compound was prepared according to the general coupling procedure 
and the product was purified by precipitation form dichloromethane/methanol. (Yield 75%) 
1
H NMR (300 MHz, CDCl3) δ: 12.44 (s, 1 H), 12.41 (s, 1 H), 9.07 (d, J = 7.6 Hz, 1 H), 9.06 
(d, J = 7.6 Hz, 1 H), 8.81 (s, 1 H), 8.73 (d, J = 8.3 Hz, 2 H), 8.40 (s, 1 H), 8.35 (d, J = 8.8 Hz, 
2 H), 8.08 (d, J = 8.8 Hz, 1 H), 8.06 (d, J = 8.4 Hz, 1 H), 7.96-7.89 (m, 3 H), 7.82 (s, 1 H), 
7.81 (d, J = 8.6 Hz, 1 H), 7.78 (d, J = 8.6 Hz, 1 H), 7.74 (t, J = 8.3 Hz, 1 H), 7.68 (t, J = 8.3 
Hz, 1 H), 7.58 (d, J = 8.3 Hz, 1 H), 7.42 (t, J = 8.3 Hz, 1 H), 6.72 (s, 1 H), 4.19 (d, J = 6.6 Hz, 
2 H), 3.82 (d, J = 6.3 Hz, 2 H), 3.61 (s, 3 H), 2.41-2.21 (m, 3 H), 1.38 (s, 9 H), 1.20 (d, J = 6.6 
Hz, 6 H), 1.17 (d, J = 6.9 Hz, 6 H) ppm. 
 
Compound 11: To a dry flask was added with 10 (40 mg, 0.04 mmol), then 3 mL of 
dichloromethane was added to dissolve the solid and then 1 mL of TFA was added and the 
resulting solution was stirred at room temperature for 2 hours. Then the reaction mixture was 
diluted with dichloromethane and then washed three times with NaHCO3 solution. The 
organic layer was dried over sodium sulfate and then filtrated and the solvent was removed. 
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The residue solid was pure enough for subsequent reaction and no further purification. 
1
H 
NMR (300 MHz, CDCl3) δ: 12.39 (s, 1 H), 12.35 (s, 1 H), 9.11 (d, J = 8.0 Hz, 1 H), 8.95 (d, J 
= 7.6 Hz, 1 H), 8.77 (s, 1 H), 8.73 (d, J = 8.6 Hz, 2 H), 8.33 (d, J = 8.9 Hz, 2 H), 8.05 (d, J = 
8.5 Hz, 1 H), 7.98 (d, J = 8.4 Hz, 1 H), 7.91 (d, J = 8.6 Hz, 1 H), 7.88 (d, J = 8.8 Hz, 1 H), 
7.80-7.69 (m, 6 H), 7.23 (t, J = 7.8 Hz, 1 H), 6.85 (s, 1 H), 6.06 (d, J = 7.7 Hz, 1 H), 4.18 (d, J 
= 6.4 Hz, 2 H), 3.86 (d, J = 6.4 Hz, 2 H), 3.57 (s, 1 H), 2.38-2.24 (m, 3 H), 1.19 (d, J = 6.3 Hz, 
6 H), 1.17 (d, J = 6.3 Hz, 6 H). 
 
Compound 1a: The compound was prepared according to the general coupling steps. 
Yield: 240 mg, 76%. 
1
H NMR (300 MHz, CDCl3) δ: 11.98 (s, 1 H), 11.92 (s, 1 H), 11.83 (s, 1 
H), 11.81 (s, 1 H), 8.76 (d, J = 8.4 Hz, 2 H), 8.72 (d, J = 7.8 Hz, 1 H), 8.62 (d, J = 7.8 Hz, 1 
H), 8.39 (d, J = 8.4 Hz, 2 H), 8.34 (d, J = 6.9 Hz, 1 H), 8.18 (d, J = 7.5 Hz, 1 H) , 8.12 (d, J = 
8.6 Hz, 1 H), 8.07 (s, 1 H), 8.05-7.85 (m, 9 H), 7.74 (t, J = 8.5 Hz, 1 H), 7.71 (t, J = 8.5 Hz, 1 
H), 7.53 (t, J = 8.0 Hz, 1 H), 7.45 (s, 1 H), 7.40 (s, 1 H), 7.40 (d, J = 7.6 Hz, 1 H), 7.36 (t, J = 
8.0 Hz, 1 H), 7.24 (t, J = 8.0 Hz, 1 H), 6.87 (s, 1 H), 6.63 (s, 1 H), 4.47-4.40 (m, 2 H), 
4.26-4.17 (m, 2 H), 3.96 (d, J = 6.2 Hz, 2 H), 3.86-3.81 (m, 2 H), 3.29 (s, 3 H), 2.61-2.27 (m, 
4 H), 1.36-1.17 (m, 24 H), 1.13 (s, 9 H) ppm; 
13
C NMR (75 MHz, CDCl3) δ: 164.0, 163.9, 
163.6, 163.3, 162.5, 161.7, 161.2, 161.1, 160.6, 151.6, 150.2, 149.8, 149.1, 148.82, 147.4, 
145.5, 139.3, 138.4, 137.9, 137.0, 136.6, 134.4, 134.3, 133.8, 133.7, 133.5, 130.7, 130.4, 
130.3, 129.4, 127.8, 127.8, 127.7, 127.3, 127.2, 127.1, 126.9, 126.5, 126.2, 122.6, 122.4, 
122.1, 122.0, 121.2, 119.5, 117.4, 117.3, 117.2, 116.6, 116.3, 116.2, 115.6, 114.7, 114.6, 100.5, 
99.7, 99.5, 99.3, 98.1, 93.6, 80.6, 75.7, 75.6, 75.3, 75.2, 52.3, 28.4, 28.4, 28.3, 28.3, 27.9, 19.6, 
19.5, 19.5, 19.5, 19.4 ppm. 
 
Compound 13: The procedure was the same as compound 11, yield quantitative. 
1
H 
NMR (300 MHz, CDCl3) δ: 12.00 (s, 1 H), 11.97 (s, 1 H), 11.83 (s, 1 H), 11.71 (s, 1 H), 8.76 
(d, J = 8.6 Hz, 2 H), 8.64 (d, J = 8.6 Hz, 1 H), 8.61 (d, J = 8.8 Hz, 1 H), 8.39 (d, J = 8.4 Hz, 2 
H), 8.23 (s, 1 H), 8.20 (s, 1 H), 8.12 (d, J = 8.1 Hz, 2 H), 8.06-7,84 (m, 8 H), 7.71 (t, J = 8.1 
Hz, 1 H), 7.70 (t, J = 8.4 Hz, 1 H), 7.62-7.56 (m, 2 H), 7.42 (s, 1 H), 7.35 (s, 1 H), 7.35 (t, J = 
7.5 Hz, 1 H), 7.07 (t , J = 8.1 Hz, 1 H), 6.87 (s, 1 H), 6.67 (s, 1 H), 5.93 (d, J = 7.8 Hz, 1 H), 
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4.46-4.32 (m, 2 H), 4.25-4.11 (m, 2 H), 3.96 (d, J = 6.3 Hz, 2 H), 3.85 (q, J = 2.7 Hz, 2 H), 
3.32 (s, 2 H), 2.58-2.27 (m, 4 H), 1.35-1.18 (m, 24 H) ppm. 
 
Compound 14: To a flask added compound 1a (120 mg, 0.08 mmol) and NaOH (33 mg, 
0.8 mmol), then 1.8 mL of THF and 0.2 mL of MeOH was added. The resulting mixture was 
stirred at room temperature for 2 hours. Upon completion of the reaction, the pH was adjusted 
to 3. The orange precipitate was filtrated and washed 3 times with methanol and 3 times with 
water. Then the solid was died to yield orange solid 100 g (84% yield) 
1
H NMR (300 MHz, 
CDCl3) δ: 12.08 (s, 1 H), 12.01 (s, 1 H), 11.86 (s, 1 H), 11.80 (s, 1 H), 8.75 (d, J = 8.6 Hz, 2 
H), 8.62 (dd, J = 7.8, 1.1 Hz, 1 H), 8.45 (dd, J = 7.8, 1.5 Hz, 1 H), 8.37 (d, J = 8.5 Hz, 2 H), 
8.30 (d, J = 7.6 Hz, 1 H), 8.20 (d, J = 8.3 Hz, 1 H), 8.09 (dd, J = 8.5, 1.3 Hz, 1 H), 8.05 (s, 1 
H), 8.02 (s, 2 H), 8.02 (dd, J = 8.5, 1.3 Hz, 1 H), 7.95 (dd, J = 8.5, 1.3 Hz, 1 H), 7.93 (dd, J = 
8.5, 1.3 Hz, 1 H), 7.87 (dd, J = 8.5, 1.3 Hz, 1 H), 7.84 (dd, J = 8.5, 1.3 Hz, 1 H), 7.82 (dd, J = 
8.5, 1.3 Hz, 1 H), 7.76 (s, 1 H), 7.71-7.53 (m, 4 H), 7.50 (s, 1 H), 7.43-7.24 (m, 5 H), 6.87 (s, 
1 H), 6.72 (s, 1 H), 4.48-4.38 (m, 2 H), 4.26-4.13 (m, 2 H), 3.96 (dd, J = 6.3, 2.6 Hz, 2 H), 
3.80 (d, J = 6.1 Hz, 2 H), 2.45-2.26 (m, 4 H), 1.35-1.14 (m, 24 H), 1.11 (s, 9 H) ppm;  
 
Compound 1b: The compound was prepared according to the general coupling 
procedures with minor changes. The acid 14 was activated with Ghosez reagent for overnight. 
The rest of the procedure was the same. The product was purified with silica gel column 
chromatography (eluent: DCM/EA 100/3). Yield: 40 mg, 55%. 
1
H NMR (300 MHz, CDCl3) δ: 
11.34 (s, 1 H), 11.25 (s, 1 H), 11.18 (s, 1 H), 11.17 (s, 1 H), 10.98 (s, 1 H), 10.85 (s, 1 H), 
10.73 (s, 1 H), 10.56 (s, 1 H), 10.53 (s, 1 H), 8.54 (m, 4 H), 8.29 (d, J = 8.8 Hz, 2 H), 8.26 (d, 
J = 8.5 Hz, 1 H), 8.19-8.05 (m, 8 H), 7.95 (d, J = 8.4 Hz, 2 H), 7.85 (d, J = 8.3 Hz, 1 H), 7.77 
(d, J = 8.3 Hz, 1 H), 7.74-7.65 (m, 8 H), 7.65 (s, 1 H), 7.57-7.28 (m, 18 H), 7.23-7.07 (m, 7 
H), 7.00 (s, 1 H), 6.95 (t, J = 7.9 Hz, 2 H), 6.90 (s, 1 H), 6.84 (s, 1 H), 6.55 (s, 1 H), 6.44 (s, 1 
H), 6.35 (s, 1 H), 6.34 (s, 1 H), 6.27 (s, 1 H), 6.22 (s, 1 H), 4.15-3.77 (m, 14 H), 3.63 (d, J = 
6.2 Hz, 2 H), 3.04 (s, 3 H), 2.55-2.13 (m, 8 H), 1.39-1.03 (m, 48 H), 0.93 (s, 9 H) ppm; 
13
C 
NMR (75 MHz, CDCl3) δ: 163.3, 163.2, 162.9, 162.8, 162.7, 162.4, 162.0, 161.1, 160.6, 
160.5, 160.1, 159.4, 159.2, 159.2, 159.1, 158.0, 151.4, 149.4, 149.1, 148.7, 148.6, 148.5, 
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148.5, 147.1, 146.2, 145.0, 138.7, 137.9, 137.4, 137.4, 137.3, 137.2, 136.4, 136.1, 134.1, 
133.7, 133.5, 133.3, 133.2, 133.1, 132.9, 132.6, 132.4, 132.1, 130.6, 130.3, 130.2, 129.9, 
129.8, 128.8, 128.7, 128.0, 127.6, 127.4, 127.2, 126.9, 126.8, 126.6, 126.6, 126.3, 126.0, 
125.8, 122.5, 122.3, 122.2, 122.0, 121.9, 121.6, 121.5, 121.3, 120.2, 119.5, 117.4, 116.9, 
116.7, 116.2, 116.1, 115.7, 115.2, 114.5, 114.4, 100.2, 99.8, 99.2, 99.0, 98.8, 98.6, 98.4, 97.7, 
93.1, 92.9, 80.2, 75.4, 75.3, 75.0, 74.8, 52.0, 45.9, 28.3, 28.2, 28.1, 28.0, 27.7, 19.7, 19.7, 19.5, 
19.5, 19.4, 19.4, 19.3, 19.3, 19.3, 19.2, 8.7 ppm.  
 
The corresponding amine of 1b: The compound was prepared the same as compound 11, 
the yield was considered to be quantitative by NMR and no further purification was done and 
used directly. 
1
H NMR (300 MHz, CDCl3) δ: 11.34 (s, 1 H), 11.25 (s, 1 H), 11.20 (s, 1 H), 
11.03 (s, 1 H), 11.00 (s, 1 H), 10.88 (s, 1 H), 10.82 (s, 1 H), 10.60 (s, 1 H), 8.58-8.52 (m, 4 H), 
8.29-8.20 (m, 5 H), 8.15-8.03 (m, 7 H), 7.97 (q, J = 3.3 Hz, 2 H), 7.84 (d, J = 8.2 Hz, 2 H), 
7.76-7.26 (m, 22 H), 7.19 (t, J = 8.2 Hz, 1 H), 7.16 (s, 1 H), 7.13 (t, J = 7.6 Hz, 1 H), 7.10 (t, J 
= 7.6 Hz, 1 H), 6.84 (s, 1 H), 6.82 (s, 1 H), 6.79 (t, J = 7.6 Hz, 1 H), 6.56 (s, 1 H), 6.43 (s, 1 
H), 6.36 (s, 1 H), 6.34 (s, 1 H), 6.30 (s, 1 H), 6.24 (s, 1 H), 5.65 (d, J = 7.6 Hz, 1 H), 
4.16-3.78 (m, 14 H), 3.64 (d, J = 6.1 Hz, 2 H), 3.04 (s, 3 H), 2.54-2.13 (m, 8 H), 1.42-1.04 (m, 
48 H) ppm. 
 
Compound 1c: The same procedure as the preparation of compound 1b. The pure 
product was obtained by GPC and silica gel column chromatography. yield 25 mg, 44%. 
1
H 
NMR (300 MHz, CDCl3) δ: 11.15 (s, 1 H), 11.08 (s, 1 H), 10.99 (s, 1 H), 10.95 (s, 1 H), 10.70 
(s, 1 H), 10.50 (s, 1 H), 10.32 (s, 1 H), 10.28 (s, 2 H), 10.22 (s, 1 H), 10.20 (s, 1 H), 10.18 (s, 
1 H), 10.06 (s, 1 H), 10.02 (s, 1 H), 8.45-8.42 (m, 2 H), 8.38 (d, J = 8.3 Hz, 2 H), 8.25 (t, J = 
8.7 Hz, 3 H), 8.15-7.95 (m, 8 H), 7.89 (dd, J = 8.2, 1.3 Hz, 3 H), 7.82-7.59 (m, 12 H), 7.52 (s, 
1 H), 7.48 (d, J = 7.8 Hz, 1 H), 7.46-7.28 (m, 13 H), 7.23-7.04 (m, 14 H), 7.01-6.89 (m, 6 H), 
6.84 (t, J = 8.1 Hz, 1 H), 6.83 (s, 1 H), 6.80 (s, 1 H), 6.77 (s, 1 H), 6.70 (s, 1 H), 6.44 (s, 1 H), 
6.24 (s, 1 H), 6.23 (s, 1 H), 6.13 (s, 1 H), 6.08 (s, 1 H), 6.04 (s, 1 H), 5.93 (s, 1 H), 5.91 (s, 1 
H), 5.88 (s, 1 H), 5.76 (s, 1 H), 4.02-3.53 (m, 24 H), 2.94 (s, 3 H), 2.44-2.04 (m, 12 H), 
1.31-0.96 (m, 72 H), 0.85 (s, 9 H) ppm; 
13
C NMR (75 MHz, CDCl3) δ: 163.2, 163.1, 162.7, 
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162.6, 162.5, 162.4, 162.2, 162.0, 162.0, 160.9, 160.5, 160.4, 160.0, 159.1, 158.9, 158.8, 
158.8, 158.5, 157.7, 151.2, 149.3, 148.9, 148.7, 148.6, 148.4, 148.3, 148.3, 148.2, 148.1, 
148.0, 147.7, 151.3, 149.3, 148.9, 148.7, 148.6, 148.4, 148.3, 148.3, 148.2, 148.1, 148.0, 
147.7, 146.9, 146.0, 145.9, 144.9, 138.6, 137.8, 137.2, 137.1, 136.9, 136.9, 136.8, 136.7, 
136.2, 136.0, 135.8, 133.9, 133.6, 133.3, 133.2, 133.2, 133.1, 133.0, 132.6, 132.4, 132.3, 
132.1, 131.9, 131.6, 130.5, 130.4, 130.2, 130.0, 129.8, 129.7, 129.5, 128.7, 128.5, 127.9, 
127.5, 127.2, 127.1, 127.0, 126.8, 126.7, 126.5, 126.4, 126.1, 125.7, 125.6, 122.3, 122.2, 
122.1, 122.0, 121.9, 121.8, 121.6, 121.5, 121.4, 121.1, 120.2, 117.2, 117.1, 116.8, 116.6, 
116.0, 115.6, 115.1, 114.3, 100.2, 100.1, 99.7, 99.1, 98.7, 98.2, 98.6, 93.0, 92.8, 92.5, 80.1, 
75.4, 75.3, 75.2, 75.0, 52.0, 28.4, 28.2, 28.2, 28.1, 28.0, 28.0, 27.9, 27.7, 19.9, 19.8, 19.7, 19.7, 
19.6, 19.6, 19.5, 19.5, 19.4, 19.4, 19.3, 19.3, 19.3, 19.2 ppm. 
 
Compound 17: To a 25 mL flask was added with compound 7 (200 mg, 0.4 mmol). Then 
6 mL of dichloromethane and 2 mL of TFA was added into the flask. The resulting solution 
was stirred at room temperature for 2 hours. Then the solvent was removed under high 
vacuum and the residue solid was added with 5 mL of toluene to co-evaporation under 
reduced pressure. The solid was dried under high vacuum and used without further 
purification. To a separate flask was added with 8-Bocamide-2-carboxylic acid-quinoline 15 
(214 mg, 0.594 mmol) and 3 mL of dry dichloromethane. Then Ghosez reagent (119 mg, 
0.892 mmol) was added into the flask. The resulting solution was stirred at room temperature 
for 2 hours. Then solvent was removed under high vacuum and the residue solid was dried 
under high vacuum for 3 hours. Then the solid was dissolved into 3 mL of dry chloroform and 
transferred into the flask containing the amine and DIEA (230 mg, 1.78 mmol). The resulting 
mixture was stirred at room temperature under N2 for overnight. Then the solvent was 
removed and minimum amount of chloroform was added to dissolve the residue and methanol 
was added slowly to form a precipitate. The precipitate was filtrated and washed with 
methanol and then dried under vacuum. Yield a yellow solid 120 mg (40% over two steps). 
1
H 
NMR (300 MHz, CDCl3) δ: 12.46 (s, 1 H), 9.07 – 8.98 (m, 1 H), 8.72 (s, 1 H), 8.66 (dd, J = 
8.8, 1.4 Hz, 2 H), 8.50 (dd, J = 7.8, 1.3 Hz, 1 H), 8.32 (dd, J = 8.4, 1.2 Hz, 2 H), 8.00 – 7.82 
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(m, 3 H), 7.81 – 7.70 (m, 2 H), 7.60 (t, J = 8.1 Hz, 1 H), 4.12 (d, J = 7.0 Hz, 2 H), 4.11 (s, 3 
H), 2.33 (m, 1 H), 1.51 (s, 9 H), 1.16 (d, J = 7.1 Hz, 6 H) ppm. 
 
Compound 18: To a 25 mL flask was added with compound 17 (120 mg, 0.16 mmol). 
Then 2 mL of dichloromethane and 1 mL of TFA was added into the flask. The resulting 
solution was stirred at room temperature for 2 hours. Then 10 mL dichloromethane was added 
to dilute the reaction mixture. The solution was then washed with water and NaHCO3 (5%) 
aqueous solution three times. The organic layer was collected and dried over Na2SO4. Then 
the solvent was removed after filtration to give an orange solid. The solid was dried under 
high vacuum and used without further purification. To a separate flask was added with 8 (118 
mg, 0.24 mmol) and 3 mL of dry dichloromethane. Then Ghosez reagent (48 μL, 0.36 mmol) 
was added into the flask. The resulting solution was stirred at room temperature for 2 hours. 
Then solvent was removed under high vacuum and the residue solid was dried under high 
vacuum for 3 hours. Then the solid was dissolved into 3 mL of dry chloroform and transferred 
into the flask containing the amine and DIEA (126 μL, 0.72 mmol). The resulting mixture was 
stirred at room temperature under N2 for overnight. Then the solvent was removed and 
minimum amount of dichloromethane was added to dissolve the residue slurry and methanol 
was added slowly to form a precipitate. The precipitate was filtrated and washed with 
methanol and then dried under vacuum. Yield a yellow solid 120 mg (67% over two steps). 
1
H 
NMR (300 MHz, CDCl3) δ: 12.47 (s, 1 H), 12.45 (s, 1 H), 9.23 (d, J = 7.9 Hz, 1 H), 9.08 (d, J 
= 7.5 Hz, 1 H), 8.83 (s, 1 H), 8.73 (d, J = 8.4 Hz, 2 H), 8.65 (d, J = 8.6 Hz, 2 H), 8.50 (s, 1 H), 
8.34 (d, J = 8.7 Hz, 2 H), 8.27 (dd, J = 8.4, 1.3 Hz, 1 H), 8.11 (ddd, J = 8.5, 4.6, 1.3 Hz, 2 H), 
8.00 – 7.82 (m, 6 H), 7.81 – 7.72 (m, 5 H), 7.65 (d, J = 7.8 Hz, 1 H), 7.54 (t, J = 8.0 Hz, 1 H), 
4.21 (d, J = 6.5 Hz, 2H), 3.70 (s, 3 H), 2.39 (m, 1 H), 1.41 (s, 9 H), 1.22 (d, J = 6.7 Hz, 6 H) 
ppm. 
 
Compound 2a: To a 25 mL flask was added with compound 18 (120 mg, 0.10 mmol). Then 3 
mL of dichloromethane and 1 mL of TFA was added into the flask. The resulting solution was 
stirred at room temperature for 2 hours. Then 10 mL dichloromethane was added to dilute the 
reaction mixture. The solution was then washed with water and NaHCO3 (5%) aqueous 
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solution three times. The organic layer was collected and dried over Na2SO4. Then the solvent 
was removed after filtration to give an orange solid. The solid was dried under high vacuum 
and used without further purification. To a separate flask was added with 12 (92 mg, 0.15 
mmol) and 3 mL of dry dichloromethane. Then Ghosez reagent (31 μL, 0.23 mmol) was 
added into the flask. The resulting solution was stirred at room temperature for 2 hours. Then 
solvent was removed under high vacuum and the residue solid was dried under high vacuum 
for 3 hours. Then the solid was dissolved into 3 mL of dry chloroform and transferred into the 
flask containing the amine and DIEA (80 μL, 0.46 mmol). The resulting mixture was stirred at 
room temperature under N2 for overnight. Then the solvent was removed and minimum 
amount of dichloromethane was added to dissolve the residue slurry and methanol was added 
slowly to form a precipitate. The precipitate was filtrated and washed with methanol and then 
dried under vacuum. Yield a yellow solid 150 mg (87% over two steps). 
1
H NMR (300 MHz, 
CDCl3) δ: 12.08 (s, 1 H), 11.96 (s, 1 H), 11.89 (s, 1 H), 11.85 (s, 1 H), 8.84 – 8.66 (m, 6 H), 
8.44 – 8.33 (m, 5 H), 8.29 (d, J = 7.6 Hz, 1 H), 8.25 (dd, J = 8.4, 1.1 Hz, 1 H), 8.13 (dd, J = 
8.4, 1.3 Hz, 1 H), 8.09 (s, 1 H), 8.04 (d, J = 8.0 Hz, 2 H), 8.00 (d, J = 8.0 Hz, 1 H), 7.98 – 
7.85 (m, 7 H), 7.84 – 7.74 (m, 3 H), 7.69 (s, 1 H), 7.66 (t, J = 8.0 Hz, 1 H), 7.52 (s, 1 H), 7.44 
(s, 1 H), 7.42 – 7.34 (m, 2 H), 7.26 (t, J= 8.2 Hz, 1 H), 6.87 (s, 1 H), 4.51 – 4.40 (m, 2 H), 
4.24 (dt, J = 12.2, 8.2 Hz, 2 H), 3.97 (d, J = 6.4 Hz, 2 H), 3.39 (s, 3 H), 2.66 – 2.48 (m, 2 H), 
2.39 (dt, J = 13.1, 6.5 Hz, 1 H), 1.39 – 1.23 (m, 18 H), 1.12 (s, 9 H) ppm. 
 
Compound 2b: To a 25 mL flask was added with compound 2a (150 mg, 0.09 mmol), NaOH 
(38 mg, 0.94 mmol). Then 2.7 mL of THF and 0.3 mL of MeOH was added into the flask. 
The resulting red solution was stirred at room temperature for 1.5 hours. Then 5% citric acid 
aqueous solution was added into the flask to adjust the pH to around 4 and yellow precipitate 
was formed. The precipitate was filtrated and washed with water. The solid was collected and 
dried under high vacuum. Then the solid was added into a dry flask and 3 mL of dry 
dichloromethane was added to dissolve the solid. Then Ghosez reagent (31 μL, 0.23 mmol) 
was added into the flask. The resulting solution was stirred at room temperature for overnight. 
Then solvent was removed under high vacuum and the residue solid was dried under high 
vacuum for 3 hours. Then the solid was dissolved into 3 mL of dry chloroform and transferred 
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into the flask containing the amine 13 (100 mg, 0.07 mmol) and DIEA (46 μL, 0.26 mmol). 
The resulting mixture was stirred at room temperature under N2 for overnight. Then the 
solvent was removed and minimum amount of dichloromethane was added to dissolve the 
residue slurry and methanol was added slowly to form a precipitate. The precipitate was then 
dissolved in chloroform and purified with GPC and followed by silica gel column 
chromatography to obtain small amount (25 mg, 7% over two steps) of pure 2b as yellow 
solid. 
1
H NMR (300 MHz, CDCl3) δ: 11.37 (s, 1 H), 11.32 (s, 1 H), 11.28 (s, 1 H), 11.20 (s, 1 
H), 11.01 (s, 1 H), 10.78 (s, 1 H), 10.65 (s, 2 H), 10.61 (s, 1 H), 8.86 (d, J = 8.5 Hz, 2 H), 8.55 
(m, 4 H), 8.47 – 8.40 (m, 3 H), 8.27 (d, J = 8.8 Hz, 2 H), 8.24 (d, J = 7.6 Hz, 1 H), 8.20 – 8.13 
(m, 5 H), 8.09 (t, J = 6.4 Hz, 2 H), 8.04 – 7.96 (m, 4 H), 7.94 – 7.82 (m, 4 H), 7.80 – 7.65 (m, 
7 H), 7.64 – 7.40 (m, 9 H), 7.39 – 7.30 (m, 4 H), 7.14 (dt, J = 14.1, 7.3 Hz, 3 H), 6.98 (d, J = 
1.7 Hz, 2 H), 6.94 (d, J = 7.9 Hz, 1 H), 6.89 (s, 1 H), 6.56 (s, 1 H), 6.51 (s, 1 H), 6.43 (s, 1 H), 
6.34 (s, 1 H), 6.16 (s, 1 H), 4.23 – 3.73 (m, 15 H), 3.55 (d, J = 6.6 Hz, 2 H), 3.06 (s, 3 H), 
2.61 – 2.20 (m, 8 H), 2.06 – 1.94 (m, 1 H), 1.43 – 1.06 (m, 30 H), 0.94 – 0.79 (m, 21H) ppm. 
 
Compound 21: The compound was prepared according to the general coupling procedure, 
yield: 300 mg, 75%. 
1
H NMR (300 MHz, CDCl3) δ: 12.42 (s, 1 H), 9.08 (s, 1 H), 8.98 (dd, J = 
7.8, 1.3 Hz, 1 H), 8.85 (s, 1 H), 8.69 (d, J = 8.6 Hz, 2 H), 8.32 (d, J = 8.8 Hz, 2 H), 8.28 (dd, J 
= 8.8, 1.3 Hz, 2 H), 8.03 (dd, J = 8.6, 1.3 Hz, 1 H), 7.90 (dd, J = 8.8, 1.4 Hz, 1 H), 7.87 (d, J = 
8.8 Hz, 1 H), 7.86 (t, J = 8.5 Hz, 1 H), 7.78 (dd, J = 8.6, 1.1 Hz, 1 H), 7.75 (dd, J = 8.3, 1.2 Hz, 
1 H), 7.72 (t, J = 8.2 Hz, 1 H), 7.68 (s, 1 H), 4.11 (d, J = 6.4 Hz, 2 H), 4.06 (s, 3 H), 2.38-2.29 
(m, 1 H), 1.50 (s, 9 H), 1.18 (d, J = 6.8 Hz, 6 H) ppm. 
 
Compound 22: To a flask added 21 (300 mg, 0.4 mmol) and NaOH (160 mg, 4 mmol), 
then 3.6 mL of THF and 0.4 mL of MeOH was added into the flask. The resulting mixture 
was stirred at room temperature for 2 hours. After completion of the reaction as followed by 
TLC, the pH was adjusted to 3 with citric acid (5%). The precipitate was filtrated and then 
precipitated in CHCl3 and methanol to obtain an orange solid after filtration, yield: 180 mg,  
62 %. 
1
H NMR (300 MHz, CDCl3) δ: 11.09 (s, 1 H), 8.82 (d, J = 7.3 Hz, 1 H), 8.46 (br, 1 H), 
8.39 (s, 1 H), 8.34 (d, J = 7.8 Hz, 1 H), 8.29 (d, J = 7.8 Hz, 2 H), 8.12 (d, J = 8.2 Hz, 2 H), 
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8.05 (d, J = 8.2 Hz, 2 H), 7.79 (s, 1 H), 7.68 (t, J = 7.8 Hz, 1 H), 7.67 (t, J = 8.2 Hz, 1 H), 
7.60-7.49 (m, 4 H), 4.18 (d, J = 6.8 Hz, 2 H), 2.42-2.31 (m, 1 H), 1.64 (s, 9 H), 1.21 (d, J = 
6.4 Hz, 6 H) ppm. 
 
Compound 23: The compound was prepared according to the general coupling procedure, 
yield: 55 mg, 46%. 
1
H NMR (300 MHz, CDCl3) δ: 11.85 (s, 1 H), 11.76 (s, 1 H), 11.63 (s, 1 
H), 11.60 (s, 1 H), 11.45 (s, 1 H), 8.84 (d, J = 8.1 Hz, 2 H), 8.76 (d, J = 8.5 Hz, 2 H), 8.70 (d, 
J = 7.8 Hz, 1 H), 8.42-8.34 (m, 5 H), 8.27 (d, J = 8.1 Hz, 1 H), 8.25 (d, J = 8.1 Hz, 1 H), 8.16 
(dd, J = 8.4, 1.3 Hz, 1 H), 8.14 (s, 1 H), 8.12 (d, J = 8.2 Hz, 1 H), 8.08 (dd, J = 7.6, 1.1 Hz, 1 
H), 8.04 (dd, J = 8.3, 1.0 Hz, 1 H), 8.02 (dd, J = 8.3, 1.3 Hz, 1 H), 7.98-7.78 (m, 15 H), 7.73 (t, 
J = 8.2 Hz, 2 H), 7.66 (t, J = 8.1 Hz, 2 H), 7.48 (s, 2 H), 7.46 (t, J = 7.8 Hz, 1 H), 7.46 (t, J = 
8.2 Hz, 1 H), 7.43 (t, J = 8.2 Hz, 1 H), 7.39 (t, J = 8.2 Hz, 1 H), 7.36 (t, J = 7.9 Hz, 1 H), 6.79 
(s, 1 H), 6.55 (s, 1 H), 6.51 (s, 1 H), 4.50-3.67 (m, 8 H), 3.27 (s, 3 H), 2.64-2.30 (m, 4 H), 
1.38-1.01 (m, 24 H) ppm. 
 
The corresponding amine of 23: The compound was prepared according to the same 
procedure as compound 11, the yield was considered to be quantitative and used for next step 
without any further purification. 
1
H NMR (300 MHz, CDCl3) δ: 11.87 (s, 1 H), 11.79 (s, 1 H), 
11.69 (s, 1 H), 11.55 (s, 1 H), 11.47 (s, 1 H), 8.85 (d, J = 7.7 Hz, 2 H), 8.75 (d, J = 8.3 Hz, 2 
H), 8.71 (d, J = 7.7 Hz, 1 H), 8.41 (d, J = 7.8 Hz, 2 H), 8.36 (d, J = 8.8 Hz, 2 H), 8.35 (d, J = 
7.9 Hz, 1 H), 8.29 (d, J = 7.7 Hz, 1 H), 8.23 (d, J = 7.4 Hz, 1 H), 8.15 (d, J = 7.2 Hz, 2 H), 
8.13 (s, 1 H), 8.09 (d, J = 8.5 Hz, 1 H), 8.08 (d, J = 8.5 Hz, 1 H), 8.00-7.70 (m, 14 H), 7.64 (t, 
J = 8.0 Hz, 1 H), 7.45 (t, J = 8.0 Hz, 3 H), 7.44 (s, 1 H), 7.20 (t, J = 8.0 Hz, 1 H), 6.82 (s, 1 H), 
6.64 (s, 1 H), 6.55 (s, 1 H), 5.97 (d, J = 7.4 Hz, 1 H), 4.47 (m, 1 H), 4.27-4.15 (m, 2 H), 
3.95-3.88 (m, 3 H), 3.77-3.67 (m, 2 H), 3.64 (br, 2 H), 3.29 (s, 3 H), 2.62-2.10 (m, 4 H), 
1.38-1.24 (m, 18 H), 1.04 (dd, J = 6.6, 1.6 Hz, 6 H) ppm. 
 
Compound 24: The compound was prepared according to the general coupling 
procedures. The pure compound was obtained by GPC, yield 58 mg, 95%. 
1
H NMR (300 
MHz, CDCl3) δ: 11.56 (s, 1 H), 11.43 (s, 1 H), 11.36 (s, 1 H), 11.31 (s, 1 H), 11.19 (s, 1 H), 
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11.01 (s, 1 H), 10.87 (s, 1 H), 8.77 (d, J = 8.2 Hz, 2 H), 8.59 (d, J = 8.6 Hz, 2 H), 8.55 (d, J = 
7.8 Hz, 2 H), 8.41 (d, J = 8.6 Hz, 2 H), 8.39 (d, J = 7.2 Hz, 1 H), 8.35 (d, J = 8.6 Hz, 1 H), 
8.34 (d, J = 7.8 Hz, 1 H), 8.27 (d, J = 8.9 Hz, 2 H), 8.20 (d, J = 8.5 Hz, 1 H), 8.17 (d, J = 7.8 
Hz, 1 H), 8.15 (d, J = 8.6 Hz, 1 H), 8.12 (d, J = 7.8 Hz, 2 H), 8.08 (d, J = 7.8 Hz, 1 H), 
7.97-7.93 (m, 6 H), 7.86-7.68 (m, 9 H), 7.64-7.30 (m, 17 H), 7.28 (s, 1 H), 7.05 (s, 1 H), 6.68 
(s, 1 H), 6.66 (s, 1 H), 6.59 (s, 1 H), 6.40 (s, 1 H), 4.27-4.16 (m, 3 H), 4.11-3.97 (m, 3 H), 
3.88 (d, J = 6.4 Hz, 2 H), 3.59 (d, J = 5.7 Hz, 2 H), 3.12 (s, 3 H), 2.61-2.31 (m, 5 H), 
1.43-1.37 (m, 12 H), 1.28-1.21 (m, 12 H), 1.02 (s, 9 H), 0.90 (dd, J = 6.4, 2.5 Hz, 6 H) ppm. 
 
The corresponding amine of 24: The compound was prepared as the same procedure of 
compound 11. The yield was considered to be quantitative and used for next step without any 
further purification. 
1
H NMR (300 MHz, CDCl3) δ: 11.58 (s, 1 H), 11.46 (s, 1 H), 11.37 (s, 1 
H), 11.27 (s, 1 H), 11.16 (s, 1 H), 11.09 (s, 1 H), 10.96 (s, 1 H), 8.77 (d, J = 7.9 Hz, 2 H), 8.61 
(d, J = 7.9 Hz, 2 H), 8.56 (dd, J = 7.9, 2.0 Hz, 2 H), 8.42 (d, J = 8.8 Hz, 2 H), 8.36-8.31 (m, 4 
H), 8.27 (d, J = 7.8 Hz, 2 H), 8.20-8.14 (m, 4 H), 8.10 (d, J = 7.9 Hz, 1 H), 8.06 (d, J = 7.6 Hz, 
1 H), 8.01-7.92 (m, 5 H), 7.90 (s, 1 H), 7.86 (d, J = 8.6 Hz, 1 H), 7.84 (d, J = 8.4 Hz, 1 H), 
7.80 (s, 1 H), 7.75-7.46 (m, 16 H), 7.42 (s, 1 H), 7.41-7.29 (m, 5 H), 7.16 (t, J = 7.9 Hz, 1 H), 
7.01 (s, 1 H), 6.69 (s, 1 H), 6.67 (s, 1 H), 6.61 (s, 1 H), 6.41 (s, 1 H), 5.89 (d, J = 7.5 Hz, 1 H), 
4.26-4.17 (m, 3 H), 4.11-3.96 (m, 3 H), 3.89 (d, J = 6.1 Hz, 2 H), 3.60 (d, J = 6.3 Hz, 2 H), 
3.51 (br, 2 H), 3.13 (s, 3 H), 2.63-2.29 (m, 5 H), 1.42-1.37 (m, 12 H), 1.28-1.21 (m, 12 H), 
0.91 (d, J = 6.8 Hz, 6 H) ppm. 
 
Compound 25: The compound was prepared according to the general coupling 
procedures. The compound was purified with GPC. Yield 50 mg, 68%. 
1
H NMR (300 MHz, 
CDCl3) δ: 11.47 (s, 1 H), 11.42 (s, 1 H), 11.33 (s, 1 H), 11.28 (s, 1 H), 11.10 (s, 1 H), 10.85 (s, 
1 H), 10.78 (s, 1 H), 10.76 (s, 1 H), 8.84 (d, J = 7.8 Hz, 2 H), 8.58 (d, J = 7.5 Hz, 2 H), 8.57 (d, 
J = 8.2 Hz, 2 H), 8.43 (d, J = 8.5 Hz, 2 H), 8.40 (dd, J = 7.1, 2.1 Hz, 2 H), 8.30 (d, J = 7.4 Hz, 
1 H), 8.28 (d, J = 8.5 Hz, 2 H), 8.17-8.07 (m, 7 H), 8.01-7.85 (m, 10 H), 7.79 (s, 1 H), 
7.76-7.31 (m, 23 H), 7.17 (d, J = 7.8 Hz, 1 H), 7.11 (t, J = 8.2 Hz, 1 H), 6.99 (t, J = 7.8 Hz, 1 
H), 6.93 (s, 1 H), 6.64 (s, 1 H), 6.58 (s, 1 H), 6.47 (m, 1 H), 6.38 (s, 1 H), 6.04 (s, 1 H), 
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4.24-3.84 (m, 7 H), 3.79 (d, J =6.4 Hz, 2 H), 3.64 (t, J = 8.2 Hz, 1 H), 3.58 (d, J = 5.7 Hz, 2 
H), 3.10 (s, 3 H), 2.62-2.22 (m, 6 H), 1.41 (d, J = 6.7 Hz, 6 H), 1.38 (d, J = 6.4 Hz, 3 H), 1.34 
(d, J = 6.7 Hz, 3 H), 1.28-1.14 (m, 18 H), 0.96 (s, 9 H), 0.90 (dd, J = 6.7, 1.4 Hz, 6 H) ppm. 
 
The corresponding amine of 25: The compound was prepared according to the same 
procedure of compound 11. The yield was considered to be quantitative and used for next step 
without any further purification. 
1
H NMR (300 MHz, CDCl3) δ: 11.49 (s, 1 H), 11.34 (s, 1 H), 
11.30 (s, 2 H), 11.12 (s, 1 H), 10.92 (s, 1 H), 10.82 (s, 2 H), 8.85 (d, J = 8.7 Hz, 2 H), 8.58 (d, 
J = 8.7 Hz, 4 H), 8.42 (d, J = 8.7 Hz, 2 H), 8.39 (d, J = 8.2 Hz, 1 H), 8.37 (d, J = 8.2 Hz, 1 H), 
8.29 (d, J = 9.4 Hz, 2 H), 8.29 (d, J = 7.7 Hz, 1 H), 8.14-8.08 (m, 7 H), 8.02-7.95 (m, 6 H), 
7.92 (s, 1 H), 7.91-7.84 (m, 4 H), 7.80 (s, 1 H), 7.76-7.69 (m, 4 H), 7.67 (d, J = 8.3 Hz, 1 H), 
7.61-7.28 (m, 21 H), 7.12 (t, J = 8.2 Hz, 1 H), 6.91 (s, 1 H), 6.84 (t, J = 7.7 Hz, 1 H), 6.65 (s, 
1 H), 6.59 (s, 1 H), 6.47 (s, 1 H), 6.38 (s, 1 H), 6.17 (s, 1 H), 5.70 (d, J = 7.2 Hz, 1 H), 
4.25-3.58 (m, 12 H), 3.17 (br, 2 H), 3.10 (s, 3 H), 2.61-2.22 (m, 6 H), 1.42-1.12 (m, 30 H), 
0.90 (dd, J = 6.8, 1.4 Hz, 6 H) ppm. 
 
Compound 26: The compound was prepared according to the general coupling procedure. 
The compound was purified with GPC. Yield 35 mg, 66%. 
1
H NMR (300 MHz, CDCl3) δ: 
11.32 (s, 1 H), 11.22 (s, 1 H), 11.14 (s, 1 H), 11.12 (s, 1 H), 10.90 (s, 1 H), 10.75 (s, 1 H), 
10.66 (s, 1 H), 10.58 (s, 1 H), 10.53 (s, 1 H), 10.51 (s, 1 H), 8.65 (d, J =7.5 Hz, 2 H), 8.61 (d, 
J = 8.7 Hz, 2 H), 8.53 (d, J = 8.7 Hz, 2 H), 8.51-8.47 (m, 2 H), 8.38 (d, J = 7.1 Hz, 1 H), 8.32 
(d, J = 8.5 Hz, 2 H), 8.27 (d, J = 8.5 Hz, 2 H), 8.22 (d, J = 7.5 Hz, 1 H), 8.19 (d, J = 7.9 Hz, 2 
H), 8.18 (dd, J = 8.3, 1.3 Hz, 1 H), 8.14-8.10 (m, 4 H), 8.03 (d, J = 7.3 Hz, 2 H), 7.98 (d, J = 
7.7 Hz, 1 H), 7.96 (d, J = 7.7 Hz, 1 H), 7.91 (d, J = 8.2 Hz, 1 H), 7.89 (s, 1 H), 7.86-7.29 (m, 
39 H), 7.24 (s, 1 H), 7.22-7.16 (m, 3 H), 7.15 (s, 1 H), 7.06 (t, J = 8.1 Hz, 1 H), 6.98 (s, 1 H), 
6.51 (s, 1 H), 6.49 (s, 1 H), 6.30 (s, 2 H), 6.12 (s, 1 H), 6.04 (s, 1 H), 4.20-3.75 (m, 14 H), 
3.52 (d, J = 6.7 Hz, 2 H), 3.03 (s, 3 H), 2.59-2.17 (m, 10 H), 1.41-1.13 (m, 36 H), 0.93 (s, 9 
H), 0.84 (d, J = 6.6 Hz, 3 H), 0.83 (d, J = 6.6 Hz, 3 H) ppm. 
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The corresponding amine of 26: The compound was prepared as the same procedure of 
compound 11. The yield was considered to be quantitative and used for the next step without 
any further purification. 
1
H NMR (300 MHz, CDCl3) δ: 11.32 (s, 1 H), 11.23 (s, 1 H), 11.16 (s, 
1 H), 11.01 (s, 1 H), 10.91 (s, 1 H), 10.85 (s, 1 H), 10.69 (s, 1 H), 10.63 (s, 1 H), 10.59 (s, 1 
H), 10.56 (s, 1 H), 8.65 (d, J = 7.4 Hz, 2 H), 8.63 (d, J =7.4 Hz, 2 H), 8.52 (d, J = 8.5 Hz, 2 H), 
8.49 (d, J = 8.9 Hz, 2 H), 8.36 (d, J = 7.8 Hz, 1 H), 8.31 (d, J = 8.9 Hz, 2 H), 8.27 (d, J = 8.7 
Hz, 2 H), 8.24-8.12 (m, 8 H), 8.01 (d, J = 8.1 Hz, 1 H), 8.04 (d, J = 7.4 Hz, 1 H), 7.98 (d, J = 
8.1 Hz, 2 H), 7.92 (d, J = 8.1 Hz, 1 H), 7.89 (s, 1 H), 7.83 (d, J = 8.5 Hz, 4 H), 7.78-7.28 (m, 
36 H), 7.22 (s, 2 H), 7.15 (s, 2 H), 7.15 (t, J = 8.3 Hz, 1 H), 7.07 (t, J = 7.8 Hz, 1 H), 7.03 (t, J 
= 7.8 Hz, 1 H), 6.93 (s, 1 H), 6.51 (s, 1 H), 6.49 (s, 1 H), 6.32 (s, 1 H), 6.30 (s, 1 H), 6.17 (s, 1 
H), 6.14 (s, 1 H), 5.75 (d, J = 8.1 Hz, 1 H), 4.21-3.75 (m, 15 H), 3.63 (t, J = 7.4 Hz, 1 H), 3.52 
(d, J = 6.1 Hz, 2 H), 3.27 (br, 2 H), 3.04 (s, 3 H), 2.57-2.32 (m, 7 H), 1.39-1.13 (m, 42 H), 
0.84 (d, J = 6.5 Hz, 3 H), 0.83 (d, J = 6.8 Hz, 3 H) ppm. 
 
Compound 27: The compound was prepared according to the general coupling procedure. 
The compound was purified with GPC. Yield 30 mg, 66%. 
1
H NMR (300 MHz, CDCl3) δ: 
11.23 (s, 1 H), 11.15 (s, 1 H), 11.00 (s, 2 H), 10.77 (s, 1 H), 10.50 (s, 2 H), 10.46 (s, 2 H), 
10.35 (s, 2 H), 10.33 (s, 1 H), 8.56 – 8.47 (m, 4 H), 8.45 – 8.32 (m, 4 H), 8.32 – 7.95 (m, 12 
H), 7.89 (q, J = 8.8, 8.1 Hz, 2 H), 7.82 – 7.68 (m, 7 H), 7.68 – 7.54 (m, 2 H), 7.54 – 7.39 (m, 
9 H), 7.37 (d, J = 4.0 Hz, 1 H), 7.32 (dd, J = 9.0, 4.3 Hz, 4 H), 7.22 (d, J = 7.0 Hz, 4 H), 7.18 
(s, 1 H), 7.15 (s, 1  H), 7.13 (s, 1H), 7.10 (s, 1 H), 7.08 (s, 1 H), 7.05 (s, 1 H), 7.04 (s, 1 H), 
7.02 (s, 1 H), 6.99 (s, 1 H), 6.92 (s, 1 H), 6.47 (s, 1 H), 6.37 (s, 1 H), 6.26 (s, 1 H), 6.24 (s, 1 
H), 6.13 (s, 1 H), 6.10 (s, 1 H), 5.98 (s, 1 H), 4.14 – 3.19 (m, 10 H), 2.98 (s, 3 H), 2.59 – 2.09 
(m, 8 H), 1.39 – 1.08 (m, 72 H), 0.91 (s, 9 H), 0.79 (d, J = 6.7 Hz, 6 H) ppm. 
 
Compound 2c: The corresponding amine of 27 was obtained by treatment with TFA 
similar as procedure to make compound 11 and was used without any further purification. The 
compound was prepared according to the general coupling procedures by reacting with the 
corresponding amine of 27 with the corresponding acid chloride of 12. The compound was 
purified with GPC. Yield 25 mg, 44%. 
1
H NMR (300 MHz, CDCl3) δ: 11.23 (s, 1 H), 11.52 (s, 
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1 H), 11.00 (s, 2 H), 10.77 (s, 1 H), 10.50 (s, 2 H), 10.46 (s, 2 H), 10.35 (s, 2 H), 10.33 (s, 1 
H), 8.54-8.49 (m, 4 H), 8.42-7.97 (m, 28 H), 7.90 (q, J = 6.8 Hz, 4 H), 7.80-7.30 (m, 42 H), 
7.24-6.99 (m, 15 H), 6.92 (s, 1 H), 6.47 (s, 1 H), 6.36 (s, 1 H), 6.26 (s, 1 H), 6.24 (s, 1 H), 
6.13 (s, 1 H), 6.10 (s, 1 H), 5.98 (s, 1 H), 4.09-3.71 (m, 17 H), 3.48 (d, J = 6.0 Hz, 2 H), 2.98 
(s, 3 H), 2.54-2.17 (m, 12 H), 1.34-1.10 (m, 104 H), 0.91 (s, 9 H), 0.80 (d, J = 6.6 Hz, 3 H), 
0.78 (d, J = 6.6 Hz, 3 H) ppm.  
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V Helix-helix Assembly Directed by Palladium Coordination 
5.1 Introduction 
Metal coordination is a bonding event between a metal center and a ligand. The 
compound formed in this manner is known as metal coordination complex. The metal centers 
usually have empty electron orbitals which are able to accept electrons from the ligands. The 
structure of a metal complex is usually described by coordination number and the geometry. 
Coordination number is the number of atoms/ligands that coordinate to the metal center. The 
geometry of a metal complex is the spatial arrangement of the ligands which is determined 
mostly by the electron configuration of the metal center and affected by the nature of the 
ligands. Linear, trigonal planar, tetrahedral, square planar, trigonal bipyramidal, octahedral are 
examples of commonly founded geometries in metal complexes. 
The metal coordination has been used as a powerful way to form various types of 
self-assembled structures.
1-4
 The metal coordination directed assembly is achieved by proper 
design of ligands and choice of metal centers. The ligands have multiple coordination sites 
which are usually pre-organized in space. Ligands, such as pyridine, bipyridine, terpyridine, 
are covalently linked with spacer that arranges them at the right distances and angles.
5,6
 In 
order to achieve the pre-organization of the ligand groups, rigid spacers are usually used. The 
choice of metal center is largely based on the requirement of geometry. For a given ligand, the 
geometry of the coordination is determined by the metal center which defines the angles 
between the ligands. Palladium (II), for instance, forms square planar coordination geometry 
with most ligands. Hence, palladium (II) can be used as turn by blocking two adjacent 
coordination sites or can be used as a vertex to connect four ligands. For example, the 
self-assembly of pyridine ligands P1 and P3 with cis-palladium can form a [3+2+6] molecular 
cage (fig. 5-1).
7
 This cage was formed by using palladium as a vertex which connected the 
two pyridine ligand at an angle of 90
o
. 
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Figure 5-1: The self-assembly of pyridine ligands P1 and P3 with cis-palladium to afford [3+2+6] cage 
molecule. 
 
Metal binding is a very important strategy to design protein/peptide assemblies also. The 
importance of metal binding can be seen from a lot of essential enzymes: metalloproteins.
8
 
The use of metal as a design element to guide the self-assembly of proteins/peptides has 
leaded to many novel architectures beyond the scope of natural proteins. Metal-three-helix 
bundles were made by taking advantage of the metal binding of three stranded helical 
coiled-coils.
9
 By employing the strategy called “metal-templated interface redesign”, F. 
Tezcan and coworkers have developed de novo designed metalloprotein assemblies.
10-14
 This 
strategy allowed modular design to combine different proteins and structures to form more 
sophisticated architectures. Also, functions such as allosteric structure change were achieved 
using this method.
15,16
 Metal binding was easy to be performed and also orthogonal to many 
intermolecular interactions. Also, metal coordination is dynamic and directional which 
facilitate the design. 
Recently, Sawada and Fujita reported interlocking structures of metal coordination 
directed folding and assembly of peptides.
17
 This study has elegantly demonstrated that metal 
coordination was able to guide the assembly of short peptide to form complicated structures. 
In our group, helical folded aromatic oligoamide foldamers have been well established. The 
formation of helix bundles and assemblies of the aromatic amide foldamers are interesting 
objects which mimic the α-helix bundles of proteins. Metal coordination is a useful method to 
direct the self-assembly of proteins/peptides as mentioned above. It would be interesting to 
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use metal coordination to guide the self-assembly of foldamers to form helix bundles or 
complex structures as found in metalloproteins and de novo designed proteins/peptides. 
Herein, we developed acridine and pyridine functionalized oligo-quinolinecarboxamides and 
successfully prepared helix-helix assembly driven by metal coordination. 
In this chapter, the acridine functionalized oligoamides described in previous chapter are 
used as a ligand to form helix-helix assembly by coordinating with palladium in the first part. 
Since these oligomers are asymmetrical, parallel and antiparallel orientations are possible. In 
the second part, a new design of foldamers which have a C2 symmetric axis at the center is 
discussed. Pyridine units are introduced as ligand group to enable coordination with 
palladium. With this new design, the possibility of parallel and antiparallel orientation is 
eliminated.  
antiparallel parallel antiparallel/parallel
helix with no central symmetry central symmetrical helix
 
 
5.2 Compounds design 
Oligo-quinoline carboxylic amides might be considered as nice spacers in which the 
positions and orientations of functional groups can be easily controlled and well predicted 
based on the 2.5 units per turn helical structures.
18
 The side chains of foldamers can be 
functionalized with various different groups at convenience to fulfil the functions wanted. By 
carefully choosing the side chains to functionalize, the relative distances and angles between 
the functional groups are controlled. The properties and functions of the foldamers can be 
tuned by changing the functional groups of the side chains. The functional groups of the side 
chains as well as their sequences together define the properties of the foldamers controlled by 
the outer surfaces.  
In order to achieve helix-helix assembly mediated by metal coordination, suitable 
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ligands are needed to be introduced on the surface of foldamers at proper positions. Acridine, 
which was introduced in previous chapter, was used in here as a ligand. Another choice of 
ligand is pyridine. Pyridine was extensively used as ligand to form complexes with various 
transition metals. In the last past few decades, many types of complexes, including 
macrocycles, cages and catenenes, have been prepared by using pyridine as ligand.
1,4,6,7,19
 
For a given helix, the handedness of it can be P or M. When two asymmetric helices are 
assembled together, four possible stereoisomers are generated: PP/MM-parallel; PM-parallel; 
PP/MM-antiparallel and PM-antiparallel which results into complex mixtures of 
stereoisomers. In order to reduce this complexity, helices with C2 axis are designed. The 
symmetric compounds not only reduce the number of signals in 
1
H NMR spectroscopy to half 
for the ligand itself but also eliminate the possibility to form parallel/antiparallel oriented 
helix-helix structures. The stereoisomers left possible are the PM and PP/MM isomers. 
Another consideration of the foldamers’ design is the relative orientation of the ligand groups. 
In order to facilitate the formation of helix-helix assemblies, the spatial angle between the 
ligands has to be controlled in order to form closed macrocyclic systems and avoid 
polymerization. For example, angles of 0
o
, 60
o
 or 120
o
 are preferred which are easier to form 
closed ring systems. Based on above considerations, we designed sequences as showed in 
figure 5-2. The pyridine ligand was linked to the quinoline monomer through acetylene 
similar to the acridine unit. Depending on the positions of pyridine, i.e. para or meta to the 
acetylene, that links to quinoline, two monomer, Q
mp
 and Q
pp
, with pyridine side chain were 
prepared. Pyridine diamine (P
n
), pyridine dicarboxylic acid (P
c
) and 
phenantroline-2,9-dicarboxylic acid (Phe) were used as the central units to afford a C2 axis in 
the foldamers. The length of the oligomers was chosen based on the 2.5 units per turn 
structure of the quinoline carboxylic amide oligomers that after every five units the side 
chains are pointing to the same side of the helices. Energy minimized models were built for 
all sequences as presented in Figure 5-3. The sequences L1 and L2 share the same pyridine 
dicarboxylic acid central unit. The pyridine side chains are pointed at the same side of the 
helix where only very small off-set are observed (fig. 5-3 a and d). The sequences L3 and L4 
use the pyridine diamine as central unit. Due to the wider curvature of the central pyridine 
diamine, the pyridine side chains, in this case, are diverging with spatial angle around 120
o
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are observed (Fig. 5-3 b and e). The sequence L5 use phenantroline-2,9-dicarboxylic acid as 
central unit which required one more units to allow the pyridine side chains to be at the same 
side of the oligomer (Fig. 5-3 c and f). Oligomers with acridine units introduced in previous 
chapter are also showed in figure 5-2. These oligomers are used here to form helix-helix 
assembly. S-camphanic amide was introduced at N-terminus of 1b (S-1b) to obtain pure 
P-helix of 1b. The use of camphanic acid at N-terminus to induce complete handedness 
induction of quinoline oligoamides has been reported previously.
20
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Figure 5-2: residues of monomers and sequences of foldamers. 
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Figure 5-3: Energy minimized molecular models of the designed oligomers with pyridine group at the 
side chain as coordination site and pyridine-2,6-dicarboxylic acid (L2, a and d), pyridine-2,6-diamine 
(L4, b and e) and phenotroline-1-10-dicarboxylic acid (L5, c and f) as central units to generate C2 
symmetry of the oligomers. The models were produced with Maestro software package, using MFFS 
force field, chloroform as solvent and PRCG as minimization method. 
 
5.3 Results and discussions 
5.3.1 Compounds synthesis 
The monomers and oligomers were synthesized according to the schemes 5-1 to 5-7. The 
monomer with pyridine side chain was prepared using palladium catalyzed Sonogashira cross 
coupling reaction with good yield. The oligomers were prepared by stepwise coupling 
reaction of acid chloride and amine to afford the amide. For oligomers L1 and L2, the Q
pp
 and 
Q
mp
 monomer were first treated with TFA to remove the boc-protecting group. Two times 
coupling of quinoline carboxylic amide dimer (Q2) acid to this amine afforded intermediate 
oligomers Q4Q
mp
/Q4Q
pp
 which were then coupled with pyridine diacidchloride to give the 
desired foldamers. For oligomers L3 and L4, different strategies were applied. The pyridine 
diamine was first coupled two times with 2 equivalent of quinoline carboxylic amide dimer 
(Q2) acid to give Q4P
n
Q4. This intermediate oligomer was then coupled with Q
mp
 or Q
pp
 acid 
chloride to yield the desired oligomers. The oligomer L5 was prepared according to similar 
V Helix-helix Assembly Directed by Palladium Coordination 
 
- 125 - 
 
strategy as oligomer L1 and L2. The difference is that for the preparation of oligomer L5, 
Q5Q
pp
 was first prepared and then this intermediate was coupled with 
phenantroline-2.9-dicarboxylic acid chloride to obtain L5. All the targeted oligomers were 
characterized with NMR and HRMS to confirm the successful preparation of those oligomers.  
 
Scheme 5-1: Synthetic route for the monomer 5.  
 
Scheme 5-2: Synthetic route for the oligomer 13 (L1).  
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Scheme 5-3: Synthetic route for the oligomer 19 (L3).  
 
Scheme 5-4: Synthetic router for the monomer 28. 
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Scheme 5-5: Synthetic route for the oligomer 30 (L4). 
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Scheme 5-6: Synthetic route for the compound 36 (L2). 
 
 
Scheme 5-7: Synthetic route for the compound 41 (L5). 
 
5.3.2 Self-assembly of acridine functionalized oligomers with palladium 
Acridine has been used as ligand to form complexes with various metal ions. Here, we 
tried to form helix-helix structure by taking advantage of the metal coordination with the 
acridine. We started by testing the formation of complex between the acridine and palladium 
(II). By heating the mixture of 2 equivalents of acridine and 1 equivalent of PdCl2(CH3CN)2 
at 50 
o
C for about 4 hours in chloroform, the 
1
H NMR spectrum showed a clean new set of 
peaks which was different from the starting material (figure 5-4). The new set of peaks was 
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assigned to the 2-to-1 complex of PdCl2(Acr)2. In order to test our assumption that the new 
peaks are the 2-to-1 complex of the acridine and palladium, we mixed the acridine with 
palladium salt of different ratios. When more than 2 equivalents of acridine were added, the 
set of peaks corresponding to the product of complex and the excess of acridine were 
observed. When less than 2 equivalents of acridine was added, the NMR spectra showed two 
sets of news peaks which belonged to the 2-to-1 complex and 1-to-1 complex and the peaks 
corresponding to the acridine are not observed. This observation clearly indicated the 
formation of complex between acridine and palladium.  
 
Figure 5-4: The 
1
H NMR spectra (300 MHz, CDCl3) of acridine (red) and the complex PdCl2(Acr)2 
(blue). 
 
The shifts of signals after formation of complex were made clear by full assignment of 
the acridine and the complex signals using 2D NMR spectra. As showed in figure 5-4, the 
signal of H
1
 proton of the acridine unit shifted from 8.23 ppm to 10.89 ppm, a 2.67 ppm of 
chemical shifts variations which can be explained by the position of those protons are close to 
the coordination sites and thereby face the major surrounding environment differences. Other 
signals also displayed significant chemical shifts variations. The signals of protons 2, 3, and 4 
shifted from 7.81, 7.63 and 8.47 ppm to 8.27, 7.80 and 8.55 ppm respectively.  
After this preliminary study, we started to test metal coordination of the acridine 
functionalized oligomers. A solution of 1a and PdCl2(CH3CN)2 in CDCl3 was heated at 60 
o
C 
for three days to form the expected 2-to-1 complex. The kinetics to form the complex was 
slower compared to the acridine itself which might be due to the size of the foldamer and 
steric hindrance. NMR analysis showed that after complexation, a new peak appeared at 11.11 
ppm in the 
1
H NMR spectrum which is a clear indication of the complex formation. The slow 
reaction kinetics allowed following the process with NMR spectroscopy. After 30 minutes of 
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mixing the oligomer with palladium salt (2 to 1 ratio), a clear distinct doublet appeared at 
10.55 ppm which we attribute to the formation of the intermediate 1-to-1 complex. This 
distinct new peak was assigned to the acridine H
1
 proton at the side chain based on previous 
assignment of the acridine complex with palladium alone. Upon further incubating the 
reaction mixture, the doublet at 11.11 ppm slowly glowed while the doublet at 10.55 ppm 
disappeared concomitantly. This change in the NMR spectra was consistent with a two steps 
formation of the complex. First step is the formation of 1-to-1 complex and the second is the 
formation of 2-to-1 complex. Upon formation of the 2-to-1 complex, the size of the molecule 
is doubled; nevertheless, the amide peaks in 
1
H NMR spectrum were not shifted dramatically 
to upper field which indicated weak helix-to-helix interactions. Other peaks in 
1
H NMR 
spectrum were mostly showing only small chemical shifts variations except for those protons 
from the acridine unit. The complex showed only one set of peaks probably due to the fast 
rotation around the coordinating bond and also fast handedness inversion at the NMR time 
scale. For each helix, the handedness can be either P or M. The P/M helices can exchange 
with each other through inversion of handedness. Upon connecting two helices together, 
PP/MM and PM diastereomers can be formed. The two diastereomers may display different 
NMR spectrum. Similar as the P/M handedness inversion, the PP/MM and PM diastereomers 
also exchange with each other. In the case here, the one set of signals observed maybe the 
average signal of PP/MM and PM due to their fast exchange. The HRMS showed the peaks of 
expected mass of the 2-to-1 complex (m/z 3123.06 was found) which has the isotope 
distribution match with the calculated one. The formation of 2-to-1 complex was also 
confirmed by DOSY NMR spectroscopy (fig. 5-6). As showed in the figure, the diffusion 
coefficient of the complex was bigger than 1a which indicated that the complex has bigger 
size than 1a alone.  
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Figure 5-5: The changes of 
1
H NMR spectra (300 MHz, CDCl3) of 1a after mixing with 1 equivalent of 
PdCl2(CH3CN)2, a) 1a; b) 0.5 hours c) 30 hours and d) 140 hours after mixing 1a and PdCl2(CH3CN)2; 
e) carton representation of PM and PP/MM exchange, red color represent P-helix, blue color represent 
M-helix. 
 
Figure 5-6: DOSY NMR spectra of 1a and the complex between 1a and Pd (II), the red peaks 
corresponding to 1a and the black corresponding to the complex. 
 
The crystal structure of the complex showed the expected 2-to-1 complex (fig. 5-7). Two 
molecules were observed in the unit cell. The two molecules displayed different orientation 
between the two helices connected through the palladium coordination. One has an angle of 
around 180
o
 between the axis of two helices and the other has an angle around 30
o
 (fig. 5-7b 
and 5-7c). The two different relative angles between the two helices in the same crystals were 
merely two snap shots of the numerous orientations between the two helices due to the fast 
rotation around the coordination bond. The handedness of the two helices in the crystals is 
P/M which might result from the preferential crystallization of the P/M over P/P and M/M. 
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The distance between the two helices was around 1.7 nm which was too far to allow any 
interactions between the two helices. The coordination geometry of the palladium metal was 
square planar as expected; however, the two acridine rings were not exactly parallel with each 
other. The triple bonds which connected the acridine and the helices substantially deviated 
from linearity which produced a wave shape of the link between helices. The reason behind 
this distortion might be the packing of crystal and illustrate the flexibility of the linker. 
 
Figure 5-7: The crystal structure of Pd-1a complex, a) view from the side of the helix; b) and c) side 
view of two molecules found in the same unit cell, the line indicate the axis of the helix.  
 
After the success of the formation of a complex with an oligomer with only one acridine 
side chain, oligomers with more acridine side chains were tested. The oligomer 1b which 
bears two acridines on the same side of the helix was expected to form a macrocycle with two 
palladium atoms. The oligomer 1b and palladium salt were mixed in a 1 to 1 ratio in 
chloroform. The complexation was slow also, after overnight reaction, still small amount of 
1b can be found. At this time, the NMR spectrum was complicated. The complicated NMR 
spectrum indicated many species formed at this time (fig. 5-9 showed possible species of 
incomplete complexation). After heating the solution for around 4 days, the peaks 
corresponding to 1b disappeared and new sets of peaks appeared in the NMR spectra. The 
reaction was very slow which was not surprising given the fact that 1a already showed slow 
kinetics to form the complexes with palladium. Four sets of new peaks correspond to the 
expected 2-to-2 complex were observed in the NMR spectrum after complete conversion. 
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This multiple sets of peaks can be rationalized as follows: the handedness of each of the helix 
can be P or M, and the orientation of the helix can be parallel or antiparallel. Due to the 
formation of macrocycle, the rotation of the helices around the coordination bonds were 
restricted which gives two steric isomers: parallel and antiparallel. The handedness inversion 
was slow in longer oligomers which also give two isomers: P and M helices. These two 
reasons caused the four isomers of the 2-to-2 complexes (fig. 5-9 the species of complete 
complexation). The multiple sets of signals of the macrocyclic complex made the analysis of 
the spectra complicated. However, the four peaks of the methyl group from the methylester of 
the terminus of the oligomer were clearly seen as equal ratio which indicated that there is no 
preference of any of the four isomers. Unlike in the case of 1a that distinct new peak was 
observed, in the case of 1b, the macrocyclic complex of 1b and palladium showed 
complicated NMR spectrum due to the existence of isomers and also overlapping of some 
signals. The signal peaks of the complex from the H
1
 proton of the acridine side chain was 
overlapping with amide protons of the oligomers. Despite the complicated NMR, the clear 
changes in the NMR spectra indicated the formation of expected complexes. DOSY NMR 
spectroscopy (fig. 5-10) further confirmed the size of the complex was bigger than 1b since it 
had lower diffusion coefficient as showed in the figure 5-10. The high resolution mass 
spectroscopy showed the expected mass peak (m/z 2990.987, z = 2) corresponding to the 
2-to-2 macrocyclic complex. The experimental isotope distribution also matched with 
calculated one. In order to test our hypothesis that P/M handedness of the helices was one of 
the reasons for the four sets of products observed, we prepared oligomer with 1s-camphanic 
amide functionalized at the N-terminus of the 1b which was known to be completely P-helix 
(S-1b). The complex formed of S-1b with palladium was prepared similarly to the previously 
described procedure and showed only two sets of peaks by NMR. (fig. 5-11) The observation 
of only two sets of complexes formed from single handed helix proved that the assumption of 
P/M steroisomer was correct.  
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Figure 5-8: Parts of 
1
H NMR spectra showing the amide, aromatic and methyl ester regions of a) 1b; b) 
18 hours after mixing 1b with PdCl2(CH3CN)3 and c) complete complexation of 1b with palladium. 
 
 
Figure 5-9: The possible complexes of incomplete complexation and the possible isomers of complete 
complexation of 1b and PdCl2(CH3CN)2, red color represent P-helix and blue color represent M-helix.  
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Figure 5-10: DOSY NMR spectra of 1b and the complex between 1b and Pd (II), the red peaks 
corresponding to 1a and the blue corresponding to the complex. 
 
Figure 5-11: Parts of 
1
H NMR spectra of S-1b and the complex Pd-S-1b showing the amide, aromatic 
and side chain regions, a) S-1b; b) intermediate state of the formation of complex of Pd-S-1b; c) the 
complex Pd-S-1b.  
 
Single crystal of the macrocyclic complex Pd-1b was obtained by slow diffusion of 
acetonitrile into the stock solution in chloroform. The crystal structure is presented in figure 
5-12. In the crystal, the stereoisomer of P/M helices with anti-parallel orientation was found. 
The two helices were connected with two palladium atoms to form a metal coordinated 
macrocycle as expected. The distance between the two helices was around 1.78 nm so that the 
two helices were well separated in space. This long distance is probably the cause for the lack 
of chiral communication between the two helices. The acridine ligands connected with 
palladium were not in the same plan with each other. The angles formed by the two planes of 
the acridines were 30
o
 and 35
o
 respectively. (fig. 5-12c) Small distortions of the acetylene 
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linkages were found in order to form the macrocyclic complexes. Compared to the crystal 
structure of 1b alone, small differences in the structures of the helices and orientation of the 
acridines have been observed by overlaying the crystal structures of 1b and the complex. The 
structural differences can be viewed as induced fit due to complexation. From the side view, 
the two palladium atoms were not aligning parallel with the helices. Instead, a small angle can 
be found between the two palladium atoms and the axis of helices (around 20
o
, fig. 5-12e). 
This misalignment was probable caused by the small offset between the acridine side chains. 
The acridine planes have angle around 40
o
 with respect to the axis of the helix (fig. 5-12d). 
Within the macrocycle, not much space was left by the acridine ligands. From the side view, 
the acridine actually bent towards each other probably to allow more efficient stacking 
effects.  
 
Figure 5-12: Crystal structure of Pd-1b, a) view from the top of helix; b) view from the side of the helix; 
c) and d) view form the side where two helices were overlapped.  
 
The crystal packing of the complex was also interesting. As mentioned earlier, the 
quinoline oligomers formed a 2.5 units per turn helical structure where a C5 screw axis 
existed. Hence the shape of quinoline oligomers can be represented by a five star. However, 
pentagon itself is not possible to fill a plane without leaving gaps. The geometry of quinoline 
oligomers was reflected in the crystal packing that normally they packed loosely to leave as 
less amount of space as possible and no particular pattern presented. The packing of Pd-1b, 
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however, was different that they organized in a way to leave periodic solvent channels. As 
showed in the figure below, from the view of crystal a-axis, parallelogram shaped channels 
were found produced by the packing of the macrocycle. The solvent channels were also seen 
from the c-axis view. The unique packing pattern formed a supramolecular sponge that large 
pores left. The unique packing pattern was probably resulted from few factors. The metal 
coordination macrocycle enforced the two helices to be at anti-parallel orientation which 
created a C2 axis through the two helices. The acridine side chains also affected the packing. 
From the view, the acridine side chains and the helices were separated from each other. The 
packing of macrocycles was AB type that all the helices were aligned.  
 
Figure 5-13: The crystal packing pattern of Pd-1b at different view. 
 
The longer oligomer 1c was also tested for the formation of complexes with palladium. 
As showed in figure 5-14, after complexation with palladium, the 
1
H NMR spectrum became 
very broad and complicated. In the methyl ester region, four major new sets of peaks were 
observed similar with 1b which indicated that four stereoisomers were formed. It was 
speculated that two helices were complexed with palladium to form a [2+3] complex with 
three ladders of acridines. The formation of [2+3] complex was also supported by mass 
spectrum where a peak at m/z 2210.7291 (z = 4) was found. This mass peak matched with 
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two helices complex with three palladium atoms. 
 
Figure 5-14: Parts of 
1
H NMR spectra of 1c and the complex Pd-1c showing the amide, aromatic and 
side chain regions, a) 1c; b) the complex Pd-1c. 
 
The sequence of 2a (Q2QaQQa) was also used to make complex with palladium. As 
showed in the figure below, the formation of complex was slow. After mixing the foldamer 
with palladium salt, new peaks slowly appeared. After 50 minutes, new peaks appeared at 
10.5 ppm and very tiny new peaks appeared at 11.1 ppm and at 3.3 ppm. The new peaks 
appeared at 10.5 ppm were attributed to 1-to-1 complex that formed faster and the peaks at 
11.1 ppm were attributed to macrocycle. The peaks at 10.5 ppm slowly disappeared after 
longer incubation time and only the broad peaks at 11.1 ppm remain. After such time, no 
starting material was left. The changes of NMR spectra signals indicated formation of 
complexes. However, the final product formed was complicated due to multiple stereoisomers 
as showed by the broad signals. Mass spectrometry indicates that a 3-to-3 complex was 
favored. The isotope distribution matched with the calculation. The formation of larger 
macrocycle was possible because of the acridine side chains were on two different faces of 
the helices. The possibility to form larger macrocycle by introducing the acridine side chains 
at two different faces of the helices was very inspiring for the design of more complicated 
metal coordination directed assembly of helices. However, the complexity caused by the 
handedness and steric orientation rendered difficulty of analysis. 
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Figure 5-15: The changes of 
1
H NMR spectra (300 MHz, CDCl3) of 2a after mixing with 1.5 
equivalent of PdCl2(CH3CN)2, the bottom was the spectrum of 2a, and upper ones were after the time 
specified. 
 
5.3.3 Self-assembly of pyridine functionalized oligomers with palladium 
In order to perform preliminary studies, the intermediate oligomer 10 (Q4Q
mp
) which was 
half size of the symmetrical L1 (Q
mp
Q4P
c
Q4Q
mp
) was mixed with PdCl2(CH3CN)2 in 
chloroform. The 
1
H NMR spectrum after mixing with 0.5 equivalent of PdCl2(CH3CN)2 
changed immediately as seen in figure 5-16. The singlet at 9.05 ppm of compound 10 which 
was the signal of H
2
 proton of the pyridine side chain shifted to lower field (9.15 ppm). Also, 
the peaks at 8.70 ppm became separated and shifted to lower field. Other significant changes 
in the aromatic regions can also be observed, however, it’s difficult to follow all the chemical 
shifts variations due to signal overlapping. The methyl ester protons’ signal (3.21 ppm) 
showed slight lower field shift. The amide region, however, almost remained unchanged. The 
overall changes in the 
1
H NMR spectroscopy clearly indicated the complex formation. Only 
one set of signals corresponding to the complex was observed indicated fast exchange 
between different stereoisomers (i.e. PP/MM and PM similar as in the case of 1a). 
 
Figure 5-16: Parts of 
1
H NMR spectra (300 MHz, CDCl3), a) compound 10 and b) the complex 
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(10)2-PdCl2 showing the amide, aromatic and side chain regions. 
 
The complexation of the symmetric foldamers with metal ions such as palladium was 
tested by mixing foldamers with palladium salt. The pyridine functionalized foldamers L1-L5 
were mixed with 1 equivalent of PdCl2(CH3CN)2 in chloroform, the color of the solution 
turned from yellow to light orange after heated at 50 
o
C for around 30 minutes. The NMR 
spectroscopy of the solution after mixing with palladium was checked. As showed in figures 
5-17 to 5-21, clear changes were observed in all cases. Substantial chemical shifts differences 
were observed between the complexes and the foldamers alone. However, due to the 
complexity of the proton resonances of the foldamers, it was difficult to track all the changes. 
Nevertheless, some of the signals were possible to follow. For example, the protons of the 
pyridine side chains are influenced by the palladium upon complexation and hence great 
chemical shifts variations were expected. Indeed, in the cases of L1 and L3, the H
2
 proton of 
the pyridine side chain shifted from to 8.85 ppm and 8.87 ppm to 9.17 ppm and 9.18 ppm 
respectively. In the cases of L2 and L4, since the pyridine side chains were connected in para 
position, these protons appeared as two doublets at 8.72 ppm, 7.47 ppm and 8.69 ppm, 7.51 
ppm. Two proton resonances at lower field of those protons shifted to 8.99 ppm and 9.00 ppm 
in the complexes. The other two resonances were difficult to follow due to overlap with 
aromatic signals. For foldamer L1 and L2, the methyl ester resonances slightly shifted to 
upper field and appeared as two peaks in the complexes. The two peaks of the methyl ester 
resonances in the complexes clearly indicated two stereoisomers of the complexes formed 
which were attributed as PM and PP/MM similar as in the case of 1b. This phenomenon was 
also observed in L3. In the case of L4, the proton NMR spectrum was broad which probably 
indicated less defined objects are formed. In the case of L5, two major stereoisomers are 
formed, but there were some other species formed as indicated by small signals in the NMR 
spectrum. The major signals were attributed to PP/MM and PM similar as L2. This 
observation clearly indicated slow helical inversion of the foldamers which was in agreement 
with the handedness inversion kinetic study performed previously.
21
 The handedness 
inversion of the foldamers is slow due to the length of the oligomer that the rate of 
handedness inversion slowed down with increasing the length of the oligomers. The 
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formation of macrocycle upon complexation might further decrease the rate of handedness 
inversion. Other parts in the NMR spectra of the complexes can also observe similar split into 
two peaks upon complexation. For example, in the amide region, two sets of amide peaks 
were observed in all cases.  
 
Figure 5-17: Parts of 
1
H NMR spectra (300 MHz, CDCl3) of L1 and the complex L1-PdCl2 showing 
the amide, aromatic and methyl ester regions; a) compound L1 and b) the complex L1-PdCl2. 
 
Figure 5-18: Parts of 
1
H NMR spectra (300 MHz, CDCl3) of L3 and the complex L3-PdCl2 showing 
the amide and aromatic regions; a) compound L3 and b) the complex L3-PdCl2 (4 hours after mixing 
L3 and palladium) and c) the complex L3-PdCl2 (1 month after mixing L3 and palladium). 
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Figure 5-19: Parts of 
1
H NMR spectra (300 MHz, CDCl3) of L2 and the complex L2-PdCl2 showing 
the amide, aromatic and methyl ester regions; a) compound L2 and b) the incomplete complexation 
L2-PdCl2 and c) the complex L2-PdCl2. 
 
Figure 5-20: Parts of 
1
H NMR spectra (300 MHz, CDCl3) of L4 and the complex L4-PdCl2 showing 
the amide and aromatic regions; a) compound L4 and b) the incomplete complexation L4-PdCl2 and c) 
the complex L4-PdCl2. 
 
Figure 5-21：Parts of 1H NMR spectra (300 MHz, CDCl3) of L5 and the complex L5-PdCl2 showing 
the amide, aromatic and side chain regions; a) compound L5 and b) the complex L5-PdCl2. 
 
The foldamers used here were racemic and hence the complexes formed should be 
optically non-active. Nevertheless, some chiral selections were observed in the complexes. As 
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calculated from the integrations of one amide resonance that clearly separated from others, 
the ratios of the PM and PP/MM isomers were not exactly 1 to 1 ratio. Diastereomeric excess 
of 20%, 5% and 43% were found for foldamers L1, L2 and L3 respectively. The origin of 
bias between PM and PP/MM was not very clear by now, but we suspected that steric 
hindrance is slightly different between PM and PP/MM isomers that causes the selectivity 
between PM and PP/MM.  
The complexes should contain two foldamer molecules which result in doubling the size 
of the complexes compared with the foldamers alone. The increase in molecular size was 
supported by DOSY spectroscopy which measures the diffusion coefficient of a compound in 
solution. As showed in figure 5-22 to 5-24, in the DOSY spectra, two lines were observed in 
which the line with lower diffusion coefficient corresponding to the complex and the line with 
higher diffusion coefficient corresponding to the foldamer ligand alone. These observations 
clearly indicated that the complexes have larger size than the foldamer alone. All the 
complexes showed lower diffusion coefficient compared to the corresponding foldamer ligand 
as reference. The lower diffusion coefficients of all complexes clearly support the formation 
of complexes with at least of two foldamer ligands. In the case of L4 and L5, the complexes 
formed were less defined and the DOSY spectra were not recorded. 
 
Figure 5-22: DOSY NMR spectra (400 MHz) of the L1 and complex L1-PdCl2 in chloroform at 298 K, 
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the blue line indicated L1 and the red line indicated the complex. 
 
Figure 5-23: DOSY NMR spectra (400 MHz) of the L3 and complex L3-PdCl2 in chloroform at 298 K, 
the blue line indicated L3 and the red line indicated the complex. 
 
Figure 5-24: DOSY NMR spectra (400 MHz) of the L2 and complex L2-PdCl2 in chloroform at 298 K, 
the blue line indicated L2 and the red line indicated the complex. 
 
The formation of complexes was also confirmed by HRMS spectroscopy that the peaks 
corresponding to the complexes were observed. The calculated molecular weights were 
5699.7754 for L1-PdCl2 and L2-PdCl2 and 5928.0068 for L3-PdCl2 and L4-PdCl2 
respectively. The mass peaks observed at 1902.7 (3+), 1902.7 (3+) and 11979.7 (3+) for 
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L1-PdCl2, L2-PdCl2 and L3-PdCl2 respectively. The observed mass peaks matched with the 
[2+2] complex. For the complex L4-PdCl2, the expected molecular mass of [2+2] complex 
was not observed which might indicated that the [2+2] complex might not formed or not 
stable. This observation also matched with the broad peaks observed in the NMR 
spectroscopy. For the observed molecular mass, the isotope distributions of the observed mass 
peaks also matched with the calculated one which again confirmed the formation of expected 
[2+2] complexes. 
While the formation of expected complexes of the foldamers and palladium as we 
designed was successful, the foldamer L3 showed some behaviors that fall out of our design. 
As discussed above, foldamer L3 formed the expected [2+2] complexes with palladium 
similar as other foldamers. However, when we repeated the complexation reaction at higher 
concentration (10 mM solution in chloroform), one set of additional broad signals was 
observed which was not seen at lower concentration (1 mM solution in chloroform). The ratio 
of the broad signals increased as increasing the reaction concentration. The appearance of new 
set of signals at higher concentration indicated other species were formed and they were 
preferred at higher concentration. Hence, higher order of aggregate was suspected to form at 
higher concentration. 
 
Figure 5-25: Part of 
1
H NMR spectra (300 MHz) of L3-PdCl2 at different concentration in CDCl3 after 
reaction, a) 1 mM; b) 4 mM and c) 10 mM. 
 
Luckily, single crystal of the complexes L3-PdCl2 was obtained by slow diffusion of 
acetonitrile into the chloroform solution in about 2 to 3 days. The structure was showed in 
figure 5-26. As displayed in the figure, a 2-to-2 metal macrocycle complex was formed as 
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designed. The two helices stand almost parallel with each other as showed in the front view of 
the structure. Off-set between the two helices was observed which allowed better 
accommodation of all the side chains. The top view showed that the overall shape of the 
complex was pseudo hexagonal which was made possible by the meta-substituted pyridine 
ligand and also the angles between the two pyridine defined by the helix shape of the 
foldamers. The two helices were PM which was one of the stereoisomer expected. The other 
stereoisomer (PP/MM) was not observed in the crystal. 
 
Figure 5-26: Crystal structure of L3-PdCl2 showing the a) top view from the helices; b) front view from 
the helices, all the proton atoms were removed for clarity. 
 
Since in the crystal of L3-PdCl2 only contains PM isomer of 2-to-2 macrocyclic complex, 
the assignment of the different sets of signals in proton NMR spectra was possible. 
Immediately after dissolving the crystal of L3-PdCl2 in chloroform, the recorded proton NMR 
spectrum was compared with the spectrum of complexation reaction. As displayed in figure 
5-27b, the NMR spectrum of the crystal immediately after dissolving showed only one set of 
signals. By comparing with the spectrum of complexation reaction, the minor set of signals in 
the complexation reaction can be assigned as PM helices as found in the crystal structure. The 
major set of signals was then naturally assigned to PP/MM helices. This assignment was also 
supported by the DOSY spectrum which indicated that the two sets of signals corresponding 
to complexes have same diffusion coefficient, i.e. similar size of the compounds. The PP/MM 
stereoisomer was the major one formed after complexation and the ratio of PP/MM to PM 
was around 3 to 1 indicated by the integration in proton NMR spectrum. 
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Figure 5-27: Part of 
1
H NMR spectra (300 MHz, CDCl3) showing the amide and aromatic regions of 
the complex L3-PdCl2 a) the complexation reaction at 1 mM concentration; b) 5 minutes after 
dissolving the single crystals of the complex in chloroform; c) 5 minutes after dissolving the new types 
of crystals and d) the mother liquid of the mixtures that gave the new types of crystals, the spectra was 
recorded after removing solvent and redissolved in chloroform. 
 
Under the same crystallization condition that gave the crystal of L3-PdCl2 presented in 
figure 5-26, another form of crystals appeared after longer period (about one week after the 
set-up). This new form of crystal had more deep color than the previous one and the shape 
was completely different. To our disappointment, this crystal diffracted only at low resolution 
which made the solving structure impossible. Nevertheless, the 
1
H NMR was able to be 
measured immediately after dissolving the crystals. As showed in figure 5-27c of the 
1
H NMR 
spectra, this form of crystal showed new set of peaks that was not seen before in the reaction 
mixture. Three new peaks appeared at 10.15, 10.3, and 9.86 ppm which may correspond to 
amide protons. The three peaks might indicate that this new species may be composed by 
three non-equal foldamers or is a mixture. The new forms of crystals were obtained in 
different batch reactions and they always gave the three peaks with similar ratio which 
favored the assumption of single specie with three non-equal foldamers. By checking DOSY 
NMR, lower diffusion coefficient than the 2-to-2 macrocyclic complex of L3-PdCl2 was 
found for this specie which indicated this specie has larger size than 2-to-2 complex of 
L3-PdCl2. After incubating the solution in chloroform at 60 
o
C, the new specie slowly 
converted to the two 2-to-2 species. The kinetics for the conversion was slow and took around 
13 hours to complete conversion as observed by NMR spectrum. The converting of the new 
specie to the 2-to-2 complex of L3-PdCl2 clearly indicated that the new specie was merely 
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another form of complex of the foldamer L3 and palladium. 
 
Figure 5-28: DOSY NMR spectra (400 MHz) of two types of complexes of L3-PdCl2 in chloroform at 
298 K, the blue line indicated the [2+2] complex found in crystal structure and the red line indicated 
the new type of complex. 
 
In order to understand the equilibrium of the complexes formed by foldamer L3 and 
palladium ion, three tubes of the complexes at same concentration (1 mM) were incubated in 
chloroform/acetonitrile mixing solvent. The ratios of the solvents were different between the 
three tubes. The volume percentages of acetonitrile of the solutions in the three tubes were 
10%, 20% and 50% respectively. After overnight incubation which was presumably 
considered enough to reach equilibrium, the ratios of two species were different. The ratios of 
PM specie increased as the content of acetonitrile increased. Then the solvent were changed 
to pure chloroform and incubated for overnight, the ratios of the two 2-to-2 complexes in 
three tubes changed back to originally observed. If acetonitrile was added again, the ratio of 
PM specie was increased again. We noticed that at higher acetonitrile content, some 
precipitations were observed. The precipitate was found to be PM helices as indicated by 
1
H 
NMR measured immediately after dissolving the solid in chloroform. These experiments 
justified that PM and PP/MM helices interconvert with each other and the equilibrium can be 
controlled by solvents where PP/MM was favored in chloroform while PM was favored by 
acetonitrile. The completely shifting of equilibrium to PM in acetonitrile was probably driven 
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by lower solubility of PM helices in acetonitrile. At higher concentration or after long time of 
crystallization conditions, species of larger sized complexes were formed as discussed above 
which added another equilibrium species into the system. The overall equilibrium can be 
represented as in figure 5-30. The two stereoisomers of 2-to-2 complexes undergo equilibrium. 
The equilibrium state was able to be controlled by solvents. The 2-to-2 complexes were also 
equilibrating with higher order aggregates. Since each helix is either P or M, much more 
complicated stereoisomers are possible in higher order of aggregates than the 2-to-2 
complexes.  
 
Figure 5-29： Parts of 1H NMR spectra of 1 mM solution of L3 and PdCl2(CH3CN)2 (1 to 1 molar ratio) 
after incubation in a) CDCl3/CD3CN (9/1 v/v) for 17 hours; b) CDCl3/CD3CN (7/3 v/v) for 17 hours; c) 
CDCl3/CD3CN (5/5 v/v) for 17 hours and d) CDCl3/CD3CN (9/1 v/v) for 17 hours and then remove all 
solvents and incubated in CDCl3 for 1 day; e) CDCl3/CD3CN (7/3 v/v) for 17 hours and then remove all 
solvents and incubated in CDCl3 for 2 days; f) CDCl3/CD3CN (5/5 v/v) for 17 hours and then remove 
all solvents and incubated in CDCl3 for 3 days. 
PM
PP/MM
CHCl3CH3CN PPP/PMP/MPP/PMM......
solvent dependent concentration dependent  
Figure 5-30: Equilibrium between PM, PP/MM and higher order complexes, the equilibrium between 
the PM and PP/MM was solvent dependent and the equilibrium the PM/PP/MM and higher order 
complexes were concentration dependent. 
 
One of the stereoisomers of the complexes from foldamers L1, L2 and L3 could be 
obtained in a pure form after slow precipitation or crystallization with acetonitrile. The pure 
stereoisomers were incubated in chloroform to follow the kinetics of equilibrium. At room 
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temperature, the kinetics was found to be very slow that no obvious changes were observed in 
the NMR spectra after few hours’ incubation. The kinetics for the sequence L1 and L3 was 
found to be faster at higher temperature (60 
oC). After about 15 hours’ incubating of the 
L1-PdCl2, the ratio stopped changing as observed by NMR spectroscopy which indicated the 
ratio is at the equilibrium. For oligomer L3, it took around 24 hours to reach equilibrium state 
at 60 
o
C. However, for oligomer L2, the kinetics was even slow at higher temperature (60 
o
C) 
and it took few weeks of heating to reach the equilibrium. The kinetic profiles were plotted in 
figure 5-31. The PP/MM and PM interconverting reaction was a first order reaction. Based on 
this model, we were able to extract the kinetics constant of PM and PP/MM isomerization for 
all three compounds. For the complexes formed form oligomers L1, L2 and L3 with 
palladium, the kinetics constants were found to be 0.12 h
-1
, 0.01 h
-1
 and 0.13 h
-1
 respectively. 
For complex L2-PdCl2, the kinetic constant was one order magnitude smaller than the other 
two.  
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Figure 5-31: Kinetics for the equilibrium of PM and PP/MM helices of L1/L2/L3-PdCl2 starting from 
pure single stereoisomers incubated in chloroform at 60 
o
C.  
 
The obvious differences of the kinetics probable can be explained by the mechanism of 
P/M equilibrium in the systems. As showed in figure 5-32 of the proposed mechanism of P/M 
equilibrium, three mechanisms were considered. One possible mechanism does not require 
any dissociation of the coordinating bond and one helix undergo handedness inversion while 
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keeping the metal macrocycle intact (path 3). The other two mechanisms require either partial 
(path 1) or complete (path 2) dissociation of the coordination bonds first, and then helical 
handedness inversion and re-association of the coordination are proceeded to complete the 
P/M interconverting. The differences in the kinetic constants probably rule out path 3 
mechanism where no dissociation happened. This is based on the observation previously of 
the dependence of helical handedness inversion rate on the length of oligomers.
21
 In the cases 
considered here, all the oligomers here are the same length hence similar handedness 
inversion kinetics were expected based on the first mechanism. The other two mechanisms 
which involve breaking and reforming of coordinating bond were difficult to differentiate 
based on current data.  
 
Figure 5-32：Possible mechanism for the handedness inversion of PP/MM and PM helices. 
 
5.4 Conclusions and perspectives 
In conclusion, we have successfully designed and prepared acridine and pyridine 
functionalized oligoamide foldamers at the side chain. In the case of acridine functionalized 
oligomers, four sets of signals were observed after formation of macrocyclic [2+2] complexes 
with palladium. The four sets of signals are assigned to parallel-PP/MM, parallel-PM and 
antiparallel-PP/MM, antiparallel-PM. In the case of pyridine functionalized oligomers, the 
symmetrical unit at the center of those oligomers generates C2 symmetry of these oligomers. 
Upon formation of complexes with palladium (II) ion, macrocyclic [2+2] complexes were 
successfully prepared. Due to the C2 symmetry of the foldamers, the parallel and antiparallel 
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oriented isomers were ruled out and only PP/MM and PM stereoisomers of the complexes 
could be obtained. The PP/MM and PM stereoisomers were in equilibrium in solution. Some 
more complicated equilibrium was observed in the complex formed between L3 where higher 
order complexes were formed. The successful formation of helix-helix structures by metal 
coordination paved a new way to design helical assembly.  
For perspectives, more complicated helix-helix assemblies were encouraged to be made 
based not only the side chain functionalization but also on the main chain of foldamer 
sequences. For example, ligand groups such as pyridine can be introduced on the main chain. 
A possible design is showed in the below figure. Two quinoline oligoamides are attached on a 
Tröger's base which served as turn unit. Nicotinic acid, isonicotiic acid or 2-picolinic acid can 
be attached to enable coordination with suitable metals. This design is possible to make 
square shaped assembly of quinoline oligoamide foldamers. 
N
OR2
NH
O
N
OR2
NH
O 8
N
H
R1O
OR1
H
NN
N
N
R2O
O
N
R2O
HN
O
5
HN
R
R
N
O N
O
N
O
R =
 
Figure 5-33: Chemical structure of ligand attached on the main chain. 
 
5.5 Experiments 
5.5.1 General remarks 
All the solvents and reagents were used as received unless otherwise specified. Dry 
dichloromethane was obtained passing the solvent through a alumina column of solvent 
drying system. Dry chloroform and DIEA were obtained by refluxing with CaH2 and the dry 
solvent was collected after distillation before using. 
1
H NMR, 
13
C NMR and 2D NMR were 
recorded on 300 MHz and 400 MHz Bruker Avance 300 and 400 spectrometer. Reactions 
were monitored by thin layer chromatography (TLC) on Merck silica gel 60-F254 plates and 
observed under UV light. Column chromatography purifications were carried out on Merck 
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GEDURAN Si60 (40-63 µm). ESI mass spectra were obtained from the Mass Spectrometry 
Laboratory at the European Institute of Chemistry and Biology (UMS 3033 - IECB), Pessac, 
France. 
 
5.5.2 X-ray crystallography 
The single crystals were obtained by slow diffusion of poor solvents such as acetonitrile, 
hexane or methanol into the stock solution in chloroform. Typically, the crystals were 
obtained in around 1 to 2 weeks and suitable crystals were picked for X-ray diffraction.  
 
5.5.3 Monomer and oligomers synthesis 
The compound 2 and 3 was prepared according to reported procedures.
22
 
Compound 5: To a 50 mL flask was charged with compound 4 (520 mg, 1.37 mmol), 3 (170 
mg, 1.65 mmol), PdCl2(PPh3)2 (48 mg, 0.068 mmol), PPh3 (36 mg, 0.14 mmol), CuI (13 mg, 
0.068 mmol) and equipped with condenser. The flask was then exchanged with Ar three times. 
The degassed solvent THF/Et3N (v/v 1/1, mL) was added into the flask through a syringe. The 
mixture was then heated at 75 
o
C under inert atmosphere for overnight. After cooling down to 
room temperature, the solvent was removed and residue was purified with silica gel 
chromatogram. The product was eluted with DCM/EA (v/v 10/1). The product was obtained 
as yellow solid after remove solvent and dry under vacuum. Yield: 350 mg, 85%. 
1
H NMR 
(300 Mhz, CDCl3): δ = 9.03 (s, 1 H), 8.91 (d, J = 1.3 Hz, 1 H), 8.66 (dd, J = 5.1, 1.7 Hz, 1 H), 
8.56 (d, J = 7.6 Hz, 1 H), 8.36 (s, 1 H), 7.97-7.93 (m, 2 H), 7.71 (t, J = 8.2 Hz, 1 H), 7.38 (dd, 
J = 7.8, 4.8 Hz, 1 H), 4.09 (s, 3 H), 1.60 (s, 9 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ = 165.3, 
152.8, 152.7, 150.0, 145.0, 139.0, 137.7, 136.9, 130.8, 130.6, 128.7, 124.4, 123.4, 117.9, 
115.8, 96.2, 88.1, 81.2, 53.2, 28.5 ppm. 
 
Compound 6: Compound 5 (100 mg, 0.25 mmol) was dissolved in about 3 mL of dry DCM 
and then about 1 mL of TFA was added in to the solution. The mixture was then stirred at 
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room temperature for about 2 hours. The mixture was then diluted with DCM and washed 
three times with NaHCO3 saturated aqueous solution. The organic layer was combined and 
dried over Na2SO4. The solvent was removed after filtration and dried under high vacuum to 
yield the desired amine. The compound was pure enough as indicated by NMR for the 
subsequent reaction and no further purification required. 
1
H NMR (300 MHz, CDCl3): δ = 
8.90 (d, J = 1.3 Hz, 1 H), 8.65 (dd, J = 4.8, 1.7 Hz, 1 H), 8.31 (s, 1 H), 7.94 (dt, J = 7.8, 1.7 
Hz, 1 H), 7.63 (dd, J = 8.3, 1.3 Hz, 1 H), 7.52 (t, J = 7.6 Hz, 1 H), 7.37 (dd, J = 8.0, 5.0 Hz, 1 
H), 6.99 (dd, J = 7.6, 1.3 Hz, 2 H), 4.05 (s, 3 H) ppm. 
 
Compound 8: To a 25 mL dry flask was added with 7 (164 mg, 0.27 mmol), then the flask 
was exchanged with N2 three times. Dry DCM (3 mL) was added into the flask through a 
syringe to dissolve the solid. Ghosez reagent (55 μL, 0.41 mmol) was added into the solution 
and the mixture was stirred at room temperature for 2 hours. Then the solvent was removed 
under high vacuum and the residue solid was dried for further 3 hours under high vacuum. 
The acid chloride was then dissolved into 2 mL of dry chloroform and transferred into the 
amine 6 (75 mg,0.25 mmol) under N2 atmosphere. Dry DIEA (86 μL, 0.49 mmol) was added 
into the mixture. Then the mixture was stirred under N2 for overnight. Then solvent was 
evaporated and the residue was purified with flash silica gel chromatogram to afford the pure 
product as reddish solid after removing solvent. Yield 160 mg (73 %).
1
H NMR (300 MHz, 
CDCl3): δ = 12.44 (s, 1 H), 12.37 (s, 1 H), 9.13 (d, J = 7.8 Hz, 1 H), 9.00 (dd, J = 7.6, 1.1 Hz, 
1 H), 8.94 (d, J = 1.3 Hz, 1 H), 8.70 (dd, J = 4.9, 1.6 Hz, 1 H), 8.33 (s, 1 H), 8.05 (d, J = 8.4 
Hz, 2 H), 7.99 (dt, J = 7.9, 1.8 Hz, 1 H), 7.82 (t, J = 7.9 Hz, 1 H), 7.80 (s, 1 H), 7.76 (dd, J = 
8.3, 1.2 Hz, 1 H), 7.73 (d, J = 7.9 Hz, 1 H), 7.72 (s, 1 H), 7.48 (s, 1 H), 7.42 (m, 2 H), 7.25 (t, 
J = 8.0 Hz, 1 H), 4.19 (d, J = 6.6 Hz, 2 H), 4.16 (d, J = 6.7 Hz, 1 H), 3.53 (s, 3 H), 2.45-2.29 
(m, 2 H), 1.35 (s, 9 H), 1.22 (d, J = 6.6 Hz, 6 H), 1.20 (d, J = 6.6 Hz, 6 H) ppm; 
13
C NMR (75 
MHz, CDCl3): δ = 164.2, 163.8, 163.4, 163.3, 163.2, 152.7, 151.8, 150.8, 150.4, 149.9, 143.8, 
139.1, 139.0, 138.4, 136.9, 135.6, 134.7, 134.1, 130.5, 130.1, 128.3, 128.2, 127.4, 123.5, 
123.4, 122.6, 121.9, 119.9, 119.4, 117.5, 117.4, 116.4, 115.0, 114.4, 99.2, 98.4, 95.9, 87.9, 
80.7, 75.6, 52.5, 28.4, 28.2, 19.4, 19.4 ppm. 
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Compound 9: This compound was prepared according to the same procedure as compound 6. 
1
H NMR (300 MHz, CDCl3): δ = 12.39 (s, 2 H), 9.05 (dd, J = 7.7, 1.2 Hz, 1 H), 9.02 (dd, J = 
7.7, 1.1 Hz, 1 H), 8.95 (q, J = 0.9 Hz, 1 H), 8.69 (dd, J = 4.9, 1.6 Hz, 1 H), 8.08 (dd, J = 8.4, 
1.2 Hz, 1 H), 8.03 (dd, J = 8.4, 1.2 Hz, 1 H), 7.99 (dt, J = 7.9, 2.0 Hz, 1 H), 7.87 (t, J = 7.8 Hz, 
1 H), 7.78 (s, 1 H), 7.70 (t, J = 7.9 Hz, 1 H), 7.69 (s, 1 H), 7.62 (s, 1 H), 7.45 (dd, J = 8.3, 1.2 
Hz, 1 H), 7.42 (ddd, J = 7.8, 5.0, 1.0 Hz, 1 H), 7.07 (t, J = 7.8 Hz, 1 H), 5.93 (dd, J = 7.5, 1.1 
Hz, 1 H), 4.18 (d, J = 6.5 Hz, 2 H), 4.12 (d, J = 6.5 Hz, 2 H), 3.97 (br, 2 H), 3.50 (s, 3 H), 
2.42-2.29 (m, 2 H), 1.19 (d, J = 6.7 Hz, 12 H) ppm. 
 
Compound 10: This compound was synthesized the same way as compound 8. Yield 242 mg 
(69 %).
1
H NMR (300 MHz, CDCl3): δ = 11.94 (s, 2 H), 11.80 (s, 1 H), 11.76 (s, 1 H), 8.97 (d, 
J = 1.3 Hz, 1 H), 8.71 (dd, J = 4.9, 1.6 Hz, 1 H), 8.69 (dd, J = 7.7, 1.2 Hz, 1 H), 8.65 (dd, J = 
7.7, 1.0 Hz, 1 H), 8.17 (dd, J = 8.6, 1.3 Hz, 2 H), 8.10-7.98 (m, 6 H), 7.89-7.82 (m, 3 H), 7.72 
(t, J = 7.9 Hz, 1 H), 7.45 (d, J = 7.8 Hz, 1 H), 7.45 (s, 1 H), 7.42 (s, 1 H), 7.38 (s, 1 H), 7.35 (d, 
J = 7.9 Hz, 2 H), 7.14 (t, J = 8.0 Hz, 1 H), 6.84 (s, 1 H), 6.76 (s, 1 H), 4.45-4.36 (m, 2 H), 
4.25-4.11 (m, 3 H), 3.95 (d, J = 6.1 Hz, 2 H), 3.86 (m, 1 H), 3.21 (s, 3 H), 2.60-2.33 (m, 4 H), 
1.35-1.23 (m, 24 H), 1.08 (s, 9 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ = 163.9, 163.8, 163.3, 
163.2, 162.9, 161.4, 161.4, 161.2, 152.8, 151.6, 150.4, 149.9, 149.8, 149.4, 148.8, 143.7, 
139.1, 138.5, 138.3, 138.0, 137.8, 136.9, 135.1, 134.2, 133.9, 133.6, 133.0, 130.0, 128.4, 
127.5, 127.1, 126.7, 123.5, 123.5, 122.5, 122.4, 122.1, 121.4, 120.2, 119.5, 117.4, 117.1, 
116.9, 116.3, 116.2, 116.1, 115.7, 114.6, 99.4, 99.3, 98.0, 97.4, 95.8, 88.0, 80.4, 75.7, 75.6, 
75.4, 75.3, 52.2, 45.9, 28.4, 28.4, 28.4, 28.3, 27.9, 19.6, 19.6, 19.6, 19.5, 19.5, 19.4, 8.8 ppm. 
 
Compound 12: This compound was prepared according to the same procedure as compound 6. 
1
H NMR (300 MHz, CDCl3): δ = 11.99 (s, 1 H), 11.95 (s, 1 H), 11.82 (s, 1 H), 11.67 (s, 1 H), 
8.98 (d, J = 1.4 Hz, 1 H), 8.71 (dd, J = 5.0, 1.6 Hz, 1 H), 8.67 (dd, J = 7.8, 1.0 Hz, 1 H), 8.56 
(dd, J = 7.5, 1.0 Hz, 1 H), 8.14 (dd, J = 8.3, 1.0 Hz, 1 H), 8.11-8.00 (m, 4 H), 7.97 (dd, J = 8.4, 
1.2 Hz, 1 H), 7.90 (dd, J = 8.3, 1.2 Hz, 1 H), 7.84 (t, J = 7.9 Hz, 1 H), 7.69 (t, J = 7.9 Hz, 1 H), 
7.54 (dd, J = 8.2, 0.9 Hz, 1 H), 7.47-7.42 (m, 1 H), 7.43 (s, 1 H), 7.42 (t, J = 7.9 Hz, 1 H), 
7.39 (s, 1 H), 7.34 (s, 1 H), 7.32 (t, J = 8.2 Hz, 1 H), 6.98 (t, J = 7.6 Hz, 1 H), 6.88 (s, 1 H), 
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6.83 (s, 1 H), 5.85 (dd, J = 7.4, 0.9 Hz, 1 H), 4.44-3.84 (m, 8 H), 3.57 (br, 2 H), 3.25 (s, 3 H), 
2.59-2.30 (m, 4 H), 1.34-1.22 (m, 24 H) ppm. 
 
Compound 13 (L1): Amine 12 (224 mg, 0.176 mmol) was added into a dry flask and 
exchanged with N2 three times. Dry DIEA (46 μL, 0.264 mmol) was added into the flask with 
a syringe. 2,6-pyridinediacidchloride (17 mg, 0.083 mmol) was dissolved in 2 mL dry 
chloroform and added into the flask. The resulting mixture was stirred under N2 for overnight. 
Then solvent was evaporated and the residue was purified with silica gel chromatography to 
afford the pure product as yellow solid after removing solvent. Yield: 115 mg (48 %).
1
H NMR 
(300 MHz, CDCl3): δ = 11.31 (s, 2 H), 11.21 (s, 2 H), 10.99 (s, 2 H), 10.80 (s, 2 H), 9.87 (s, 2 
H), 8.85 (d, J = 1.4 Hz, 2 H), 8.67 (dd, J = 4.8, 1.6 Hz, 2 H), 8.29 (d, J = 7.9 Hz, 2 H), 8.24 (d, 
J = 7.8 Hz, 2 H), 7.90 (dt, J = 7.8, 1.9 Hz, 2 H), 7.85 (dd, J = 8.4, 1.2 Hz, 2 H), 7.80 (dd, J = 
8.4, 1.0 Hz, 2 H), 7.73 (dd, J = 8.2, 1.2 Hz, 2 H), 7.63 (d, J = 8.1 Hz, 2 H), 7.53 (t, J = 7.8 Hz, 
2 H), 7.53 (d, J = 7.2 Hz, 2 H), 7.45 (t, J = 7.7 Hz, 2 H), 7.39 (dd, J = 7.8, 4.7 Hz, 2 H), 7.23 
(dd, J = 8.2, 1.0 Hz, 2 H), 7.12 (s, 2 H), 7.12 (s, 2 H), 7.10 (d, J = 4.5 Hz, 2 H), 7.08 (t, J = 8.0 
Hz, 2 H), 6.98 (dd, J = 7.6, 1.2 Hz, 2 H), 6.77-6.71 (m, 6 H), 6.44 (t, J =7.8 Hz, 2 H), 6.43 (s, 
2 H), 6.41 (s, 2 H), 4.30-3.61 (m, 16 H), 2.97 (s, 6 H), 2.60-2.15 (m, 8 H), 1.39-1.09 (m, 48 H) 
ppm; 
13
C NMR (75 MHz, CDCl3): δ = 163.0, 162.9, 162.7, 162.7, 160.9, 160.8, 159.9, 159.9, 
159.0, 152.7, 149.8, 149.6, 148.7, 148.6, 148.1, 148.1, 143.2, 139.0, 137.9, 137.8, 137.1, 
136.8, 136.7, 134.5, 133.3, 132.2, 131.9, 131.8, 129.7, 129.5, 128.0, 127.0, 126.4, 126.1, 
123.4, 123.1, 121.9, 121.6. 121.4, 121.2, 119.8, 119.5, 117.1, 116.9, 116.5, 116.3, 116.1, 115.9, 
115.7, 115.4, 113.9, 99.9, 99.1, 97.5, 97.1, 95.4, 87.9, 75.4, 75.2, 75.2, 75.0, 52.0, 28.5, 28.3, 
28.2, 28.2, 19.7, 19.6, 19.5, 19.5, 19.4, 19.3 ppm. 
 
Compound 21: To a dry flask was added with the acid 20 (560 mg, 1.05 mmol), the flask was 
exchanged with N2 three times and then 4 mL of dry CHCl3 was added to dissolve the solid. 
Oxalyl chloride (0.45 mL, 5.25 mmol) was added into the solution with a syringe. The 
resulting mixture was stirred at room temperature under N2 for 2 hours. Then the solvent was 
removed under high vacuum and the residue solid was kept under vacuum for additional 3 
hours. To another dry flask was added with the 2,6-pyridinediamine (55 mg, 0.5 mmol) and 
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the flask was then exchanged with N2 three times. Dry DIEA (262 μL, 1.5 mmol) was added 
into the flask was a syringe. The dry acid chloride of 20 was dissolved into 3 mL of dry 
chloroform and transferred into the flask with amine. The mixture was stirred at room 
temperature under N2 for overnight. Then solvent was removed and the residue solid was 
redissolved into minimum amount of dichloromethane and then methanol was added till large 
amount of precipitate formed. The solid was filtrated and washed three times with methanol 
and then dried under high vacuum to afford yellow solid. Yield: 500 mg (87.8 %).
1
H NMR 
(300 MHz, CDCl3): δ = 11.20 (s, 2 H), 9.55 (s, 2 H), 8.96 (dd, J = 7.5, 1.0 Hz, 2 H), 8.12-8.07 
(m, 6 H), 7.96 (dd, J = 8.7, 7.3 Hz, 1 H), 7.84 (s, 2 H), 7.77 (s, 2 H), 7.70 (t, J = 8.0 Hz, 2 H), 
7.11 (dd, J = 8.3, 1.4 Hz, 2 H), 6.41 (t, J = 8.0 Hz, 2 H), 4.29 (d, J = 5.8 Hz, 4 H), 4.22 (d, J = 
6.5 Hz, 4 H), 2.41 (m, 2 H), 2.18 (m, 2 H), 1.24 (d, J = 6.8 Hz, 12 H), 1.14 (d, J = 6.6 Hz, 12 
H) ppm; 
13
C NMR (75 MHz, CDCl3): δ = 163.9, 163.5, 162.0, 161.4, 152.9, 149.0, 141.1, 
140.9, 139.9, 138.4, 134.0, 128.3, 127.8, 127.7, 123.7, 123.4, 122.2, 118.6, 116.8, 110.1, 99.6, 
98.8, 75.8, 75.7, 28.4, 28.2, 19.6, 19.5 ppm.  
 
Compound 22: To a dry flask was added with compound 21 (500 mg, 0.439 mmol), 
ammonium formate (2.77 g, 43.93 mmol), and ammonium metavanadate (45 mg, 0.386 
mmol). Then ethyl acetate (25 mL), ethanol (6 mL) and water (1.25 mL) were added into the 
flask. Then Pd/C (10%, 100 mg) was added into the flask and start stirring at room 
temperature. Then a condenser of suitable size was equipped and then exchanged with N2 
three times. The mixture was then heated at 75 
o
C for overnight. After cooling down to room 
temperature, an amount of 40 mL of dichloromethane was added to dilute the solution. Then 
the mixture was filtrated through a pack of celite to remove the Pd/C. The solution was then 
washed with 5% ammonium chloride solution two times. The organic layer was combined 
and dried over sodium sulfate. After filtration and remove the solvent, the product was 
obtained as a yellow solid. The product was pure enough for subsequent reaction and no 
further purification needed. Yield: quantitative.
1
H NMR (300 MHz, CDCl3): δ = 10.83 (s, 2 
H), 9.74 (s, 2 H), 9.01 (dd, J = 7.6, 1.0 Hz, 2 H), 8.16 (d, J = 7.9 Hz, 2 H), 8.04 (dd, J = 8.6, 
1.2 Hz, 2 H), 7.98 (t, J = 8.2 Hz, 1 H), 7.74 (s, 2 H), 7.67 (t, J = 8.0 Hz, 2 H), 7.58 (s, 2 H), 
6.31 (dd, J = 6.9, 1.7 Hz, 2 H), 6.19-6.09 (m, 4 H), 4.30 (br, 4 H), 4.20 (d, J = 6.5 Hz, 8 H), 
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2.40 (m, 2 H), 2.17 (m, 2 H), 1.23 (d, J = 6.7 Hz, 12 H), 1.14 (d, J = 6.7 Hz, 12 H) ppm.  
 
Compound 23: This compound was prepared according to the same procedure as compound 
21. Yield: 780 mg (84 %).
1
H NMR (300 MHz, CDCl3): δ = 11.47 (s, 2 H), 11.28 (s, 2 H), 
10.35 (s, 2 H), 8.48 (s, 2 H), 8.43-8.39 (m, 4 H), 8.20 (dd, J = 7.3, 1.3 Hz, 2 H), 8.15 (d, J = 
8.1 Hz, 2 H), 7.94 (d, J = 7.7 Hz, 2 H), 7.89 (d, J = 8.4 Hz, 2 H), 7.79 (m, 1 H), 7.74 (t, J = 8.3 
Hz, 2 H), 7.60 (t, J = 7.7 Hz, 2 H), 7.34 (s, 2 H), 7.22-7.12 (m, 8 H), 6.91 (s, 2 H), 6.38 (s, 2 
H), 6.17 (t, J = 8.2 Hz, 2 H), 6.10 (dd, J = 8.4, 1.5 Hz, 2 H), 4.34-3.96 (m, 14 H), 3.41 (t, J = 
8.4 Hz, 2 H), 2.56-2.39 (m, 6 H), 2.02 (m, 2 H), 1.34-1.23 (m, 36 H), 1.14 (d, J = 6.8 Hz, 6 H), 
1.06 (d, J = 6.6 Hz, 6 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ = 163.3, 163.0, 162.9, 162.5, 
161.1, 161.0, 160.4, 159.7, 153.6, 150.8, 148.5, 147.7, 147.7, 145.1, 139.3, 138.8, 138.2, 
137.9, 137.8, 134.5, 133.4, 133.3, 127.6, 126.5, 126.4, 126.2, 125.5, 124.0, 123.8, 122.1, 
121.9, 121.2, 117.2, 117.0, 116.8, 116.7, 116.2, 114.3, 109.1, 100.3, 99.4, 98.0, 97.1, 75.8, 
75.5, 75.5, 74.6, 28.5, 28.4, 28.4, 28.1, 19.9, 19.6, 19.6, 19.6, 19.5 ppm.  
 
Compound 24: The compound was prepared according to the same procedure of compound 
22. Yield: quantitative.
1
H NMR (300 MHz, CDCl3): δ = 11.69 (s, 2 H), 11.44 (s, 2 H), 10.33 
(s, 2 H), 8.59 (s, 2 H), 8.44 (d, J = 7.4 Hz, 2 H), 8.13-8.08 (m, 4 H), 7.85-7.77 (m, 7 H), 7.63 
(t, J = 8.0 Hz, 2 H), 7.38 (dd, J = 8.3, 1.0 Hz, 2 H), 7.18 (s, 2 H), 7.17 (t, J = 7.9 Hz, 2 H), 
7.08 (s, 2 H), 6.90 (s, 2 H), 6.77 (t, J = 7.6 Hz, 2 H), 6.49 (s, 2 H), 6.20 (d, J = 2.5 Hz, 2 H), 
6.19 (s, 2 H), 5.53 (d, J = 7.4 Hz, 2 H), 4.25-3.96 (m, 14 H), 3.45 (t, J = 8.1 Hz, 2 H), 3.26 (br, 
4 H), 2.50-2.38 (m, 6 H), 2.00-1.94 (m, 2 H), 1.34-1.24 (m, 36 H), 1.13 (d, J = 6.7 Hz, 6 H), 
1.06 (d, J = 6.6 Hz, 6 H) ppm. 
 
Compound 14: To a dry flask was added with compound 5 (80 mg, 0.2 mmol) and NaOH (80 
mg, 2 mmol). Then THF (1.8 mL) and MeOH (0.2 mL) were added into the flask. The 
resulting mixture was stirred at room temperature for 1.5 hours. Then citric acid (5%) was 
added to adjust the pH to around 3. The precipitate was filtrated and washed with distilled 
water twice. The solid was dried under high vacuum. Yield: quantitative.
1
H NMR (300 MHz, 
CDCl3): δ = 8.92 (dd, J = 2.0, 0.9 Hz, 1 H), 8.73 (s, 1 H), 8.68 (dd, J = 4.9, 1.6 Hz, 1 H), 8.59 
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(d, J = 8.1 Hz, 1 H), 8.49 (s, 1 H), 8.02 (dd, J = 8.3, 1.1 Hz, 1 H), 7.97 (dt, J = 7.9, 1.8 Hz, 1 
H), 7.77 (t, J = 8.1 Hz, 1 H), 7.40 (ddd, J = 7.9, 4.9, 1.0 Hz, 1 H), 1.62 (s, 9 H) ppm. 
 
Compound 19 (L3): The compound was prepared according to the same procedure as 
compound 21 except that the acid 14 was activated with Ghosez reagent to corresponding 
acid chloride. Yield: 200 mg (76 %).
1
H NMR (300 MHz, CDCl3): δ = 11.44 (s, 2 H), 11.12 (s, 
2 H), 11.02 (s, 2 H), 10.12 (s, 2 H), 8.87 (dd, J = 2.1, 0.7 Hz, 2 H), 8.64 (dd, J = 4.9, 1.6 Hz, 2 
H), 8.52 (dd, J = 7.6, 1.1 Hz, 2 H), 8.14 (dd, J = 8.2, 1.0 Hz, 2 H), 8.14 (s, 2 H), 7.95 (dt, J = 
7.9, 1.8 Hz, 2 H), 7.89 (dd, J = 7.5, 1.1 Hz, 2 H), 7.85 (dd, J = 8.5, 1.3 Hz, 2 H), 7.78 (dd, J = 
8.4, 1.2 Hz, 2 H), 7.69-7.61 (m, 10 H), 7.54 (dd, J = 6.8, 2.1 Hz, 2 H), 7.40 (t, J = 8.2 Hz, 1 
H), 7.37 (ddd, J = 7.9, 4.9, 0.9 Hz, 2 H), 7.31 (s, 2 H), 7.26-7.06 (m, 9 H), 6.74 (s, 2 H), 6.38 
(s, 2 H), 6.19-6.10 (m, 4 H), 6.04 (s, 2 H), 4.35 (dd, J = 8.9, 6.4 Hz, 2 H), 4.20-4.12 (m, 4 H), 
4.03 (dd, J = 8.8, 6.4 Hz, 2 H), 3.92 (dd, J = 8.7, 6.8 Hz, 2 H), 3.82 (dd, J = 8.9, 6.2 Hz, 2 H), 
3.64 (dd, J =8.7, 7.0 Hz, 2 H), 3.52 (t, J = 8.4 Hz, 2 H), 2.60-2.27 (m, 6 H), 2.12-2.03 (m, 2 
H), 1.38-1.14 (m, 48 H), 0.95 (s, 18 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ = 163.6, 163.0, 
162.8, 162.5, 161.1, 160.5, 159.8, 159.5, 158.9, 152.8, 151.4, 150.3, 149.6, 149.1, 147.9, 
147.8, 147.2, 147.1, 139.3, 139.1, 137.6, 136.6, 137.5, 137.3, 135.5, 134.6, 133.2, 133.0, 
132.9, 132.6, 130.9, 128.6, 128.5, 126.8, 126.7, 126.3, 125.5, 123.3, 122.3, 121.8, 121.8, 
121.4, 121.0, 119.7, 118.2, 117.2, 116.7, 116.4, 116.1, 116.0, 115.7, 115.4, 115.1, 114.7, 108.5, 
99.6, 97.8, 98.8, 97.6, 95.8, 88.8, 80.6, 75.6, 75.4, 75.3, 74.6, 28.5, 28.3, 28.2, 27.7, 20.0, 19.7, 
19.6, 19.6, 19.5, 19.5 ppm. 
 
Compound 26 and 27 were prepared according to reported procedures.
22
  
Compound 28: The compound was prepared according to the same procedure as compound 5. 
Yied: 92%. 
1
H NMR (300 MHz, CDCl3): δ = 9.02 (s, 1 H), 8.71 (dd, J = 4.4, 1.7 Hz, 2 H), 
8.57 (d, J = 7.8 Hz, 1 H), 8.37 (s, 1 H), 7.92 (dd, J = 8.3, 1.5 Hz, 1 H), 7.72 (t, J = 8.1 Hz, 1 
H), 7.52 (dd, J = 4.2, 1.4 Hz, 2 H), 4.09 (s, 3 H), 1.60 (s, 9 H) ppm; 
13
C NMR (75 MHz, 
CDCl3): δ = 165.2, 152.8, 150.2, 145.0, 137.7, 136.9, 131.0, 130.1, 129.7, 125.8, 124.6, 117.8, 
115.8, 96.3, 88.8, 81.2, 53.2, 28.5 ppm. 
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Compound 29: This compound was prepared according to the same procedure as compound 
14. Yield: 230 mg (93%).
1
H NMR (300 MHz, CDCl3): δ = 8.73 (dd, J = 4.5, 1.3 Hz, 2 H), 
8.66 (br, 1 H), 8.61 (d, J = 7.6 Hz, 1 H), 8.50 (s, 1 H), 8.00 (dd, J = 8.3, 1.1 Hz, 1 H), 7.78 (t, J 
= 8.1 Hz, 1 H), 7.54 (dd, J = 4.4, 1.5 Hz, 2 H), 1.62 (s, 9 H) ppm.  
 
Compound 30 (L4): This compound was prepared according to the same procedure as 
compound 19. Yield: 190 mg (74 %).
1
H NMR (300 MHz, CDCl3): δ = 11.43 (s, 2 H), 11.11 (s, 
2 H), 11.02 (s, 2 H), 10.12 (s, 2 H), 8.69 (dd, J = 4.4, 1.6 Hz, 4 H), 8.51 (d, J = 7.6 Hz, 2 H), 
8.14 (d, J = 8.2 Hz, 2 H), 8.14 (s, 2 H), 7.89 (d, J = 7.6 Hz, 2 H), 7.85 (dd, J = 8.4, 1.2 Hz, 2 
H), 7.79 (dd, J = 8.4, 1.0 Hz, 2 H), 7.69-7.60 (m, 9 H), 7.54-7.50 (m, 5 H), 7.41 (t, J = 7.9 Hz, 
1 H), 7.31 (s, 2 H), 7.23-7.05 (m, 9 H), 6.74 (s, 2 H), 6.38 (s, 2 H), 6.19-6.10 (m, 4 H), 6.03 (s, 
2 H), 4.35 (dd, J = 8.6, 6.4 Hz, 2 H), 4.21-4.12 (m, 4 H), 4.03 (m, 2 H), 3.93 (m, 2 H), 3.82 (m, 
2 H), 3.64 (m, 2 H), 3.52 (t, J = 8.3 Hz, 2 H), 2.59-2.27 (m, 6 H), 2.07 (m, 2 H), 1.38-1.14 (m, 
48 H), 0.95 (s, 18 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ = 163.6, 163.0, 162.8, 162.5, 161.1, 
160.5, 159.6, 159.5, 158.9, 151.4, 150.3, 150.2, 150.1, 149.1, 147.9, 147.8, 147.2, 147.1, 
139.1, 137.6, 137.6, 137.5, 137.3, 135.5, 134.7, 133.2, 133.0, 132.9, 132.6, 130.5, 130.4, 
128.7, 128.4, 126.9, 126.7, 126.3, 126.0, 125.5, 122.3, 122.1, 121.8, 121.4, 121.0, 118.1, 
117.2, 116.7, 116.5, 116.0, 115.7, 115.4, 115.1, 114.8, 108.4, 99.6, 97.8, 97.6, 95.9, 89.7, 80.6, 
75.6, 75.4, 75.3, 74.6, 28.5, 28.3, 28.2, 27.7, 20.0, 19.7, 19.6, 19.6, 19.5, 19.5 ppm. 
 
Compound 31: This compound was prepared according to the same procedure as compound 6. 
Yield: quantitative.
1
H NMR (300 MHz, CDCl3): δ = 8.70 (dd, J = 4.3, 1.6 Hz, 2 H), 8.32 (s, 1 
H), 7.60 (dd, J = 8.3, 1.4 Hz, 1 H), 7.54 (d, J = 7.3 Hz, 1 H), 7.51 (dd, J = 4.5, 1.6 Hz, 2 H), 
6.99 (dd, J = 7.4, 1.4 Hz, 1 H), 5.25 (br, 2 H), 4.06 (s, 3 H) ppm. 
 
Compound 32: This compound was prepared according to the same procedure as compound 8. 
Yield: 1.1 g (65 %).
1
H NMR (300 MHz, CDCl3): δ = 12.43 (s, 1 H), 12.36 (s, 1 H), 9.14 (dd, J 
= 7.5, 1.0 Hz, 2 H), 9.00 (dd, J = 7.6, 1.1 Hz, 2 H), 8.75 (dd, J = 4.4, 1.6 Hz, 2 H), 8.32 (s, 1 
H), 8.06 (d, J = 8.5 Hz, 1 H), 8.03 (d, J = 8.6 Hz, 1 H), 7.83 (t, J = 7.9 Hz, 1 H), 7.80 (s, 1 H), 
7.77-7.69 (m, 3 H), 7.55 (dd, J = 4.6, 1.6 Hz, 2 H), 7.49 (s, 1 H), 7.42 (d, J = 6.9 Hz, 1 H), 
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7.24 (t, J = 8.1 Hz, 1 H), 4.19 (d, J= 6.7 Hz, 2 H), 4.16 (d, J = 6.5 Hz, 2 H), 3.53 (s, 3 H), 
2.43-2.32 (m, 2 H), 1.35 (s, 9 H), 1.22 (d, J = 5.7 Hz, 6 H), 1.20 (d, J = 5.7 Hz, 6 H) ppm; 
13
C 
NMR (75 MHz, CDCl3): δ = 164.2, 163.8, 163.4, 163.2, 163.1, 151.8, 150.8, 150.4, 150.3, 
143.8, 139.0, 138.4, 136.9, 135.7, 134.7, 134.1, 130.7, 130.2, 129.6, 128.3, 128.2, 127.4, 
125.8, 123.6, 122.6, 121.9, 119.8, 117.5, 117.4, 116.5, 115.0, 114.4, 99.2, 98.4, 96.0, 88.7, 
80.8, 75.6, 52.6, 28.4, 28.3, 19.4, 19.4 ppm. 
 
Compound 33: This compound was prepared the same way as compound 6. Yield: 
quantitative.
1
H NMR (300 MHz, CDCl3): δ = 12.39 (s, 2 H), 9.05 (dd, J = 7.5, 1.0 Hz, 1 H), 
9.02 (dd, J = 7.8, 1.3 Hz, 1 H), 8.75 (dd, J = 4.4, 1.5 Hz, 2 H), 8.06 (dd, J = 4.8, 1.1 Hz, 1 H), 
8.03 (dd, J = 4.9, 1.3 Hz, 1 H), 7.88 (t, J = 7.8 Hz, 1 H), 7.78 (s, 1 H), 7.71 (t, J = 8.0 Hz, 1 H), 
7.69 (s, 1 H), 7.63 (s, 1 H), 7.56 (dd, J = 4.4, 1.6 Hz, 2 H), 7.45 (dd, J = 8.3, 1.1 Hz, 1 H), 
7.06 (t, J = 7.9 Hz, 1 H), 5.92 (dd, J = 7.5, 1.1 Hz, 1 H), 4.18 (d, J = 6.6 Hz, 2 H), 4.12 (d, J = 
6.6 Hz, 2 H), 3.97 (br, 2 H), 3.50 (s, 3 H), 2.40-2.32 (m, 2 H), 1.19 (d, J = 6.8 Hz, 12 H) ppm. 
 
Compound 34: This compound was prepared according to the same procedure of compound 8. 
Yield: 1.78 g (89 %).
1
H NMR (300 MHz, CDCl3): δ = 11.94 (s, 2 H), 11.80 (s, 1 H), 11.76 (s, 
1 H), 8.77 (dd, J = 4.4, 1.5 Hz, 2 H), 8.70 (d, J = 7.8 Hz, 1 H), 8.65 (d, J = 7.9 Hz, 1 H), 8.14 
(dd, J = 8.4, 1.1 Hz, 1 H), 8.09 (d, J = 8.4 Hz, 1 H), 8.07-7.98 (m, 4 H), 7.88-7.82 (m, 3 H), 
7.72 (t, J = 8.2 Hz, 1 H), 7.58 (dd, J = 4.4, 1.6 Hz, 2 H), 7.44 (s, 1 H), 7.42 (s, 1 H), 7.38 (s, 1 
H), 7.37-7.31 (m, 3 H), 7.14 (t, J = 8.2 Hz, 1 H), 6.84 (s, 1 H), 6.77 (s, 1 H), 4.45-4.36 (m, 2 
H), 4.25-4.14 (m, 3 H), 3.97-3.92 (m, 3 H), 3.89-3.83 (m, 1 H), 3.21 (s, 3 H), 2.58-2.49 (m, 2 
H), 2.41-2.31 (m, 2 H), 1.35-1.23 (m, 24 H), 1.08 (s, 9 H) ppm; 
13
C NMR (75 MHz, CDCl3): 
δ = 164.0, 163.8, 163.3, 163.2, 162.8, 161.5, 161.4, 161.2, 151.6, 150.3, 150.3, 149.8, 149.4, 
148.8, 143.7, 138.4, 138.3, 138.0, 137.8, 136.9, 135.2, 134.2, 133.9, 133.6, 133.0, 130.3, 
130.1, 129.4, 128.4, 127.5, 127.1, 127.0, 126.7, 125.9, 123.8, 122.5, 122.4, 122.1, 121.4, 
120.1, 117.5, 117.2, 116.9, 116.3, 116.2, 116.1, 115.7, 114.6, 99.4, 99.3, 98.0, 97.4, 95.9, 88.8, 
80.4, 75.7, 75.6, 75.4, 75.3, 52.3, 28.4, 28.4, 28.4, 28.3, 28.1, 27.9, 19.6, 19.6, 19.6, 19.5, 19.5, 
19.4 ppm.  
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Compound 35: This compound was prepared according to the same procedure of compound 6. 
Yield: quantitative.
1
H NMR (300 Mhz, CDCl3): δ = 11.99 (s, 1 H), 11.96 (s, 1 H), 11.82 (s, 1 
H), 11.67 (s,1 H), 8.77 (dd, J = 4.4, 1.6 Hz, 2 H), 8.68 (dd, J = 7.7, 1.1 Hz, 1 H), 8.57 (dd, J = 
7.7, 1.2 Hz, 1 H), 8.13-8.09 (m, 3 H), 8.03 (dd, J = 7.6, 1.1 Hz, 1 H), 7.98 (dd, J = 8.3, 1.1 Hz, 
1 H), 7.90 (dd, J = 8.5, 1.1 Hz, 1 H), 7.85 (t, J = 8.1 Hz, 1 H), 7.70 (t, J = 8.2 Hz, 1 H), 7.58 
(dd, J = 4.3, 1.5 Hz, 2 H), 7.54 (dd, J = 8.2, 1.1 Hz, 1 H), 7.44 (s, 1 H), 7.41 (t, J = 8.2 Hz, 1 
H), 7.40 (s, 1 H), 7.34 (s, 1 H), 7.32 (t, J = 7.9 Hz, 1 H), 6.99 (t, J = 7.6 Hz, 1 H), 6.88 (s, 1 H), 
6.84 (s, 1 H), 5.86 (dd, J = 7.4, 1.0 Hz, 1 H), 4.44-4.39 (m, 1 H), 4.34-4.29 (m, 1 H), 
4.24-4.19 (m, 1 H), 4.13-4.08 (m, 1 H), 4.00-3.94 (m, 3 H), 3.90-3.85 (m, 1 H), 3.57 (br, 2 H), 
3.26 (s, 1 H), 2.59-2.32 (m, 4 H), 1.34-1.22 (m, 24 H) ppm. 
 
Compound 36 (L2): This compound was prepared according to the same procedure as 
compound 13. Yield: 120 mg (19 %).
1
H NMR (300 MHz, CDCl3): δ = 11.30 (s, 2 H), 11.20 (s, 
2 H), 11.00 (s, 2 H), 10.79 (s, 2 H), 9.87 (s, 2 H), 8.72 (dd, J = 4.5, 1.4 Hz, 4 H), 8.29 (d, J = 
7.5 Hz, 2 H), 8.25 (d, J = 7.7 Hz, 2 H), 7.83 (dd, J = 8.2, 1.0 Hz, 2 H), 7.80 (dd, J = 8.2, 1.1 
Hz, 2 H), 7.72 (dd, J = 8.1, 1.1 Hz, 2 H), 7.63 (d, J = 8.2 Hz, 3 H), 7.54 (t, J = 7.6 Hz, 4 H), 
7.46 (dd, J = 4.5, 1.5 Hz, 4 H), 7.45 (t, J = 7.8 Hz, 2 H), 7.24 (dd, J = 8.2, 1.0 Hz, 2 H), 
7.13-7.09 (m, 6 H), 7.08 (t, J = 8.2 Hz, 2 H), 6.97 (dd, J = 7.5, 1.1 Hz, 2 H), 6.77-6.71 (m, 6 
H), 6.44 (t, J = 7.7 Hz, 2 H), 6.44 (s, 2 H), 6.41 (s, 2 H), 4.25 (m, 4 H), 4.07 (m, 4 H), 
3.80-3.61 (m, 8 H), 2.97 (s, 6 H), 2.60-2.15 (m, 8 H), 1.37 (t, J = 6.0 Hz, 12 H), 1.30 (t, J = 
6.5 Hz, 12 H), 1.19 (t, J = 7.1 Hz, 12 H), 1.14 (d, J = 6.6 Hz, 6 H), 1.10 (d, J = 6.8 Hz, 6 H) 
ppm; 
13
C NMR (75 MHz, CDCl3): δ = 163.0, 162.9, 162.7, 162.7, 162.6, 160.8, 160.8, 159.9, 
159.9, 159.0, 150.2, 149.6, 148.8, 148.6, 148.1, 148.0, 143.2, 137.9, 137.8, 137.7, 137.1, 
136.8, 136.6, 134.6, 133.3, 132.2, 131.9, 131.7, 130.2, 129.9, 128.9, 127.9, 127.0, 126.3, 
126.1, 125.8, 123.3, 121.9, 121.6, 121.4, 121.2, 119.7, 117.1, 116.9, 116.6, 116.3, 116.2, 115.9, 
115.7, 115.4, 114.0, 99.9, 99.0, 97.5, 97.1, 95.5, 88.7, 75.4, 75.2, 75.2, 75.0, 52.0, 28.5, 28.3, 
28.2, 28.2, 19.7, 19.5, 19.5, 19.4, 19.4, 19.3 ppm. 
 
Compound 38: This compound was prepared according to the same procedure as compound 8. 
Yield: 270 mg (72%).
1
H NMR (300 MHz, CDCl3): δ = 11.83 (s, 1 H), 11.70 (s, 1 H), 11.58 (s, 
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1 H), 11.55 (s, 1 H), 11.34 (s, 1 H), 8.77 (dd, J = 4.3, 1.5 Hz, 2 H), 8.63 (dd, J = 7.7, 1.2 Hz, 1 
H), 8.31 (d, J = 7.8 Hz, 1 H), 8.24 (d, J = 7.7 Hz, 1 H), 8.13 (d, J = 8.6 Hz, 1 H), 8.04 (dd, J = 
8.3, 1.1 Hz, 1H), 8.01-7.92 (m, 4 H), 7.80 (s, 1 H), 7.73-7.58 (m, 4 H), 7.55 (dd, J = 4.5, 1.5 
Hz, 2 H), 7.43 (s, 1 H), 7.38-7.29 (m, 4 H), 7.07 (t, J = 8.0 Hz, 1 H), 6.99 (s, 1 H), 6.86 (s, 1 
H), 6.77 (s, 1 H), 6.43 (s, 1 H), 4.43 (m, 1 H), 4.20 (m, 1 H), 4.12-4.05 (m, 2 H), 4.01-3.83 (m, 
6 H), 3.18 (s, 3 H), 2.60-2.35 (m, 5 H), 1.35-1.22 (m, 24 H), 1.11 (d, J = 6.7 Hz, 6 H), 1.05 (s, 
9 H) ppm; 
13
C NMR (75 MHz, CDCl3): δ = 163.8, 163.3, 163.1, 163.0, 162.8, 161.6, 161.4, 
161.1, 160.8, 159.4, 151.6, 150.4, 150.3, 149.5, 149.3, 148.9, 148.8, 143.5, 138.5, 138.0, 
137.9, 137.7, 136.7, 134.8, 134.1, 133.9, 133.6, 133.4, 132.7, 130.4, 130.1, 129.1, 128.1, 
127.2, 127.0, 126.6, 125.8, 123.6, 122.7, 122.2, 122.2, 122.0, 121.8, 119.7, 117.4, 117.2, 
117.1, 116.7, 116.6, 116.3, 116.2, 116.1, 115.6, 114.7, 114.5, 99.8, 98.8, 98.3, 98.1, 97.8, 95.6, 
88.9, 80.4, 75.7, 75.5, 75.4, 75.4, 75.4, 75.3, 52.2, 28.5, 28.4, 28.4, 28.3, 28.1, 27.8, 19.7, 19.6, 
19.6, 19.6, 19.5, 19.5, 19.4, 19.3 ppm.  
 
Compound 39: This compound was prepared according to the same procedure as compound 6. 
Yield: quantitative.
1
H NMR (300 MHz, CDCl3): δ = 11.86 (s, 1 H), 11.73 (s, 1 H), 11.65 (s, 1 
H), 11.45 (s, 1 H), 11.43 (s, 1 H), 8.76 (dd, J = 4.4, 1.5 Hz, 2 H), 8.64 (dd, J = 7.7, 1.2 Hz, 1 
H), 8.36 (dd, J = 7.8, 1.2 Hz, 1 H), 8.20 (dd, J = 7.6, 1.1 Hz, 1 H), 8.11 (dd, J = 8.3, 1.2 Hz, 1 
H), 8.04-7.98 (m, 4 H), 7.95 (dd, J = 8.4, 1.2 Hz, 1 H), 7.70 (t, J = 7.9 Hz, 1 H), 7.62 (t, J = 
8.0 Hz, 1 H), 7.54 (dd, J = 7.8, 1.2 Hz, 1 H), 7.54 (dd, J = 4.6, 1.5 Hz, 2 H), 7.40 (t, J = 7.9 Hz, 
1 H), 7.38 (s, 1 H), 7.37 (dd, J = 3.1, 2.0 Hz, 1 H), 7.34 (s, 1 H), 7.31 (t, J = 7.8 Hz, 1 H), 6.99 
(s, 1 H), 6.91 (t, J = 8.0 Hz, 1 H), 6.87 (s, 1 H), 6.79 (s, 1 H), 6.56 (s, 1 H), 5.81 (dd, J = 7.4, 
1.1 Hz, 1 H), 4.42 (m, 1 H), 4.20 (m, 1 H), 4.11 (m, 1 H), 4.05-3.98 (m, 3 H), 3.93-3.80 (m, 4 
H), 3.39 (br, 2 H), 3.19 (s, 3 H), 2.59-2.25 (m, 5 H), 1.34-1.22 (m, 24 H), 1.09 (d, J = 6.7 Hz, 
6 H) ppm. 
 
Compound 41 (L5): This compound was prepared according to the same procedure as 
compound 13. Yield: 35 mg (13 %).
1
H NMR (300 MHz, CDCl3): δ = 11.40 (s, 2 H), 11.13 (s, 
2 H), 11.09 (s, 2 H), 10.63 (s, 2 H), 10.39 (s, 2 H), 8.70 (dd, J = 4.6, 1.5 Hz, 4 H), 8.06 (d, J = 
7.6 Hz, 2 H), 8.03 (d, J = 7.6 Hz, 2 H), 7.92 (d, J = 8.4 Hz, 2 H), 7.78 (d, J = 8.4 Hz, 2 H), 
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7.74-7.69 (m, 4 H), 7.52 (d, J = 7.6 Hz, 2 H), 7.45-7.37 (m, 12 H), 7.30 (d, J = 8.1 Hz, 4 H), 
7.20 (dd, J = 7.6, 1.0 Hz, 2 H), 7.15 (s, 2 H), 7.09 (s, 2 H), 7.09 (t, J = 7.4 Hz, 2 H), 7.02-6.94 
(m, 8 H), 6.64 (d, J = 8.1 Hz, 2 H), 6.45 (s, 2 H), 6.31 (s, 2 H), 6.04 (s, 2 H), 6.03 (s, 2 H), 
5.81 (s, 1 H), 4.00-3.90 (m, 4 H), 3.75-3,52 (m, 16 H), 2.86 (s, 6 H), 2.47-2.13 (m, 10 H), 
1.36 (d, J = 6.6 Hz, 6 Hz), 1.29-1.21 (m, 18 H), 1.16-1.08 (m, 36 H) ppm; 
13
C NMR (75 MHz, 
CDCl3): δ = 162.8, 162.6, 162.6, 162.5, 161.5, 161.5, 160.9, 160.6, 159.3, 158.7, 158.7, 158.6, 
150.2, 148.5, 148.3, 148.0, 147.6, 147.4, 147.1, 143.1, 141.3, 137.9, 137.7, 137.2, 137.1, 
136.7, 136.2, 135.5, 134.4, 133.2, 132.7, 132.6, 132.1, 131.9, 130.3, 129.9, 128.7, 127.9, 
127.6, 126.6, 126.1, 126.0, 125.9, 125.7, 123.3, 121.9, 121.6, 121.2, 120.7, 120.7, 119.4, 
119.0, 117.1, 117.0, 117.0, 116.7, 116.5, 116.4, 115.9, 115.7, 115.2, 115.0, 98.4, 97.8, 97.6, 
96.9, 95.3, 88.8, 75.2, 75.1, 52.0, 28.3, 28.3, 28.2, 27.9, 20.0, 19.7, 19.6, 19.6, 19.5, 19.4, 19.3 
ppm. 
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